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1 Abstract 
 
Part I 
East Indian Dragon’s blood – a resin from Daemonorops draco blume – has played and continues 
to play an enormous role in Traditional Chinese Medicine (TCM). This resin, highly priced in 
ancient times, is used against a variety of physical discomforts, in particular, to improve tissue 
generation, stimulate blood circulation and to alleviate pain. As a source of interesting and unique 
flavonoid natural products, renewed interest in finding biological active natural products has led to 
the recent isolation and characterization of the complex flavonoid trimers dragonbloodin A1 and 
A2. These remarkable natural products, with an unprecedented spiro hexadienone core represent 
the first representatives of a new class of trimeric flavonoids featuring the [3.3.1] bicyclic ketal 
moiety of A-type proanthocyanidins. Its densely functionalized and unique structure in combination 
with its unknown biogenetic origin render it a highly challenging and attractive synthetic target for 
biomimetic synthesis approaches. Starting from phloroglucinic acid the building blocks 
dracorhodin perchlorate and flavan II were synthesized in a divergent route via the shared 
intermediate I. Trimerization under buffered conditions in a biphasic system revealed the flav-2-en 
containing intermediates III as intermediates towards the dragonbloodins. Exceptional sensitivity 
against aerial oxidation led to the investigation of the exact autoxidation products and finally 
revealed an unprecedented cascade reaction forging the complex skeleton of dragonbloodin A1 & 
A2 accompanied by endoperoxide formation towards the diastereomers IV. Reduction or hydrolysis 
of these peroxo semiketals gave access to a mixture of both natural products in a racemic fashion.  
 
Scheme 1-1: Biomimetic total synthesis of dragonbloodin A1 and A2.   
Abstract VII 
 
Part II 
The second part of this thesis describes the investigations on the total synthesis of salimabromide, 
a novel secondary metabolite from the marine myxobacterium strain enhygromyxa salina SWB007. 
While more than 100 natural products from terrestrial myxobacteria are known, only seven classes 
have been isolated from the marine counterpart. Salimabromide represents one of these classes and 
was only reported in 2013 from the König group. Bearing a fascinating and unprecedented carbon 
framework featuring two contiguous quaternary carbon centers and two aromatic bound bromide 
substituents, especially the difficulties in isolation and the resulting lack of material for biological 
studies render it an attractive and challenging target for total synthesis. Starting with inexpensive 
meta-anisaldehyde we were able to quickly access tetraline VI bearing both quarternary carbon 
centers by an unprecedented Wagner–Meerwein rearrangement/ Friedel–Crafts alkylation sequence 
of epoxide V. By subsequent well-orchestrated and high-yielding transformations, the ethyl side 
chain was introduced and all carbons of the framework assembled. A keteniminium mediated [2+2] 
cycloaddition affords tetracyclic cyclobutanone VIII in impressive regioselectivity and yield. A 
variety of late-stage oxidations including a regioselective directed Baeyer–Villiger oxidation finish 
the first successful total synthesis of salimabromide. By employing robust and scalable 
methodologies the route gives access to quantities of salimabromide in the three-digit milligram 
range and allows easy late-stage modifications for structure–activity relationship studies.  
 
 
Scheme 1-2: Total synthesis of salimabromide. 
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from East Indian Dragon's Blood 
 
 
 
Introduction  1 
 
1 Introduction 
 
1.1 Flavonoids in nature 
 
Flavonoids undoubtedly play a central role in the family of natural products of plant origin. These 
molecules and their derivatives have served for a long time as colorful tools to investigate a variety 
of important plant problems, such as the regulation of gene expression. The Augustan monk Gregor 
Johann Mendel already used indirectly the flavonoid pathways in his experiments to investigate the 
segregation of visible traits in his hereditary studies on peas in the second half of the 19th century.1 
At the beginning of the 20th century, Bateson, Saunders and Punnett renewed the focus on these 
colorful studies that led to the hypothesis of genetic factors.2 In respect to the chemical structures 
of flavonoids Morot was the first to reveal the pure organic nature of these molecules already in 
1849.3 65 years later, Willstätter and colleagues revealed that the pigments of a large number of 
plant species all originated from the three anthocyanidins pelargonidin (I.1), cyanidin (I.2) and 
delphinidin (I.3) (Figure 1-1).4  It was also Willstätter who described the chemical relationship to 
the flavonols, quercetin, myricetin, kaempferol and the presence of sugar and methoxy groups on 
these molecules. Bearing sugar moieties on the 3-OH group, these molecules are referred to 
anthocyanins, not to be confused with their aglycons. Together with his research on chlorophylls, 
these groundbreaking results were awarded with the Nobel Prize for Chemistry in 1915.  
 
Figure 1-1: Structures of anthocyanidins characterized by Willstätter and corresponding flowers. 
                                                   
1 G. Mendel, Verh naturforschenden Vereines Brunn, 1865, 3–47. 
2 W. Bateson, E. R. Saunders, R. C. Punnett, Proc. R. Soc. Lond. B Biol. Sci., 1906, 77, 236–238. 
3 F. S. Morot, Ann. Sci. Nat. (Bot., Paris), 1849, 160-235. 
4 R. Willstätter, A. E. Everest, Justus Liebigs Ann. Chem., 1913, 401, 189–232, R. Willstätter, Ber. Dtsch. 
Chem. Ges., 1914, 47, 2831–2874, R. Willstätter, E. K. Bolton, Justus Liebigs Ann. Chem., 1915, 408, 42–
61, R. Willstätter, F. J. Weil, Justus Liebigs Ann. Chem., 1917, 412, 178–194. 
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1.2 Flavonoid subclasses 
 
Flavonoids represent the largest class of polyphenols in nature with the characteristic 
diphenylpropane (C6–C3–C6) structure in which a three-carbon chain connects two aromatic phenyl 
subunits (see Figure 1-2). This propane chain builds up a chromane through an ether bond towards 
a phenolic oxygen atom of the A–ring system. The B–ring is connected via a carbon-carbon bond 
at the C-2 position of the pyran (C–ring). The flavonoids can be divided into several subclasses, the 
seven largest of which represent the flavones (e.g. luteolin (I.4)), flavonols (e.g. kaempferol (I.5)), 
flavanones (e.g. naringenin (I.6)), flavanonols (e.g. taxifolin (I.7)), anthocyanidins (e.g. cyanidin 
(I.2) and luteolidin (I.8)), flavans (e.g. catechin (I.9)) and the constitutional isomeric isoflavones 
(e.g. genistein (I.10)). Their fully aromatic C–ring and the carbonyl group on C-4 characterize 
flavones and flavonols. As mostly yellow and sparely in water soluble compounds, they were 
already early used as dyes. Luteolin (I.4) is perhaps even the oldest European dye and is still used 
for dyeing leather.5 Flavanones and Flavanonoles are dihydrogenated forms of both. The saturation 
of the double bond between C-2 and C-3 introduces a chirality center on the pyran ring at the C-2 
position and in the case of flavanonols even a second one adjacent to the first. Due to the benzylic 
character of the C-2 position, some natural flavanones and flavanonols like naringenin (I.6) tend to 
racemize at pH values lower than 9.6 The already mentioned anthocyanidins are the most colorful 
group of flavonoids and important natural pigments. Their intense color is based on the 
chromophoric benzopyrilium core. Molecules like the shown luteolidin (I.8) belong to the subclass 
of the 3-deoxyanthocyanidins, lacking the 3-OH group that is the usual anchor position for 
glycosylations in nature (compare Figure 1-1). 
 
                                                   
5 H. B. Singh, K. A. Bharati, Handbook of Natural Dyes and Pigments, Elsevier, 2014. 
6 M. Krause, R. Galensa, Chromatographia, 1991, 32, 69–72. 
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Figure 1-2: Major classes of natural occurring monomeric flavonoids. 
 
Flavans that have a fully saturated chromane core structure represent in terms of volume probably 
the biggest class of natural occurring flavonoids. An important example is catechin (I.9), which 
belongs to the subfamily of flavan-3-ols and is a major building block of condensed tannins and 
precursor for theaflavins in fermentated black tea. In addition to these six classes, there are also 
several constitutional isomeric subgroups, of which the isoflavones belong to the most prominent 
one. These bear the B–ring substituent on the C-3 position instead of the C-2 position. This 
structural effect gives them completely different dietary effects. Due to a structural resemblance 
with estrogen derivatives and a resulting often similar hormonal effect, this class is also referred to 
as phytoestrogens. Consumption of appropriate plants containing these compounds can entail 
severe health risks. 
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1.3 Flavonoid significance in plants 
 
Nature does not produce these compounds without any reason. These compounds play important 
roles in plants like acting as copigments, shielding the organism from dangerous UV radiation7 and 
even contributing in some cases to male fertility by facilitating the pollen germination.8 They also 
have roles against frost hardiness, drought resistance, help the plant in detoxification, and act as 
antimicrobial defensive compounds.9 Due to the omnipresence of the flavonoids in everyday food 
like fruits, vegetables, chocolate, wine and tea, scientists were early on highly interested in the 
origin of these metabolites in the plants and intensively studied their biogenetic origin – the 
flavonoid pathway. Unsurprisingly, it is now one of the most well-studied secondary metabolite 
systems in the plant world. Stafford was able to prove that many of the enzymes involved originated 
early from the primary metabolism.10 This development occurred during the rapid evolution that 
accompanied the movement of the plants from water to land. As part of the phenylpropanoid 
pathway, L-phenylalanine (I.11) that stems from the shikimate pathway is converted into 4-
coumaroyl-CoA (I.12) by a lyase, a hydroxylase and a CoA ligase.11 This building block brings the 
first aromatic core (C-ring) with it. The second one is synthesized by the chalcone synthase that 
uses malonyl-CoA (I.13) as a C2 building block. The so formed naringenin chalcone (I.14) is closed 
by a chalcone isomerase that catalyzes the intramolecular Michael-addition in a highly 
stereoselective way favoring (2S)-naringenin (I.6) over (2R)-naringenin with a selectivity of around 
100 000:1.12 Being the central linker enzyme between the phenylpropanoid and the flavonoid 
pathway, it was also the first flavonoid pathway enzyme to be isolated from soy beans and described 
by Moustafa et al. in 1967.13 
  
                                                   
7 K. G. Ryan, E. E. Swinny, C. Winefield, K. R. Markham, Z. Naturforsch. C, 2001, 56, 745–754. 
8 L. P. Taylor, E. Grotewold, Curr. Opin. Plant. Biol., 2005, 8, 317–323. 
9 A. Samanta, G. Das, S. Das, Int. J. Pharm. Sci. Tech., 2011, 6, 12–36. 
10 H. A. Stafford, Plant Physiology, 1991, 96, 680–685. 
11 C. M. Fraser, C. Chapple, Arabidopsis Book, 2011, 9, e0152. 
12 J. M. Jez, M. E. Bowman, R. A. Dixon, J. P. Noel, Nat. Struct. Biol., 2000, 7, 786–791. 
13 E. Moustafa, Phytochemistry, 1967, 6, 625–632. 
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Scheme 1-1: Phenylpropanoid pathway from L-phenylalanine (I.11) to naringenin (I.6). 
 
For diversification of the flavanone thus formed, that is the central branching point of the flavonoid 
biogenesis, a variety of enzymes including hydroxylases, reductases and especially glucosyl 
transferases are responsible that today more than 6 500 different derivatives are known.14  
 
1.4 Dietary effects on mammalians 
 
Being an inevitable ingredient of daily food, scientists early started to investigate possible 
consumption effects of flavonoids on human health. Research in recent decades has shown that a 
flavonoid-rich diet can protect against a variety of diseases, including coronary – especially 
cardiovascular – diseases and even some cancers.15 In particular, cranberry products, which are 
known for their high flavonoid content, are intensively advertised to the public for the prophylaxis 
and treatment of bladder diseases.16 These positive health benefits are attributed especially to the 
antioxidative effect of the flavonoids. Reactive oxygen species (ROS) are permanently formed 
during normal aerobic metabolism despite the natural antioxidant defense mechanism involving 
superoxide dismutases and catalases. These species can cause severe damage to proteins, lipids and 
deoxyribonucleic acid (DNA) and are involved in cellular aging,17 mutagenis,18 carcinogenesis19 
and coronary heart diseases due to the damage they cause.20 In this respect many studies could prove 
in vitro the potent peroxyl radical scavenging abilities of flavonoids for instance in the oxidation of 
lipids and low-density lipoproteins (LDLs).21 In general, the protective effects of flavonoids in 
                                                   
14 A. Samanta, G. Das, S. Das, Int. J. Pharm. Sci. Tech., 2011, 6, 12–36. 
15 A. R. Ness, J. W. Powles, Int. J. Epidemiol., 1997, 26, 1–13. 
16 G. Abeywickrama, S. C. Debnath, P. Ambigaipalan, F. Shahidi, J. Agric. Food Chem., 2016, 64, 9342–
9351. 
17 J. Sastre, F. V. Pallardó, J. Viña, IUBMB life, 2000, 49, 427–435. 
18 W. Takabe, E. Niki, K. Uchida, S. Yamada, K. Satoh, N. Noguchi, Carcinogenesis, 2001, 22, 935–941. 
19 S. Kawanishi, Y. Hiraku, S. Oikawa, Mutat. Res., 2001, 488, 65–76. 
20 M. A. Khan, A. Baseer, J. Pak. Med. Assoc., 2000, 50, 261–264. 
21 C. Castelluccio, G. Paganga, N. Melikian, G. P. Bolwell, J. Pridham, J. Sampson, C. Rice-Evans, FEBS 
Lett., 1995, 368, 188–192, N. Salah, N. J. Miller, G. Paganga, L. Tijburg, G. P. Bolwell, C. Rice-Evans, Arch. 
Biochem. Biophys., 1995, 322, 339–346. 
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biological systems can be ascribed next to the antioxidative effects to the ability of transferring free 
radical electrons, chelate cell-toxic metal catalysts,22 regenerate Vitamin E radials23 and the direct 
inhibition of oxidases24.  
 
1.5 Oligomeric flavonoids - proanthocyanidins 
 
Flavonoids not only appear exclusively as monomers. In 1947 Jaques Masquelier, a French chemist, 
discovered and patented methods to isolate oligomeric and polymeric flavonoids from grape seeds 
during his Ph.D. studies.25 These extracts are still commercially available as food additives and are 
market under the name Anthogenol®. These first characterized procyanidins are a subclass of the 
so-called proanthocyanidins or flavolanes and consist of polymeric chains of catechin (I.9) and 
epicatechin (I.15). These two flavan-3-ols are also the most common found building blocks in 
natural condensed tannins and proanthocyanidins. The name proanthocyanidin is based on the 
observation that oxidative depolymerization leads back to monomeric anthocyanidins. They can 
exist as chains but also branched molecules of condensed tannins (I.20) are known (indicated by 
dotted line in Figure 1-3). Condensed tannins refer generally to oligomeric proanthocyanidins that 
can reach molecular masses up to 20 000.26 Proanthocyanidins are divided into a type-A and a 
type-B class. While in type-B proanthocyanidins the flavonoid subunits are connected via a single 
C-C bond (4→8 or 4→6) like in procyanidin B1 (I.16) or cinnamtannin A3 (I.19), the subunits in 
type-A proanthocyanidins are connected via an additional C-O bond (2→O-7 or 2→O-5) like in 
procyanidin A1 (I.18) or cinnamtannin B1 (I.17). This results in the characteristic bicyclic [3.3.1] 
ketal moiety of this type. Studies showed an anti-adhesion effect of type-A proanthocyanidins from 
cranberries against E. coli to the urinary tract epithelial cells, while type-B proanthocyanidins from 
grapes exhibited only minor activity.27 Yet no sufficient clinical evidence was given that this effect 
helps to prevent bladder diseases.28 Recently Takanashi et al. showed that type-B chains of 
                                                   
22 M. Ferrali, C. Signorini, B. Caciotti, L. Sugherini, L. Ciccoli, D. Giachetti, M. Comporti, FEBS Lett., 1997, 
416, 123–129. 
23 R. Hirano, W. Sasamoto, A. Matsumoto, H. Itakura, O. Igarashi, K. Kondo, J. Nutr. Sci. Vitaminol. (Tokyo), 
2001, 47, 357–362. 
24 P. Cos, L. Ying, M. Calomme, J. P. Hu, K. Cimanga, B. van Poel, L. Pieters, A. J. Vlietinck, D. Vanden 
Berghe, J. Nat. Prod., 1998, 61, 71–76. 
25 C. Izard, J. Masquelier, C. R. Acad. Sci. Paris, 1958, 246, p. 1454. 
26 P. Frutos, G. Hervás, F. J. Giráldez, A. R. Mantecón, Span. J. Agric. Res., 2004, 2, p. 191. 
27 A. B. Howell, J. D. Reed, C. G. Krueger, R. Winterbottom, D. G. Cunningham, M. Leahy, Phytochemistry, 
2005, 66, 2281–2291. 
28 R. G. Jepson, G. Williams, J. C. Craig, Cochrane Database Syst. Rev., 2012, 10, CD001321. 
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epicatechin longer than trimers (e.g. I.19) exhibit strong anticancer effects while chains of the 
epimer catechin did not show any activity at all.29  
 
 
Figure 1-3: Proanthocyanidins type-A and type-B from catechin (I.9) and epicatechin (I.15) building blocks. 
  
                                                   
29 K. Takanashi, M. Suda, K. Matsumoto, C. Ishihara, K. Toda, K. Kawaguchi, S. Senga, N. Kobayashi, M. 
Ichikawa, M. Katoh et al., Sci. Rep., 2017, 7, p. 7791. 
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1.6 Asymmetric synthesis of flavonoids 
 
Despite the omnipresence of flavonoids in nature, many interesting derivatives occur only in small 
quantities and cannot be isolated in larger amounts with justifiable effort. Synthetic approaches are 
essential for reliable access and asymmetric synthesis is due to the chiral center on C-2 all the more 
important. For this reason, the scientific community worked early on to synthesize these natural 
products and their derivatives stereoselectively. In particular, chalcones or dihydrochalcones are 
important intermediates for the synthesis of flavonoids. Their diphenylpropan frameworks are 
readily accessible via well-established routes comprising aldol-condensation of 2-
hydroxyacetophenones and benzaldehydes.30 Usually a condensation under basic conditions is 
preferred as under acidic conditions, the direct racemic formation of flavanones is observed. For an 
asymmetric synthesis, chalcone epoxides emerged early as important intermediates. Wynberg was 
the first to report quinine and quinidine benzyl chlorides (Scheme 1-2, I.21 and I.22) as phase 
transfer catalysts for asymmetric epoxidation of electron poor olefins using readily available 
aqueous hydrogen peroxide as oxidant.31 He showed that the enantiomeric excess was inversional 
proportional to the dielectric constant of the organic solvent and could synthesize chalcone epoxides 
(I.24) with up to 54% ee in toluene.32 Despite the rather low enantiomeric excesses he proved the 
preferential formation of (αS,βR)-epoxides (not shown) for I.22 and (αR,βS)-epoxides (shown) for 
I.21 as catalysts respectively. These findings lead to a variety of investigations to enhance the 
enantiomeric excess of such epoxides although many methods were limited to non-chalcone 
substrates. Only a few years later, a breakthrough was achieved by Juliá by the development of 
triphasic epoxidation conditions exploiting amino acid polymers as chiral catalysts.33 By using 
poly-(S)-alanine, enantiomeric excesses higher than 90% could be achieved. This method has been 
improved through collaboration with Colonna and has provided several efficient catalysts based on 
alanine, leucine and isoleucine.34 Under the originally published triphasic conditions, epoxidation 
takes place at the interface between the insoluble polymer and the organic solvent (e.g. toluene). 
An aqueous hydrogen peroxide solution provides the necessary oxidizing agent. Unfortunately, this 
protocol still suffered from limitations such as unacceptably long reaction times, catalyst 
degradation and sometimes the need for continuous addition of base and oxidant. Many of these 
problems were solved by Roberts and Bentley, who switched to a two-phase non-aqueous system 
                                                   
30 v. St. Kostanecki, G. Rossbach, Ber. Dtsch. Chem. Ges., 1896, 29, 1488–1494. 
31 R. Helder, J. C. Hummelen, R.W.P.M. Laane, J. S. Wiering, H. Wynberg, Tetrahedron Lett., 1976, 17, 
1831–1834. 
32 H. Wynberg, B. Greijdanus, J. Chem. Soc., Chem. Commun., 1978, 0, 427–428. 
33 S. Juliá, J. Guixer, J. Masana, J. Rocas, S. Colonna, R. Annuziata, H. Molinari, J. Chem. Soc., Perkin Trans. 
1, 1982, 1317–1324,S. Juliá, J. Masana, J. C. Vega, Angew. Chem. Int. Ed., 1980, 19, 929–931. 
34 S. Colonna, H. Molinari, S. Banfi, S. Juliá, J. Masana, A. Alvarez, Tetrahedron, 1983, 39, 1635–1641. 
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with a non-nucleophilic base.35 Nel further optimized these conditions for the epoxidation of 
hydroxylated chalcones (see Scheme 1-2).36 In his method, carbamide peroxide was used together 
with 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) and the polyleucine catalyst I.25 in 
tetrahydrofuran, which provides high amounts of chalcone epoxides of medium to high optical 
purity.  
 
Scheme 1-2: Asymmetric epoxidation of chalcones by Wynberg and Nel. I.24 possesses the absolute stereochemistry 
derived from asymmetric induction by the catalyst I.21. 
 
Since the chalcone epoxides contain a stereo center at the C-2 position, they are the key 
intermediates for an asymmetric flavonoid ring closure. The attempts by Ferreira and his colleagues 
to carry out acid-catalyzed cyclization reactions of exemplary I.28 to produce cis- and trans-2,3-
flavanonols were hampered by two main difficulties. On the one hand, aryl migration was observed, 
leading to isoflavone (I.31) formation, and on the other hand, instant epimerization of 
thermodynamically less stable (2S,3R)-cis-flavanonol (I.30), which forms the opposite enantiomer 
to the first formed (2R,3R)-trans-flavanonol (I.32), leading to an enormous decrease in optical 
purity.37 By elegantly exploiting the nucleophilic and nucleofugic character of thiols he solved this 
problem shortly after.38 Together with his coworkers the enantioenriched chalcone epoxides were 
                                                   
35 P. A. Bentley, S. Bergeron, M. W. Cappi, D. E. Hibbs, M. B. Hursthouse, T. C. Nugent, R. Pulido, S. M. 
Roberts, L. Eduardo Wu, Chem. Commun., 1997, 739–740, M. E. Lasterra-Sánchez, U. Felfer, P. Mayon, S. 
M. Roberts, S. R. Thornton, C. J. Todd, J. Chem. Soc., Perkin Trans. 1, 1996, 19, 343–348. 
36 R. J.J. Nel, P. S. van Heerden, H. van Rensburg, D. Ferreira, Tetrahedron Lett., 1998, 39, 5623–5626. 
37 J. A.N. Augustyn, C. B. Barend, Bezuidenhoudt, D. Ferreira, Tetrahedron, 1990, 46, 2651–2660. 
38 H. van Rensburg, P. S. van Heerden, B. C. B. Bezuidenhoudt, D. Ferreira, Chem. Commun., 1996, p. 2747. 
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converted into thioethers (I.33) by treatment with benzylthiol and tin tetrachloride. These 
conditions cleave also the methoxy methyl (MOM) protecting group in situ. Subsequently, the 
pyran ring was cyclized by treatment with thiophilic silver tetrafluoroborate, which resulted in high 
amounts of trans-flavanonols (I.32) and for the first time also cis-flavanonols (I.30) with complete 
retention of the optical purity. 
 
 
Scheme 1-3: Cyclization attempts of enantiomeric enriched chalcone epoxides towards cis- and trans-flavanonols and 
total synthesis of (2R,3R)-3′,4′-O,O-dimethyltaxifolin (I.39) by Park. 
 
In 1992, Barry Sharpless introduced the new class of phthalazine ligands for the asymmetric 
dihydroxylation of alkenes that quickly arrived in the scientific community.39 This exceptional 
stereoselective method was used by Park and coworkers as key-step in a highly enantioselective 
synthesis of pure (2R,3R)-3′,4′-O,O-dimethyltaxifolin (I.39).40 To forge the B-ring, a Mitsunobu 
                                                   
39 K. B. Sharpless, W. Amberg, Y. L. Bennani, G. A. Crispino, J. Hartung, K. S. Jeong, H. L. Kwong, K. 
Morikawa, Z. M. Wang, J. Org. Chem., 1992, 57, 2768–2771. 
40 S.-s. Jew, H.-a. Kim, S.-y. Bae, J.-h. Kim, H.-g. Park, Tetrahedron Lett., 2000, 41, 7925–7928. 
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reaction afforded the desired trans-flavanonol in optical purity higher than 99%. The A-ring was 
convergently introduced by nucleophilic addition of protected and lithiated phloroglucinol I.37 onto 
phenylpropanal I.36 and subsequent Ley–Griffith oxidation.  
A more general approach to enantioenriched flavanones and chromanones by an intermolecular 
conjugate addition of nucleophilic organometallic species was developed in the middle of the 
2000’s by different groups (Scheme 1-4). This is also one of the most convergent approaches to 
enantioenriched flavanones. While it has been frequently utilized for asymmetric tetralone synthesis 
previously, the application to chromones and flavones was limited before by the ease of phenoxide 
elimination after enolate formation. Hoveyda41 and Hayashi42 who both published methodologies 
in 2005 solved this issue by trapping the enolate either by an aldehyde electrophile or 
trimethylchlorosilane. Those trapping groups were removed in an additional step. Hoveyda 
employed an amino acid derived phosphine ligand I.45 in cooperation with copper triflate. Yet this 
method was limited to alkyl zinc species and not applicable to flavanone synthesis. Hayashi 
employed rhodium with (R)-BINAP (I.46) instead and synthesized quinolones derivatives that 
shortly before have been identified as a new class of antimitotic antitumor agents.43 Also Liao 
employed rhodium in his methodology five years later.44 Tetraarylboronates as nucleophilic 
component enabled to run the reaction in an aqueous system that avoids the need of enolate 
trapping. Only electron deficient arylboronates suffered from low yields but still with ee values of 
around 97%. Novel was especially the C2-symmetric chiral bis-sulfoxide ligand I.47 in his 
methodology. A similar approach was reported by Korenaga and co-workers in early 2011.45 Under 
their conditions the catalyst loadings were significantly reduced and turnover numbers up to 
320 000 achieved. This was realized by combination of rhodium with the chiral highly electron-
poor ligand (R)-MeO-F12-BIPHEP (I.48). With this methodology, it was finally possible to employ 
easy accessible aryl boronic acids as nucleophiles.  
  
                                                   
41 M. K. Brown, S. J. Degrado, A. H. Hoveyda, Angew. Chem. Int. Ed., 2005, 44, 5306–5310. 
42 R. Shintani, T. Yamagami, T. Kimura, T. Hayashi, Org. Lett., 2005, 7, 5317–5319. 
43 Y. Xia, Z. Y. Yang, P. Xia, K. F. Bastow, Y. Tachibana, S. C. Kuo, E. Hamel, T. Hackl, K. H. Lee, J. Med. 
Chem., 1998, 41, 1155–1162. 
44 J. Chen, J. Chen, F. Lang, X. Zhang, L. Cun, J. Zhu, J. Deng, J. Liao, J. Am. Chem. Soc., 2010, 132, 4552–
4553. 
45 T. Korenaga, R. Maenishi, K. Hayashi, T. Sakai, Adv. Synth. Catal., 2010, 352, 3247–3254. 
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Scheme 1-4: Asymmetric conjugate addition towards the synthesis of chromones and flavones. 
 
Next to those two approaches, scientists investigated many other ways to forge the important chiral 
C–ring of monomeric flavonoids. Next to approaches involving chiral pool compounds or kinetic 
resolutions that were already investigated by Corey,46 especially the intramolecular Michael 
addition was extensively investigated by the scientific community (Scheme 1-5). In 2007, Scheidt 
and coworkers reported the first general catalytic and enantioselective synthesis of flavanones and 
chromanones from alkylidenes (I.49).47 The intramolecular Michael addition towards the alkylidene 
is catalyzed by a chiral quinine derived thiourea catalyst I.53. The integrated tert-butyl ester 
provides a second Lewis-basic side for the organocatalyst and enhances the reactivity of the enone. 
Under mildly acidic conditions, the ester could be easily removed after the ring closing. The 
alkylidenes were generated by Knoevenagel condensation, after which the E diastereomer was 
separated and purified by recrystallization. This gave access to flavanones with excellent 
enantioselectivity. Based on transition metal catalysis Feng reported a method catalyzed by a chiral 
N,N’-dioxide nickel(II) complex employing the ligand I.54.48 Noteworthy despite the general high 
yields, substrates containing electron-donating groups resulted in decreased optical purity of the 
corresponding flavanones. The same transformation was also achieved by You who showed the 
                                                   
46 E. J. Corey, R. B. Mitra, J. Am. Chem. Soc., 1962, 84, 2938–2941. 
47 M. M. Biddle, M. Lin, K. A. Scheidt, J. Am. Chem. Soc., 2007, 129, 3830–3831. 
48 L. Wang, X. Liu, Z. Dong, X. Fu, X. Feng, Angew. Chem. Int. Ed., 2008, 47, 8670–8673. 
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general applicability of BINOL derived phosphoric acid catalysts (I.55) to catalyze the 
intramolecular Michael addition affording flavanones in up to 74% ee.49  
 
  
Scheme 1-5: Asymmetric synthesis of flavanones and chromanones by intramolecular conjugate addition. 
 
The approach most recently developed is the asymmetric hydrogenation of flavones (Scheme 1-6). 
In 2013, Glorius and his team reported on the first asymmetric hydrogenation of flavones catalyzed 
by an N-heterocyclic carbene-(NHC(I.59))-ruthenium(II) complex with enantioselectivities of up 
to 97%.50 In 2017 Wang reported on a complementary asymmetric methodology achieving a copper 
catalyzed conjugate reduction of chromones. Unfortunately despite the general high yields and 
enantioselectivities only chromones with an alkyl residue on the C-2 position could successfully be 
reduced.51    
  
                                                   
49 Z. Feng, M. Zeng, Q. Xu, S. You, Chin. Sci. Bull., 2010, 55, 1723–1725. 
50 D. Zhao, B. Beiring, F. Glorius, Angew. Chem. Int. Ed., 2013, 52, 8454–8458. 
51 D. Xiong, W. Zhou, Z. Lu, S. Zeng, J. Wang, Chem. Commun., 2017, 53, 6844–6847. 
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Scheme 1-6: Asymmetric synthesis of flavanones and chromanones by enantioselective hydrogenation.  
 
1.7 Biogenesis of B-type proanthocyanidins  
 
For an efficient biomimetic access to oligomeric and polymeric proanthocyanidins, their biological 
origin needs to be revealed in a first instance. As most procyanidins and tannins consist 
predominantly of the flavan-3-ols catechin (I.9) and epicatechin (I.15), their exact origin in the 
flavonoid pathway is of special interest and importance. To synthesize these epimers several 
enzymes are involved (Scheme 1-7). Starting from naringenin (I.6), the enzymes flavonoid 3’-
hydroxylase (F3’H) or flavonoid 3’,5’-hydroxylase (F3’5’H) adjust the hydroxylation pattern on 
the B-ring to synthesize eriodictyol (I.62) and dihydrotricetin (I.63). All of these three (2S)-
flavanones can be oxidatively hydroxylated to yield dihydroflavonols (dihydrokaempferol (I.64), 
dihydroquercetin/taxifolin (I.7) and dihydromyricetin (I.65), respectively) by the flavonoid 3-
hydroxylase (F3H). Subsequently the dihydroflavonol 4-reductase (DFR), a NADPH depending 
enzyme, reduces the dihydroflavonols to leucoanthocyanidins (leucopelargonidin (I.66), 
leucocyanidin (I.67) and leucodelphinidin (I.68), respectively).52 This reduction is like the others 
highly specific and delivers (2R,3S,4S)-leucoanthocyanidins.53 These molecules represent 
branching points for the synthesis of cis- and trans-flavan-3-ols. On the one hand, the anthocyanidin 
synthase (ANS) – an non-haem Fe2+ oxygenase – synthesizes the colored achiral anthocyanidins 
(pelargonidin (I.1), cyanidin (I.2), delphinidin (I.3), respectively) that can be converted into the cis-
flavan-3-ols (epiafzelechnin (I.69), epicatechin (I.15), epigallocatechin (I.70), respectively) by the 
anthocyanidin reductase (ANR).54 Yet for the synthesis of the trans-flavan-3-ols another route is 
purchased by nature. For this, the leucoanthocyanidin reductase (LAR) removes the benzylic 
                                                   
52 S. Martens, T. Teeri, G. Forkmann, FEBS Lett., 2002, 531, 453–458. 
53 P. Petit, T. Granier, B. L. d'Estaintot, C. Manigand, K. Bathany, J.-M. Schmitter, V. Lauvergeat, S. Hamdi, 
B. Gallois, J. Mol. Biol., 2007, 368, 1345–1357. 
54 D.-Y. Xie, S. B. Sharma, N. L. Paiva, D. Ferreira, R. A. Dixon, Science, 2003, 299, 396–399. 
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hydroxyl group to yield the trans-flavan-3-ols (afzelechnin (I.71), catechin (I.9), gallocatechin 
(I.72), respectively) directly.55 Thus, epicatechin (I.15) and catechin (I.9), the two dominant 
building blocks and potential precursors of proanthocyanidins are synthesized from two distinct 
pathway branches, employing two distinct enzymes and two different substrates although the 
difference between both is only a single stereocenter.  
 
 
Scheme 1-7: Flavonoid pathway towards trans- and cis-flavan-3-ols, highlighting possible precursors for PA 
formation. 
 
For the formation of proanthocyanidins, the cis-flavan-3-ols, the trans-flavan-3-ols, the 
anthocyanidins and the leucoanthocyanidins were discussed as potential precursors (blue 
subscriptions and bold grey arrows in Scheme 1-7). Yet the exact mechanism in vivo is still 
controversially discussed and especially the roles of enzymatic and nonenzymatic steps remain in 
many cases unclear and may differ from molecule to molecule. Furthermore type-A and type-B PAs 
have to be distinguished in many cases. In 2005 Harper and coworkers reported their findings on 
the dependency of PA formation in the seed coat endothelium of Arabidopsis thaliana on a plasma 
                                                   
55 G. J. Tanner, K. T. Francki, S. Abrahams, J. M. Watson, P. J. Larkin, A. R. Ashton, J. Biol. Chem., 2003, 
278, 31647–31656. 
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membrane H+ ATPase.56 Further studies support the hypothesis that such a H+-ATPase or even P-
type proton pumps could help acidify cytoplasmic or vacuolar compartments in which the PA-
synthesis takes place in. In mechanistic terms, this supports the theory that the PA type-B C–C bond 
(4→8 or 4→6) is initially formed by the formation of a para-quinomethide from a 
leucoanthocyanidin that acts as an electrophile on the C-4 position. Nucleophilic attack of an 
electronrich flavan-3-ol forges subsequently the intermolecular bond of the type-B PA. The attack 
of similar nucleophilic leucoanthocyanidins instead of a flavan-3-ol enables oligo- and 
polymerization until a flavan-3-ol terminates the elongation.57 Yet this theory lacks of explanation 
that epicatechin was found in many proanthocyanidins as starting and elongation unit.58 To find a 
solution for this paradox, Haslam proposed that the initially formed para-quinomethides with the 
trans-stereochemistry of catechin (I.74) can be converted via flav-3-en-3-ol intermediates (I.76) to 
their cis counterparts (I.78) (Scheme 1-8).59 This theory could not be proven in vivo yet, but is 
supported by experimental data from Creasey and Swain who showed already the synthesis of 
proanthocyanidins from leucocyanidin (I.67) with either catechin (I.9) or epicatechin (I.15) units 
in vitro.60 A highly speculative route proposed by Dixon also involves the flav-3-en-3-ols (I.76) as 
intermediate yet generated by a different pathway.61 A polyphenol oxidase (PPO) is proposed to 
oxidize the B-ring of cis- and trans-flavan-3-ols towards an ortho-quinone (I.79, I.81) first. These 
quinones oxidize subsequently the adjacent pyran ring to the flav-3-en-3-ol (I.76). However in the 
experimentally conducted PPO mediated oxidative polymerization of flavan-3-ols, researchers 
never obtained natural PAs but oligomers with bond connection towards the terminal B-ring and 
not towards the C-4 position of the C-ring.62 In addition to these theories based on the 
leucoanthocyanidins and the flavan-3-ols, anthocyanidins and anthocyanins (glycosylated 
anthocyanidins) are potential precursors for PA formation as well what should not be forgotten (see 
chapter 1.9). They were shown to condense non enzymatically with nucleophilic flavonoid 
molecules due to their partially availability as quinomethides (anhydrobase) next to their flavylium 
form depending on the pH value. Especially in the case of wine this reaction is directly observable 
as this reaction causes a change of the tannin composition over time what is relevant for the mouth-
feel and color.63  
                                                   
56 I. R. Baxter, J. C. Young, G. Armstrong, N. Foster, N. Bogenschutz, T. Cordova, W. A. Peer, S. P. Hazen, 
A. S. Murphy, J. F. Harper, Proc. Natl. Acad. Sci. U. S. A., 2005, 102, 2649–2654. 
57 M. A. S. Marles, H. Ray, M. Y. Gruber, Phytochemistry, 2003, 64, 367–383. 
58 L. J. Porter, J. Chem. Educ., 1995, 72, 23-55. 
59 A. C. Fletcher, L. J. Porter, E. Haslam, R. K. Gupta, J. Chem. Soc., Perkin Trans. 1, 1977, p. 1628, R. W. 
Hemingway, J. J. Karchesy, S. J. Branham (Eds.), Chemistry and Significance of Condensed Tannins, 
Springer, Boston, MA, 2014. 
60 L. L. Creasy, T. Swain, Nature, 1965, 208, 151–153. 
61 R. A. Dixon, D.-Y. Xie, S. B. Sharma, The New phytologist, 2005, 165, 9–28. 
62 S. Guyot, J. Vercauteren, V. Cheynier, Phytochemistry, 1996, 42, 1279–1288. 
63 S. Vidal, D. Cartalade, J.-M. Souquet, H. Fulcrand, V. Cheynier, J. Agric. Food Chem., 2002, 50, 2261–
2266. 
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 Scheme 1-8: Proposed pathways of interconversion of the C-3 stereocenter of leucoanthocyanidins and flavan-3-ols by 
flav-3-en-3-ol intermediates. 
 
1.8 Synthetic approaches towards B-type proanthocyanidins 
 
A first synthetic procyanidin derivative was afforded by Geissman and Yoshimura already in 1966 
(Scheme 1-9).64 By a mild acid catalyzed condensation a leucocyanidin derivative I.81 with free 
phenolic catechin (I.9), they received the procyanidin derivative I.82 after methylation and 
acetylation. Yet the absolute configuration was not fully elucidated as only a 60 MHz NMR 
spectrometer was used. A similar derivative but by a much less biomimetic approach was achieved 
by Weinges and coworkers four years later.65 They forged the interflavonyl bond by 1,2-additon of 
a lithiated catechin derivative I.84 onto tetra methylated taxifolin I.83. Subsequent removal of the 
benzyl protection groups by hydrogenation followed by methylation afforded a similar derivative 
identical to methylated procyanidin B3. The benzylic hydroxyl function was simultaneously 
removed in the hydrogenation step over Pearlman’s catalyst. The work of Haslam resulted in the 
                                                   
64 T. A. Geissman, N. N. Yoshimura, Tetrahedron Lett., 1966, 7, 2669–2673. 
65 K. Weinges, J. Perner, H.-D. Marx, Chem. Ber., 1970, 103, 2344–2349. 
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first synthesis of free phenolic procyanidins.66 Tannins from Salix caprea and Crataegus monogyna 
(I.86) were converted to the 4β-benzylthiocatechin and –epicatechins (I.87) under by acetic acid 
acidified conditions. These were reacted in a further step with free catechin (I.9) and epicatechin 
(I.15) to afford the procyanidins B1 – B4. With a thiophilic Lewis acid, this dimerization can also 
be achieved under neutral condition what was shown by Ferreira who afforded procyanidins B1 
(I.16) and B2 in up to 50% isolated yield.67 With slight modifications of these general concepts a 
broad range of proanthocyanidins and B-type procyanidins are accessible via more or less 
biomimetic ways.68 A rather new concept was pursuit by van der Westhuizen and coworkers in 
2008.69 They converted catechin into flavan-3-on I.88 and showed that upon treatment with silver 
tetrafluoroborate in tetrahydrofuran as single electron oxidant, the benzylic position is oxidized into 
a cationic species I.90. This cation is trapped by nucleophilic tetra-O-methylcatechin I.91 to afford 
a biflavonoid. By subsequent reduction with sodium borohydride octa-O-methylprocyanidin B3 
derivative I.92 was yielded favoring a 3,4-cis configuration.  
Modern chromatography methods enable nowadays the selective synthesis and separation of 
proanthocyanidins in a broad range of monomeric units. Only in 2017 Makabe and Fujii reported 
the selective synthesis of proanthocyanidins with up to six flavonoid monomers employing zinc 
triflate as Lewis acid and leucoanthocyanidins with ethoxyethyl leaving groups (e.g. I.95) as 
substrate.70 Their investigation revealed a strong difference between catechin derived 
proanthocyanidins and their epicatechin analogues. While epicatechin chains like cinnamtannin A3 
(I.19) showed significant activity for suppression of cell growth and Fatty Acid Binding Protein 5 
(FABP5) gene expression in human prostate cancer cells, their catechin counterparts did not show 
any activity at all.  
 
  
                                                   
66 A. C. Fletcher, L. J. Porter, E. Haslam, R. K. Gupta, J. Chem. Soc., Perkin Trans. 1, 1977, p. 1628, E. 
Haslam, J. Chem. Soc., Chem. Commun., 1974, p. 594. 
67 P. J. Steynberg, R. J.J. Nel, H. van Rensburg, B. C.B. Bezuidenhoudt, D. Ferreira, Tetrahedron, 1998, 54, 
8153–8158. 
68 D. Ferreira, C. M. Coleman, Planta Med, 2011, 77, 1071–1085. 
69 M. C. Achilonu, S. L. Bonnet, J. H. van der Westhuizen, Org. Lett., 2008, 10, 3865–3868. 
70 K. Takanashi, M. Suda, K. Matsumoto, C. Ishihara, K. Toda, K. Kawaguchi, S. Senga, N. Kobayashi, M. 
Ichikawa, M. Katoh et al., Sci. Rep., 2017, 7, p. 7791, M. Suda, W. Fujii, K. Takanashi, Y. Hattori, H. Makabe, 
Synthesis, 2014, 46, 3351–3355. 
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Scheme 1-9: Approaches towards the synthesis of B-type proanthocyanidin derivatives. 
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1.9 A-Type proanthocyanidins 
 
While in the proanthocyanidins the monomers are mostly linked only by a single C–C bond (4→8, 
4→6), the A-type shows a second C–O bond (2→O-7) that closes the characteristic bicyclic [3.3.1] 
ketal core. Important examples are the procyanidins A1 (I.18) till A4. Two main ways have been 
suggested of exactly how this connection is created starting from B-type PAs. As these molecules 
are known to react with reactive oxygen species (ROS), especially the catechol ring is prone for 
oxidation. A first oxidation of the phenolic hydroxyl group is presumably followed by the 
abstraction of the hydrogen of the C-2 position on the pyran ring that results in the formation of a 
para-quinomethide (compare Scheme 1-10, I.98). This methide is stabilized by the oxygen of the 
pyran ring (I.99) and can be attacked by nucleophiles. In a 6-exo-trig fashion this can be the free 
C-7 hydroxyl group on the other flavonoid monomer. After tautomerism this would yield 
proanthocyanidins of the A-type (e.g. I.18). Toyoda and coworkers delivered evidence for this 
mechanism by oxidizing procyanidins B1 (I.16) with a diphenylpicrylhydrazyl radical in a 
water/ethanol mixture what yielded procyanidin A1 (I.18).71 Yet this was not entirely new as the 
general concept has already been shown by Nishioka and coworkers who successfully converted 
B-type proanthocyanidins into the A-type by treatment with hydrogen peroxide and sodium 
bicarbonate in the 80’s.72 Toyoda calculated the bond dissociation energy (BDE) of the hydrogen 
atom at C-2 position to be 68.7 kcal/mol what is weak enough to be easily abstracted by radicals 
(compare BDE(methane) = 105 kcal/mol).  
 
Scheme 1-10: Radical oxidation of procyanidin B1 to A1 by diphenylpicrylhydrazyl radicals.   
                                                   
71 K. Kondo, M. Kurihara, K. Fukuhara, T. Tanaka, T. Suzuki, N. Miyata, M. Toyoda, Tetrahedron Lett., 
2000, 41, 485–488. 
72 S. Morimoto, G.-I. Nonaka, I. Nishioka, Chem. Pharm. Bull., 1987, 35, 4717–4729. 
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As already mentioned anthocyanidins and anthocyanins are plausible substrates for the PA 
formation as well. Particularly in the case of A-type PAs, they gain even more importance as 
precursors compared to B-type PAs. Already Waiss showed in 1965 that anthocyanidins undergo 
formal [3+3] addition with electron-rich phloroglucinol (I.101) towards the typical bicyclic [3.3.1] 
ketal moiety of type-A PAs under a pH range from 4–7 (Scheme 1-11).73 At an optimized pH value 
of 5.8 they observed the setting of an equilibrium of the flavylium ion and the corresponding 
quinomethide that was attacked by the C-nucleophilic phloroglucinol in a formal 1,8-fashion. 
Inspired by this work Pettus and coworkers synthesized the natural A-type PA diinsininone (I.105) 
in 2006 by exploiting this intrinsic reactivity from luteolidin (I.8) and racemic naringenin (I.6).74 
He could even prove that the C–C bond formation precedes the oxygen-carbon bond formation of 
the ketal by isolation of the non-ketalized type-B intermediate (I.104). In contrast to the first 
described pathway starting from B-type PAs, this ionic mechanism does not require any oxidation 
steps and is only dependent on the pH value. Important to note, diinsininone was received by Pettus 
as a single diastereomer in a racemic fashion. As already mentioned (see 1.2), flavanones tend to 
racemize under acidic conditions. While the nucleophilic addition of I.6 towards I.8 showed no 
preference and gave a 1:1 mixture of diastereomers (I.104), the stereocenter at the C-2 position of 
the flavanone moiety in the closed A-type PA was adjusted in situ by phenoxide elimination and 
Oxa-Michael addition in relative stereochemistry to the stereocenter set by the first nucleophilic 
attack.  
  
 
Scheme 1-11: Ionic formation of proanthocyanidin type-A skeletons from anthocyanidins and C-nucleophilic phenol 
derivatives.  
 
                                                   
73 L. Jurd, A. C. Waiss, Tetrahedron, 1965, 21, 1471–1483. 
74 C. Selenski, T. R. R. Pettus, Tetrahedron, 2006, 62, 5298–5307. 
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1.10 Dragon’s blood as source of flavonoids 
 
Flavonoids appear also in the resins of a variety of plants as important constituents. Dragon’s blood 
is a deep red resin with remarkable pharmaceutical effects. Yet there is a certain degree of confusion 
as many red resins of different origins are called Dragon’s blood in medical literature. Therefore, 
several kinds have to be strictly distinguished due to their different origins – these are especially 
East Indian Dragon's blood (from the fruit of Daemonorops draco (Willd.) Blume), West Indian 
Dragon's blood (exudates of Pterocarpus draco L.), Socotran or Zanzibar Dragon's blood (exudates 
of Dracaena cinnabari Balf. f.), Canary Dragon's blood (exudates formed from incisions of the 
trunk of Dracaena draco (L.) L.), Mexican Dragon's blood (resin of Croton lechleri Müll. Arg.) 
and Venezuelan Dragon's blood (resin of Croton gossypifolium Vahl).75 The East Indian Dragon’s 
blood from Daemonorops draco (palmaceae) is a famous traditional Chinese medicine and was 
highly priced in ancient times. For hundreds of years people have used it to heal wounds by 
improving the tissue regeneration, stimulating the blood circulation, pain alleviation and controlling 
of bleeding.76 It is obtained as deep red teardrop-shaped lumps and is isolated by pacing the fruits 
in sacks and pounding them after what the pulp is treated with boiling water. The resin is 
subsequently kneaded into balls or long sticks.77. The first pigment isolated from Brockmann and 
Haase and reported almost simultaneously and independently from Hesse was dracorubin (I.106) 
in 1936, which is the most important pigment for the deep red color.78 Yet this pigment was only 
characterized by its elemental analysis at the beginning. This anthocyanin derivative is a biflavonoid 
with the typical 4→8 and an unusual 5→7-O bond. Shortly after, the monomeric 3-
deoxyanthocyanidin dracorhodin (I.108) – as second important red pigment was reported by 
Brockmann who was able to reveal its structure as well.79 Novel mild isolation methods showed 
that up to 6.6% of the crude resin consist of this base labile 3-deoxyanthocyanidin what would 
significantly exceed the content of dracorubin (I.106).80 Based on these results and further 
experiments from Brockmann, the structural elucidation of dracorubin was finally achieved by 
Whalley in 1950.81 He was also the first to synthesize this pigment in 1976.82 Five years earlier, 
Nasini and Salvadori reported six new optical active flavans including I.110 and I.111, which are 
                                                   
75 T. Sollmann, J. Am. Pharm. Assoc. (Wash.), 1920, 9, 141–144. 
76 Chinese Pharmacopoeia Commission, Pharmacopoeia of the People's Republic of China, 2005, p. 96. 
77 T. H. Barry, R. S. Morrell, A. A. Drummond, The chemistry of the natural & synthetic resins, Van Nostrand, 
New York, 1926. 
78 H. Brockmann, R. Haase, Ber. dtsch. Chem. Ges. A/B, 1937, 70, 1733–1738, H. Brockmann, R. Haase, 
Ber. dtsch. Chem. Ges. A/B, 1936, 69, 1950–1954, G. Hesse, Justus Liebigs Ann. Chem., 1936, 524, 14–24. 
79 H. Brockmann, H. Junge, Ber. dtsch. Chem. Ges. A/B, 1943, 76, 751–763. 
80 J. Shi, R. Hu, Y. Lu, C. Sun, T. Wu, J. Sep. Sci., 2009, 32, 4040–4047. 
81 H. Brockmann, R. Haase, E. Freiensehner, Ber. dtsch. Chem. Ges. A/B, 1944, 77, 279–286, A. Robertson, 
W. B. Whalley, J. Yates, J. Chem. Soc., 1950, 0, 3117–3123. 
82 E. O. P. Agbakwuru, W. B. Whalley, J. Chem. Soc., Perkin Trans. 1, 1976, 1392–1394. 
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the reduced forms of I.108 and I.109.83 He also described interconversion of these flavans to the 3-
deoxyanthocyanidins dracorhodin (I.108) and nordracorhodin (I.109) by oxidation with 2,3-
dichloro-5,6-dicyanobenzoquinone (DDQ) and reduction with sodium borohydride respectively. In 
the case of I.110 he even observed fast autoxidation towards I.108 under air. A very interesting 
ortho-ester – dracooxepine I.118 - was reported in 1989 by the same group.84 Fine splitting in the 
13C-NMR spectra of this natural product revealed its almost 1:1 mixture of diastereomers. After 
dracoflavan A (I.119) in 1990,85 the dracoflavan series of B – D (I.112 – I.117) were the first A-type 
PAs isolated from East Indian Dragon’s blood.86 These three members all appear as pair of 
diastereomers. In 2009 the new series of daemonorols (e.g. I.120 and I.121) were reported by 
Iinuma in which I.110 or I.111 are linked by a methylene bridge.87 Next to these unique compounds 
other natural products like resin acids (e.g. abietic acid) were found in this Dragon’s blood as well.88  
 
Figure 1-4: Selection of characteristic natural products from daemonorops draco dragon’s blood and the year of their 
first description. 
                                                   
83 G. Cardillo, L. Merlini, G. Nasini, P. Salvadori, J. Chem. Soc., C, 1971, 3967–3970. 
84 G. Nasini, A. Arnone, L. Merlini, Heterocycles, 1989, 29, 1119–1125. 
85 A. Arnone, G. Nasini, L. Merlini, J. Chem. Soc., Perkin Trans. 1, 1990, 29, 2637–2640. 
86 A. Arnone, G. Nasini, O. Vajna de Pava, L. Merlini, J. Nat. Prod., 1997, 60, 971–975. 
87 K.-i. Nakashima, N. Abe, F. Kamiya, T. Ito, M. Oyama, M. Iinuma, Helv. Chim. Acta, 2009, 92, 1999–
2008. 
88 L. Merlini, G. Nasini, J. Chem. Soc., Perkin Trans. 1, 1976, 1570–1576,G. Nasini, F. Piozzi, 
Phytochemistry, 1981, 20, 514–516. 
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1.11  Isolation of dragonbloodin A1 and A2 
 
The instability of many of the flavonoid based components in dragon’s blood - especially during 
the isolation steps - greatly increased the difficulty of purification and identification of new natural 
products. However, Wu tackled this challenge by advanced chiral chromatography methods 
whereupon two novel bioactive structural complex compounds were isolated, characterized and 
even evaluated in respect to their anti-inflammatory activity. The dragonbloodins A1 (I.122) and 
A2 (I.123) are the first complex flavonoid trimers that have been reported in 2016 bearing the same 
[3.3.1] bicyclic ketal core of A-type PAs (Scheme 1-12).89 Isolated as an almost 1:1 mixture of 
diastereomers, separation was achieved by chiral column chromatography (ASTEC CELLULOSE 
DMP). Yet it was not possible to fully elucidate the structure by exclusive analysis of the complex 
NMR data. The structural elucidation was further complicated as both diastereomers proved to be 
even more unstable when separated from each other. Fortunately, crystalline material composed of 
a mixture of dragonbloodin A1 and A2 was relatively stable and a single crystal X-ray analysis 
finally revealed their complex structure. It is important to note that the relative stereochemistry is 
completely identical between I.122 and I.123 except the absolute (2S) configuration of the single 
flavan building block. Wu and coworkers solved the crystallographic data impeding the P21/n space 
group instead of the P21 group that would have been an option as well. As in this used 
centrosymmetric space group both diastereomers appear merged as one molecule (formally I.122 
and ent-I.123) with the disordered position of the absolute (2S) stereocenter, this caused a severe 
misinterpretation of the absolute stereochemistry of dragonbloodin A2 (I.123). Simply spoken 
instead of assigning both diastereomers the same absolute stereochemistry on the (2S) center, all 
other centers were assumed to have the same absolute configuration. In turn Wu and coworkers 
came up with a proposed biogenesis to explain the interpreted (2R) configuration of ent-I.123. In 
respect to the correct absolute stereochemistry of I.123, that has recently been proven 
experimentally, too,90 this proposed biogenesis is unreasonable. This mistake has been realized 
shortly after publication in April 2016 whereupon the paper was retracted in the beginning of June 
2016.  
                                                   
89 W.-K. Du, H.-Y. Hung, P.-C. Kuo, T.-L. Hwang, L.-C. Shiu, K.-B. Shiu, E.-J. Lee, S.-H. Tai, T.-S. Wu, 
Org. Lett., 2016, 18, p. 3042. 
90 Z. Guo, Z. Wang, Y. Tang, Org. Lett., 2018, 20, 1819–1823. 
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Scheme 1-12: Structures of dragonbloodin A1 and A2 and the incorrect originally proposed structure ent-I.123.  
 
As our group has a strong expertise in biomimetic synthesis of complex natural products91 we got 
quickly interested in these new molecules despite the formal retraction of the publication. Being 
outstanding and challenging targets for a biomimetic synthesis, we hoped to reveal the true 
biogenesis by exploiting biomimetic principles and intrinsic reactivity of the building blocks.   
                                                   
91 B. Cheng, D. Trauner, J. Am. Chem. Soc., 2015, 137, 13800–13803, P. Ellerbrock, N. Armanino, M. K. Ilg, 
R. Webster, D. Trauner, Nat. Chem., 2015, 7, p. 879, R. Meier, S. Strych, D. Trauner, Org. Lett., 2014, 16, 
2634–2637, S. Strych, G. Journot, R. P. Pemberton, S. C. Wang, D. J. Tantillo, D. Trauner, Angew. Chem. 
Int. Ed., 2015, 54, 5079–5083. 
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2 Results and Discussion 
 
2.1 Biomimetic Synthesis of Complex Flavonoids Isolated from Daemonorops 
“Dragon’s Blood” 
 
Reprinted with permission from M. Schmid, D. Trauner, Angew. Chem. Int. Ed. 2017, 56, 12332–
12335. Copyright © 2017 John Wiley and Sons.  
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3 Conclusion & Outlook  
The successful total synthesis of dragonbloodin A1 (I.122), A2 (I.123) and the dracoflavans C1 
(I.114), C2 (I.115) by biomimetic approaches revealed some interesting aspects of the nature of 
these complex flavonoids. With these new insights it is necessary to review the other flavonoids 
once again. During the synthesis of the dracoflavans C the observed ratio between both 
diastereomers, identical to nature’s, suggests that the formation of these A-type PAs occurs most 
probably in nature without any enzymatic assistance that could control the diastereoselectivity of 
one being prefered. Yet the question rises if the other A-type PAs dracoflavan B (I.112, I.113) and 
D (I.116, I.117) might be formed by such an ionic non-enzymatic mechanism as well. In such a 
case the anthocyanidin I.124 needs to be anticipated for the dracoflavan B biogenesis. Although 
such a molecule was not observed yet, the anticipation of this molecule bearing the additional 
hydroxyl group on the C-3 position fits perfectly to the structural similarity to the anthocyanidins 
pelargonidin (I.1), anthocyanidin (I.2) and delphinidin (I.3) and is reasonable in respect to the 
flavonoid pathway. Dracoflavan D lacks the same OH group like dracoflavan C. A similar 
retrosynthetical cleavage of this A-type PA leads to flavan-7-ol I.110 and to a demethylated 
dracorhodin I.125. Theoretically an enzymatic demethylation of dracoflavan C is plausible yet 
would be surprising as the methoxy groups are usually put on the flavonoid monomers after the 
chalcone isomerase step. This would implicate a methylation with subsequent removal a few steps 
later. More reasonable is the assumption that the methoxy group of dracorhodin is replaced in situ 
by a conjugate addition of water and methanol elimination. An aspect that also has an influence on 
biogenetic consideration of the other flavonoids is the extraordinary sensitivity of the trimeric flav-
3-en (see abstract – III) towards aerial oxidation. This intermediate proved to be so unstable in 
dichloromethane that it reacted within a few hours under air to the endoperoxide of dragonbloodin 
A (see abstract – IV). As initial experiments towards the dragonbloodins A aimed on the synthesis 
of the proposed intermediate I.127 (R1, R2 = Me), these new results shine light on this molecule 
from a different point of view. Most probably this flav-3-en is similar or even more sensitive 
towards aerial oxidation what might lead to instant oxidation to the 4-flavanyl-anthocyanidin I.126 
(R1, R2 = Me) for what reason it probably could never be observed. This molecule bears a 
fascinating structure of a linked dimer between an electronpoor para-quinomethide and an 
electronrich flavan. As a 1,6- or a 1,8-addition of the 7-OH group onto the quinone structure is 
sterically impossible, a 1,4- conjugate addition/substitution is the only way how it can react 
intramoleculary to balance these electronic differences. By such a proposed conjugate substitution 
of the 5-methoxy group, the dracorubins (I.106 and I.107) are formed following an enthropically 
favored path. This assumption further increases the crucial role played by the molecule I.127. 
According to this proposal it can not only interact with a proton electrophile towards the 
dracoflavans C (I.114 and I.115) or a dracorhodin electrophile towards the dragonbloodins A (I.122 
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and I.123), electrophilic oxygen or reactive oxygen species open a third pathway that leads to the 
dracorubins (I.106 and I.107). The sensitivity of I.110 and the observed endoperoxide formation of 
the trimeric flav-2-en give also hints onto the dracooxepine (1.118) biogenesis pathway. We suggest 
that the oxidation of I.110 towards dracorhodin (I.108) occurs via flav-3-en I.129 or a flav-2-en 
(not shown). By a radical hydrogen abstraction, I.130 should occur as an instable intermediate that 
might quickly add triplett oxygen from the air under the right conditions and upon reduction by 
exemplary another flavonoid form the endoperoxide I.132. Under the acidic conditions caused by 
the resin acids, a formal Baeyer–Villiger oxidation can be formulated, what leads to the 
dioxepinium cation I.133. Trapping by I.111 leads to dracooxepine (1.118). Further studies and 
calculations on the exact oxidation mechanisms involed in the formation of the appearing 
flavonoids in dragon’s blood could shine more light on their biogenesis and enable in future 
efficient synthesis routes to the different members.  
 
 
Scheme 3-1: Proposed biogenesis routes of flavonoids related to dragonbloodin A1 (I.122) and A2 (I.123). 
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1 Introduction 
 
1.1 Salimabromide 
 
Dragonbloodin A1 (I.122) and A2 (I.123), as complex trimers of flavonoids, belong in a broader 
sense to the family of polyketide natural products. This classification is based on the biosynthesis 
of both which involves the chalcone synthase in the synthesis of the monomeric flavonoid building 
blocks. This enzyme employs malonyl-CoA building units to build up the phloroglucinol A-ring of 
the flavonoids and belongs to the polyketide synthases (PKS). PKSs are a family of enzyme 
complexes and multi-domain enzymes, that appear in bacteria, fungi, plants and a few animal 
lineages and are responsible for a huge class of secondary metabolites in nature.92 Furthermore, the 
chalcone synthase belongs to the PKS type III family. In contrast to the type I and type II, this class 
doesn’t employ an acyl carrier protein and appears rather seldom in nature. In addition, the chalcone 
synthase was the first ever characterized PKS type III by Hahlbrock in 1972.93 They were thought 
to only appear in plants, involed in chalcone and stilbene syntheses, until the first PKS type III in 
bacteria was found just at the beginning of this millenium.94 The first representative in fungi was 
reported by Kitamoto and coworkers in 2005.95 In 2013 König and coworkers reported on a novel 
natural product from a marine myxobacterium with unprecedented skeleton. Salimabromide (II.1), 
the so-named natural product, seems to be synthesized by the bacterium employing just such a PKS 
type III.96 A very special structural characteristic besides the presumed PKS type III origin, are the 
bromide substituents on the arene core. 
 
Figure 1-1: Structure of salimabromide (II.1). 
  
                                                   
92 C. Hertweck, Angew. Chem. Int. Ed., 2009, 48, 4688–4716. 
93 F. Kreuzaler, K. Hahlbrock, FEBS Lett., 1972, 28, 69–72. 
94 J. A.N. Augustyn, C. B. Barend, Bezuidenhoudt, D. Ferreira, Tetrahedron, 1990, 46, 2651–2660, V. Pfeifer, 
G. J. Nicholson, J. Ries, J. Recktenwald, A. B. Schefer, R. M. Shawky, J. Schröder, W. Wohlleben, S. Pelzer, 
J. Biol. Chem., 2001, 276, 38370–38377, B. S. Moore, J. N. Hopke, ChemBioChem, 2001, 2, 35–38. 
95 Y. Seshime, P. R. Juvvadi, I. Fujii, K. Kitamoto, Biochem. Biophys. Res. Commun., 2005, 331, 253–260. 
96 S. Felder, S. Dreisigacker, S. Kehraus, E. Neu, G. Bierbaum, P. R. Wright, D. Menche, T. F. Schäberle, G. 
M. König, Chem. Eur. J., 2013, 19, 9319–9324. 
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In the vast universe of natural products that have been isolated and characterized, halogenated 
compounds are a small group, but with essential impact. More than 5000 compounds are known to 
date and each year several hundreds are added to this number.97 Due to the omnipresence of chloride 
and bromide ions in sea water it is unsurprising that most of them are of maritime origin. A variety 
of organisms like bacteria, fungi, lichen, plants but especially marine organisms of all types have 
the capabilities to incorporate halide substituents onto organic frameworks. Nevertheless humans 
have a certain need of halide as well that is used for important metabolites and signal molecules in 
the body. Probably the most prominent and well-known molecules in public are the tyroid hormones 
(represented as thyroxine (II.2) in Figure 1-2) that are iodinated tyrosin derivatives. Iodine has 
found its way to many households, either for daily consumption by the use of iodized table salt or 
as backup supply in the event of radioactive emergency cases. However, less people are aware of 
the need for bromine. One example is bromoacetoacetate ester II.3 which was isolated from humans 
cerebrospinal fluid and was shown to play a role in the activation of the rapid eye movement (REM) 
sleeping phase.98 In the drug sector, brominated molecules still play a minor role compared to 
fluorine and chlorine containing compounds, too. However, an often prescribed sedative-hypnotic 
thienotriazolodiazepine – yet synthetic – drug is brotizolam (II.4), that is used in the treatment of 
severe or debilitating insomnia.99 The exact role of natural occuring halogen-containing compounds 
in their mother organism is often not known, yet antifeedant or defense functions against other 
organisms have been reported. Besides, some derivatives seem also to have regulatory hormone 
and signaling activities.100  
 
Figure 1-2: Important bioactive organohalogen compounds. 
 
  
                                                   
97 G. W. Gribble, Naturally Occurring Organohalogen Compounds - A Comprehensive Update, Springer 
Vienna, Vienna, 2010. 
98 S. Torii, K. Mitsumori, S. Inubushi, I. Yanagisawa, Psychopharmacologia, 1973, 29, 65–75. 
99 R. Jochemsen, J. G. Wesselman, C. J. Boxtel, J. Hermans, D. D. Breimer, Br. J. Clin. Pharmacol., 1983, 
16, 291S-297S. 
100 G. W. Gribble, Naturally Occurring Organohalogen Compounds - A Comprehensive Update, Springer 
Vienna, Vienna, 2010. 
36   Introduction 
 
1.2 Isolation of salimabromide 
 
As part of their project on microorganisms of the intertidal zone, König and coworkers were able 
to isolate an enhygromyxa salina strain in a mud sample from the coast of the German Baltic Sea 
island Prerow. Although these myxobacteria were hitherto called “unculturable”,101 König and 
coworkers managed to cultivate these bacteria in an aquaculture. They observed a persistent 
antibiotic activity of this strain towards gram-positive microorganisms whereupon they had a closer 
look into the metabolites of this bacterium. On a large scale aquaculture and under addition of an 
adsorption resin they found minute amounts of a hitherto unknown molecule (0.5 mg in 64 L 
aquaculture). Intensive analysis lead to the structural elucidation of salimabromide (II.1). This 
molecule is the first natural product isolated from the Plesiocystis/Enhygromyxa clade (suborder 
Nannocystineae) of obligatory marine myxobacteria. It shows no resemblance to any other known 
natural product and provides several unique features. The tetracyclic system consists of a fivefold 
substituted arene with two bromide substituents annealed to a cyclohexane that bears two adjacent 
quarternary carbon centers, one of which is a stereocenter. This cyclohexane is bridged by an enone 
moiety and annealed to a γ-butyrolactone representing the fourth ring. Yet the bromide substituents 
and the ethyl group are the most uncommon features. From a structural and chemical point of view, 
salimabromide (II.1) should be in principle a product of a polyketide synthase (PKS) and one or 
two halogenases. König therefore had also a look into the genome sequence of its parent strain 
enhygromyxa salina SWB007. Bioinformatic analysis of the obtained whole-genome sequences 
found a halogenase-encoding gene adjacent to sequences coding for a PKS type III system. Further 
studies were addressed afterwards, but did not reveal any hints towards the unusual rearrangement 
reactions so far that must be responsible for the formation of the unique carbon skeleton of 
salimabromide. With 0.5 mg of salimabromide in hand, first bioassay tests revealed a moderate 
antibiotic activity against gram-positive arthrobacter cristallopoietes. Yet due to the lack of 
material, more extensive evaluation essays could not be conducted yet. Further aquacultur 
experiments from König to isolate more material even failed. The lack of material for further 
evaluation tests and the unique skeleton render it a very appealling and challenging target for natural 
product synthesis that is worth striving for. Earlier attempts to synthesize salimabromide (II.1) by 
Menche and coworkers have already revealed synthetic obstacles towards its skeleton what in fact 
prohibited a successful synthesis until recently.102   
                                                   
101 T. F. Schäberle, E. Goralski, E. Neu, O. Erol, G. Hölzl, P. Dörmann, G. Bierbaum, G. M. König, Mar. 
Drugs, 2010, 8, 2466–2479. 
102 B. Schmalzbauer, D. Menche, Org. Lett., 2015, 17, 2956–2959. 
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2 Results and discussion 
 
2.1 Total Synthesis of Salimabromide: A Tetracyclic Polyketide from a 
Marine Myxobacterium 
 
Reprinted from M. Schmid, A. S. Grossmann, K. Wurst, T. Magauer, J. Am. Chem. Soc 2018, 140, 
8444–8447. Copyright © 2018 American Chemical Society 
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2.2 Ring-Expansion Approaches for the Total Synthesis of Salimabromide 
 
Reprinted from M. Schmid, A. S. Grossmann, P. Mayer, T. Müller, T. Magauer, Tetrahedron 2019, 
https://doi.org/10.1016/j.tet.2019.03.010, in press. © 2019 The Authors  
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2.3 Conclusion & Outlook - derivative synthesis of salimabromide 
 
This first successful total synthesis of salimabromide (II.1) features a route with several advantages. 
Especially in view of the very recently finished synthesis of salimabromide by Menche following 
the same strategy of a keteniminium mediated cycloaddition and a late-stage oxidation strategy of 
the carbon framework, several aspects become very evident.103 The setting of the quarternary carbon 
centers in the early phase of the route required a multi-step protocol that we could avoid by 
developing an unprecedented reaction cascade featuring a Wagner–Meerwein rearrangement of an 
epoxide followed by an intramolecular Friedel–Crafts alkylation. This afforded tetraline II.7 in a 
racemic fashion in only four steps. However, Menche pursued an enantioselective pathway and was 
able to synthesize the brominated derivative II.12 within twelve steps in an optical purity of 94% 
ee by employing an asymmetric Denmark crotylation.104 To reach a comparable intermediate, our 
route required further six steps to afford II.6 in 28% yield over ten steps. Yet this substrate still 
lacks the bromide substitutents in comparison to II.13. Unfortunately these seem to highly influence 
the subsequent three step sequence of chain elongation by Wittig olefination, amide formation and 
[2+2] cycloaddition. This structural variation lead to a yield drop of 2/3 in the route of Menche 
compared to the less unsubstituted II.8 towards II.9, synthesized by our group. From here on we 
followed a four step sequence including a tedious allylic oxidation affording salimabromide in 13% 
over four steps. Menche could generate salimabromide in a single step from II.14 by performing 
the allylic oxidation and the Baeyer–Villiger oxidation in a one-pot procedure in 15% yield. 
 
 
Scheme 2-1: Comparative overview between the asymmetric total synthesis of Menche and our racemic route. 
 
Considering a late-stage bromination in our route, the corresponding lactone II.15 is a very 
important branching point for structure–activity relationship (SAR) studies of the core skeleton 
                                                   
103 A. Palm, C. Knopf, B. Schmalzbauer, D. Menche, Org. Lett., 2019, 21, 1939–1942. 
104 B. Schmalzbauer, D. Menche, Org. Lett., 2015, 17, 2956–2959. 
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(Figure 2-1). Major aspects include the role of the bromide substituents and the ethyl side chain on 
the arene core. As a byproduct during the bromination with silvertrifluoroacetate and elemental 
bromine, we observed the mono-brominated derivative II.16, that can give indications about the 
role of the second bromide substituent. Non-brominated II.15 might give interesting insights as 
well. With the methoxy derivative II.17 in hand, we could synthesize derivative II.18, that bears 
only the structural difference of an oxygen linker instead of a methylene unit. During the Baeyer-
Villiger oxidation towards II.15, lactone II.19 was formed as an undesired byproduct. Assuming 
that the carbonyl groups of the enone and the lactone act as hydrogen bonding acceptors in enzyme 
pockets, it is noteworth that the distance between these two oxygen atoms diverges only by 
1.52 Ångstrom in II.19 compared to lactone II.15. This structural similarity prompted us to 
synthesize derivatives II.20, II.21 and II.22 in order to compare their bioactivity to salimabromide 
(II.1) and to learn more about its unique structure.   
 
 
Figure 2-1: Derivatives of salimabromide for structure-activity relationship studies. Structural differences in 
comparison to salimabromide (II.1) highlighted by colored boxes. 
 
A very interesting and important finding was done by Menche in his succesfull asymmetric total 
synthesis of salimabromide (II.1). During chiral HPLC analysis of his synthetic material in order 
to compare its absolute stereochemistry to the natural product, they discovered an almost racemic 
appearance of natural salimabromide. In the sample that was received directly from König, analysis 
revealed an ee value of only 4% for the original isolated salimabromide sample from 2013. On the 
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one hand, this finding raises further questions about the biogenesis of salimabromide and its unique 
carbon skeleton but increases the impact of our racemic route for further bioactivity studies, on the 
other hand.  
 
  
 
Chapter III 
 
 
Experimental Part 
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1 Supporting information to chapter I – 2.1 
1.1 General experimental details  
 
All reactions were carried out with magnetic stirring, and if moisture or air sensitive, under nitrogen 
or argon atmosphere using standard Schlenk techniques in oven-dried glassware (150 °C oven 
temperature). If required glassware was further dried under vacuum with a heat-gun at 650 °C. 
External bath temperatures were used to record all reaction temperatures. Low temperature 
reactions were carried out in a Dewar vessel filled with acetone/dry ice (T between –78 °C and 
0 °C) or distilled water/ice (0 °C). High temperature reactions were conducted using a heated silicon 
oil bath in reaction vessels equipped with a reflux condenser or in a pressure tube. Tetrahydrofuran 
(THF) and diethyl ether (Et2O) were distilled over sodium and benzophenone prior to use. 
Dichloromethane (CH2Cl2), was distilled over calcium hydride under a nitrogen atmosphere. All 
other solvents were purchased from Acros Organics as ‘extra dry’ reagents. All other reagents with 
a purity > 95% were obtained from commercial sources (Sigma Aldrich, Acros, Alfa Aesar and 
others) and used without further purification.  
Flash column chromatography was carried out with Merck silica gel 60 (0.040-0.063 mm). 
Analytical thin layer chromatography (TLC) was carried out using Merck silica gel 60 F254 glass-
backed plates and visualized under UV light at 254 nm. Staining was performed with ceric 
ammonium molybdate (CAM) or by staining with an aqueous anisaldehyde solution and subsequent 
heating.  
NMR spectra (1H NMR and 13C NMR) were recorded in deuterated chloroform (CDCl3), benzene 
(C6D6), acetone (acetone-d6), dimethylsulfoxide (DMSO-d6) or methanol (MeOD-d4) on a Bruker 
Avance III HD 400 MHz spectrometer equipped with a CryoProbe™, a Varian VXR400 S 
spectrometer, a Bruker AMX600 spectrometer or a Bruker Avance III HD 800 MHz spectrometer 
equipped with a CryoProbe™ and are reported as follows: chemical shift δ in ppm (multiplicity, 
coupling constant J in Hz, number of protons) for 1H NMR spectra and chemical shift δ in ppm for 
13C NMR spectra. Multiplicities are abbreviated as follows: s = singlet, d = doublet, t = triplet, q = 
quartet, quint = quintet, br = broad, m = multiplet, or combinations thereof. Residual solvent peaks 
of CDCl3 (δH = 7.26 ppm, δC = 77.16 ppm), C6D6 (δH = 7.16 ppm, δC = 128.06 ppm), DMSO-d6 (δH 
= 2.50 ppm, δC = 39.52 ppm), acetone-d6 (δH = 2.05 ppm, δC = 29.84 ppm) and MeOD-d4 (δH = 
3.31 ppm, δC = 49.00 ppm) were used as internal reference. NMR spectra were assigned using 
information ascertained from COSY, HMBC, HSQC and NOESY experiments.  
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High resolution mass spectra (HRMS) were recorded on a Varian MAT CH7A or a Varian MAT 
711 MS instrument by electron impact (EI) or electrospray ionization (ESI) techniques at the 
Department of Chemistry, Ludwig-Maximilians-University Munich.  
Infrared spectra (IR) were recorded from 4000 cm−1 to 600 cm−1 on a PERKIN ELMER Spectrum 
BX II, FT-IR instrument. For detection a SMITHS DETECTION DuraSamplIR II Diamond ATR 
sensor was used. Samples were prepared as a neat film or a thin powder S3 layer. IR data in frequeny 
of absorption (cm−1) is reported as follows: w = weak, m = medium, s = strong, br = broad or 
combinations thereof.  
Melting Points were measured with a BÜCHI Melting Point B-450 instrument in open glass 
capillaries and are uncorrected. 
Optical rotation values were recorded on an Anton Paar MCP 200 polarimeter. The specific 
rotation is calculated as follows: [α]
D
25
 = 
∝ × 100
𝑐 × 𝑑
. Thereby, the wavelength λ is reported in nm and 
the measuring temperature in °C. α represents the recorded optical rotation, c the concentration of 
the analyte in 10 mg/mL and d the length of the cuvette in dm. Thus, the specific rotation is given 
in 10−1·deg·cm2 ·g−1 . Use of the sodium D line (λ = 589 nm) is indicated by D instead of the 
wavelength in nm. The sample concentration as well as the solvent is reported in the relevant section 
of the experimental part. 
X-ray diffraction analysis was carried out by Dr. Peter Mayer (Ludwig-Maximilians-Universität 
München). The data collections were performed an a Bruker D8Venture using MoKα-radiation (λ 
= 0.71073 Å, graphite monochromator). The CrysAlisPro software (version 1.171.33.41) was 
applied for the integration, scaling and multi-scan absorption correction of the data. The structures 
were solved by direct methods with SIR9713 and refined by least-squares methods against F2 with 
SHELXL-97.14. All non-hydrogen atoms were refined anisotropically. The hydrogen atoms were 
placed in ideal geometry riding on their parent atoms. Further details are summarized in the tables 
at the different sections. Plotting of thermal ellipsoids in this document and in the main text was 
carried out using Ortep-3 for Windows. 
High Pressure hydrogenation experiments were carried out by Mario Wiesenfeldt (Westfälische 
Wilhelms-Universität Münster, group of Prof. Dr. Frank Glorius) in Berghof high pressure Reactors 
using hydrogen gas. 
All yields are isolated, unless otherwise specified.  
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Ester S1 To a stirred suspension of 2,4,6-trihydroxybenzoic acid hydrate (19) (10.2 g, 54.0 mmol, 
1.00 eq) and potassium carbonate (16.4 g, 119 mmol, 2.20 eq) in acetone (300 mL) at 45 °C was 
added dimethyl sulfate (9.7 mL,12.9 g, 103 mmol, 1.90 eq). The solution was stirred for 3.5 h and 
water (120 mL) was added subsequently. The mixture was stirred another 30 min at 45 °C and 
extracted with ethyl acetate (3 × 200 mL). The combined organic extracts were washed with brine 
(300 mL), dried over Na2SO4 and concentrated under reduced pressure. The crude product was 
purified by FCC (4:13:1; hexane: ethyl acetate) to afford a mixture of S1 and S2 (8.88 g, 66% in 
respect to S1) in a ratio of 80:20 as a colorless crystalline solid.  
Rf: 0.31 (hexanes:EtOAc 4:1), m.p. 103–111 °C (Lit.: 114 – 116 °C for pure S1) 
1
H NMR (400 MHz, CDCl3) δ 9.82 (br s, 2H), 6.03 (s, 2H), 4.03 (s, 3H), 3.78 (s, 3H) ppm. 
13
C NMR (101 MHz, CDCl3) δ 169.76, 166.53, 162.44 (br), 94.55, 94.02, 55.58, 52.64 ppm. 
IR (ATR): ?̃?𝒎𝒂𝒙= 3408 (m), 3021 (w), 2961 (w), 2853 (w), 1644 (s), 1579 (s), 1511 (m), 1483 
(w), 1444 (w), 1427 (m), 1344 (m), 1309 (m), 1252 (s), 1181 (s), 1145 (s), 1102 (s), 1071 (s), 
1031 (s), 961 (m), 938 (m), 821 (s), 790 (m), 722 (m), 697 (m), 660 (w) cm−1 
HRMS (EI): calc. for C9H10O5 [M]
+: 198.0523, found: 198.0531. 
The reported data match those previously reported.105  
An analytical pure sample was received by deformylation of 20. The melting point measured is 
valid for the received mixture with S2.  
 
 
Aldehyde 20 To a solution of S1 (8.25 g, 80% pure, 33.3 mmol, 1.0 eq) in dry acetonitrile (105 mL) 
under N2 at 0 °C was added dry DMF (3.87 mL, 3.65 g, 49.9 mmol, 1.5 eq). Oxalyl chloride 
(3.93 mL, 5.81 g, 45.8 mmol, 1.4 eq) was added dropwise, what caused a strong gas evolution. The 
clear solution was stirred for 30 min at 0 °C and 15 h at RT. The formed colorless precipitate was 
filtered off, washed with acetonitrile, suspended in water (100 mL) and heated for 2 h at 100 °C 
                                                   
105 B. S. Balgir, L. N. Mander, S. T. K. Mander, Austr. J. Chem., 1973, 26, 2459–2472. 
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under N2. The suspension was cooled to 0 °C and the solid was filtered off, washed with water and 
dried under reduced pressure to afford aldehyde 20 (5.82 g, 26.6 mmol, 77%) as off-white solid.  
Rf: 0.38 (hexanes:EtOAc 3:1), m.p. 173 °C (Lit: 177 °C) 
1
H NMR (400 MHz, CDCl3) δ 14.28 (s, 1H), 12.94 (s, 1H), 10.04 (s, 1H), 5.98 (s, 1H), 3.98 (s, 
3H), 3.91 (s, 3H) ppm. 
13
C NMR (101 MHz, CDCl3) δ 191.93, 172.38, 171.51, 168.54, 166.99, 104.91, 95.56, 91.50, 
56.34, 52.79 ppm. 
IR (ATR): ?̃?𝒎𝒂𝒙= 2961 (w), 1715 (w), 1658 (m), 1606 (s), 1579 (s), 1470 (w), 1440 (s), 1406 
(m), 1389 (w), 1338 (s), 1285 (m), 1248 (s), 1206 (s), 1170 (s), 1127 (m), 1098 (s), 988 (m), 956 
(w), 933 (m), 886 (s), 837 (m), 813 (s), 790 (m), 737 (w), 705 (m) 677 (w) cm−1 
HRMS (EI): calc. for C10H10O6 [M]
+: 226.0472, found: 226.0477. 
 
 
Cresol S3 To a solution of 20 (226 mg, 1.00 mmol, 1.0 eq) in a mixture of CHCl3 and MeOH (2:1, 
5 mL) was added Pd/C 10% (0.10 eq, 106 mg). The gas volume was replaced by hydrogen by 
evacuating and refilling (3 ×). The suspension was vigourously stirred for 6 h at RT. Subsequently 
the reaction mixture was filtered over a plug of celite, washed with ethyl acetate and concentrated 
under reduced pressure. The crude product was purified by FCC (6:15:1, hexanes:EtOAc) to 
afford the product S3 (195 mg, 0.92 mmol, 92%) as a colorless solid.  
Rf: 0.43 (hexanes:EtOAc 3:1), m.p. 132.4 °C (Lit
106: 132–133 °C) 
1
H NMR (400 MHz, Benzene-d6) δ 10.15 (b s, 2H), 6.11 (s, 1H), 3.20 (s, 3H), 3.02 (s, 3H), 2.34 
(s, 3H) ppm. 
13
C NMR (101 MHz, C6D6) δ 170.24, 164.83, 161.51, 159.56, 105.01, 94.12, 91.82, 55.09, 51.55, 
7.95 ppm. 
IR (ATR): ?̃?𝒎𝒂𝒙= 3411 (m), 2960 (w), 1656 (s), 1638 (s), 1583 (s), 1502 (w), 1451 (m), 1435 
(m), 1413 (w), 1390 (w), 1365 (w), 1344 (m), 1314 (m), 1246 (s), 1204 (m), 1197 (m), 1156 (s), 
1134 (s), 1079 (s), 1001 (w), 979 (m), 938 (m), 864 (w), 806 (s), 794 (s), 778 (w), 754 (s), 722 
(w), 681 (m), 666 (m) cm−1 
                                                   
106 A. Robertson, W. B. Whalley, J. Chem. Soc., 1950, 0, 1882–1884. 
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HRMS (EI): calc. for C10H12O6 [M]
+: 212.0679, found: 212.0678. 
The reported data match those previously reported.107  
 
 
Aldehyde S4 To a solution of S3 (212 mg, 1.00 mmol, 1.0 eq) and 1,1-dichlorodimethyl ether 
(178 µL, 230 mg, 2.00 mmol, 2.0 eq) in DCM (4.00 mL) was added neat titanium tetrachloride 
(331 µL, 569 mg, 3.00 mmol, 3.0 eq) at −35 °C. The cooling bath was removed and the red solution 
was allowed to warm up to RT under stirring. The reaction was monitored by TLC and quenched 
with 10% HCl(aq) (5 mL) after 3 h. The crude reaction mixture was extracted with EtOAc (3 ×), 
washed with brine, dried over magnesium sulfate and concentrated under reduced pressure. Crude 
aldehyde S4 (237 mg, 0.99 mmol, 99%) was obtained as an off-white solid. 
Rf: 0.47 (hexanes:EtOAc 3:1), m.p. 120.6–123.3 °C (Lit:
108 122 °C) 
1
H NMR (400 MHz, CDCl3) δ 13.82 (s, 1H), 13.11 (s, 1H), 10.00 (s, 1H), 4.00 (s, 3H), 3.88 (s, 
3H), 2.09 (s, 3H) ppm. 
13
C NMR (101 MHz, CDCl3) δ 192.78, 171.72, 170.81, 166.32, 166.02, 110.87, 107.85, 98.15, 
63.11, 52.96, 8.33 ppm. 
IR (ATR): ?̃?𝒎𝒂𝒙= 2930 (w), 2695 (w), 1640 (s), 1583 (s), 1439 (m), 1423 (m), 1394 (m), 1377 
(m), 1353 (m), 1335 (m), 1285 (m), 1230 (s), 1159 (s), 1117 (s), 1086 (m), 1025 (w), 989 (m), 
958 (s), 928 (m), 890 (w), 830 (s), 804 (s), 758 (w), 715 (w) 700 (w) cm−1 
HRMS (EI): calc. for C10H12O6 [M]
+: 240.0628, found: 240.0624. 
The reported data match those previously reported.109  
 
 
Aldehyde 21 Ester S4 (961 mg, 4.00 mmol, 1.0 eq) and LiOH·H2O (5.04 g, 120 mmol, 30 eq) were 
dissolved in water (120 mL). The flask was purged with nitrogen for 5 min. The reaction mixture 
                                                   
107 G. P. Schiemenz, H. Behrens, C. P. Ebert, K. Maienschein, J.-M. Schröder, Z. Naturforsch. B, 1985, 40, 
681–692. 
108 A. Robertson, W. B. Whalley, J. Chem. Soc., 1950, 0, 1882–1884. 
109 G. P. Schiemenz, H. Behrens, C. P. Ebert, K. Maienschein, J.-M. Schröder, Z. Naturforsch. B, 1985, 40, 
681–692. 
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was stirred for 4 h at 90 °C in an oil bath. After complete consumption of the starting material 
(monitored by TLC) the mixture was cooled to RT and acidified by addition of HCl(aq) (~65 mL, 
2 M, Attention: Gas evolution at the end!). The precipitate was filtered off, washed with water and 
dried under reduced pressure. The aqueous filtrate was extracted with DCM (3 ×). The combined 
organic phases were dried over Na2SO4, combined with the solid and the solvents were removed 
under reduced pressure. The crude product was purified by FCC (DCM:MeOH, 97:3) to afford 
aldehyde 21 (683 mg, 3.75 mmol, 94%) as an off-white crystalline solid. 
 
Rf: 0.27 (hexanes:EtOAc 3:1), m.p. 176.3–177 °C (decomposition starts at 165 °C) 
1
H NMR (400 MHz, MeOD) δ 9.95 (s, 1H), 6.09 (s, 1H), 3.83 (s, 3H), 2.02 (s, 3H) ppm. 
13
C NMR (101 MHz, MeOD) δ 193.61, 167.26, 164.39, 164.32, 111.33, 109.46, 99.01, 63.53, 
8.19 ppm. 
IR (ATR): ?̃?𝒎𝒂𝒙= 3194 (br, w), 2938 (w), 1605 (s), 1474 (m), 1373 (s), 1353 (m), 1313 (m), 
1262 (s), 1244 (s), 1178 (m), 1151 (s), 1095 (s), 1007 (m), 934 (m), 878 (w), 825 (m), 804 (w), 
746 (s), 663 (m) cm−1 
HRMS (EI): calc. for C9H10O4 [M]
+: 182.0574, found: 182.0580. 
 
 
Dracorhodin perchlorate 22 Aldehyde 21 (650 mg, 3.57 mmol, 1.0 eq) was suspended in acetic 
acid (7.14 mL). Acetophenone (1.71 g, 1.66 mL, 14.3 mmol, 4.0 eq) and HClO4(aq) (11.6 M, 
1.23 mL, 4.0 eq) were added and the mixture was stirred at RT for 5 days. The bright orange solid 
was filtered off, washed with Et2O and dried in vacuo. Dracorhodin perchlorate 22 (846 mg, 65%) 
was obtained as fine orange crystals.  
m.p. 238 °C (decomp., Lit:110 227–230 °C) 
1
H NMR (400 MHz, MeOD) δ 9.31 (d, J = 8.6 Hz, 1H), 8.46 – 8.39 (m, 3H), 7.86 – 7.80 (m, 1H), 
7.74 (t, J = 7.7 Hz, 2H), 7.37 (s, 1H), 4.08 (s, 3H), 2.38 (s, 3H) ppm. 
13
C NMR (101 MHz, MeOD) δ 172.48, 172.11, 159.62, 158.72, 151.23, 136.78, 131.20, 130.69, 
130.03, 125.56, 118.19, 113.30, 99.25, 64.12, 9.83 ppm. 
IR (ATR): ?̃?𝒎𝒂𝒙= 3071 (w br), 1630 (m), 1596 (w), 1583 (w), 1532 (s), 1446 (m), 1388 (s), 1336 
(s), 1301 (m), 1270 (w), 1242 (s), 1196 (m), 1168 (w), 1097 (s), 1043 (s), 1015 (s), 996 (s), 950 
                                                   
110 A. Robertson, W. B. Whalley, J. Yates, J. Chem. Soc., 1950, 0, 3117–3123. 
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(m), 930 (m), 911 (m), 881 (w), 846 (ss), 787 (s), 754 (s), 706 (w), 683 (m), 668 (w) cm-1 
HRMS (ESI): calc. for C17H15O3 [M-ClO4]
+: 267.1016, found: 267.1014. 
 
 
Aldehyde 23 Ester 20 (226 mg, 1.00 mmol, 1.0 eq) and LiOH·H2O (1.26 g, 30.0 mmol, 30 eq) were 
suspended in water (30 mL) in a 50 mL flask. The flask was capped with a septa and purged with 
nitrogen for 5 min. The mixture was stirred in an oil bath at 90 °C. The reaction turned into a clear 
yellow solution after approx. 45 minutes. After complete consumption of the starting material 
indicated by TLC the reaction was cooled to RT after 2 h and acidified carefully with HCl(aq) 
(~17 mL, 2 M, Attention: Gas evolution at the end!). The precipitated crude product was extracted 
with DCM (4 ×), dried over Na2SO4 and concentrated under reduced pressure. Purification by FCC 
(DCM:MeOH, 97:3) afforded aldehyde 23 (141 mg, 84%) as colorless crystalline needles.  
Rf: 0.13 (hexanes:EtOAc 3:1), m.p. 209 °C (decomp., Lit:
[5] 203 °C) 
1
H NMR (400 MHz, DMSO-d6) δ 12.34 (s, 1H), 10.95 (s, 1H), 9.94 (s, 1H), 5.98 (d, J = 2.0 Hz, 
1H), 5.86 (d, J = 2.0 Hz, 1H), 3.81 (s, 3H) ppm. 
13
C NMR (101 MHz, DMSO-d6) δ 190.72, 167.46, 165.17, 163.98, 104.61, 94.99, 91.23, 55.94 
ppm. 
IR (ATR): ?̃?𝒎𝒂𝒙= 3185 (m br), 2584 (w), 1632 (s), 1600 (s), 1584 (s), 1535 (w), 1498 (s), 1476 
(s), 1450 (m), 1436 (m), 1380 (w), 1352 (w), 1283 (s), 1227 (s), 1206 (s), 1185 (s), 1161 (s9, 
1108 (s), 959 (m), 833 (m), 818 (m), 788 (s), 738 (m), 726 (s), 695 (s), 654 (w) cm-1 
HRMS (EI): calc. for C8H8O4 [M]
+: 168.0417, found: 168.0418. 
The reported data match those previously reported.111  
 
 
Nordracorhodin perchlorate 24 Aldehyde 23 (841 mg, 5.00 mmol, 1.0 eq) was suspended in 
acetic acid (10.0 mL). Acetophenone (1.80 g, 1.75 mL, 15.0 mmol, 3.0 eq) and HClO4(aq) (11.6 M, 
1.72 mL, 4.0 eq) were added and the mixture was stirred at RT for 2.5 h. The solid was filtered off, 
                                                   
111 W. Bradley, R. Robinson, G. Schwarzenbach, J. Chem. Soc., 1930, 0, 793–817. 
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washed with Et2O and dried in vacuo. Nordracorhodin perchlorate 24 (730 mg, 41%) was afforded 
as a red powder.  
 
m.p. 245 °C (decomp.) 
1
H NMR (400 MHz, MeOD) δ 9.31 (dd, J = 8.5, 0.7 Hz, 1H), 8.43 – 8.38 (m, 2H), 8.29 (d, J = 
8.5 Hz, 1H), 7.86 – 7.80 (m, 1H), 7.76 – 7.70 (m, 2H), 7.13 (dd, J = 1.9, 0.8 Hz, 1H), 6.86 (d, J = 
1.9 Hz, 1H), 4.15 (s, 3H) ppm. 
13
C NMR (101 MHz, MeOD) δ 174.43, 172.25, 161.51, 161.36, 150.76, 136.70, 131.16, 130.67, 
129.89, 116.21, 111.97, 101.61, 96.86, 58.04 ppm. 
IR (ATR): ?̃?𝒎𝒂𝒙= 3175 (w br), 3107 (w), 1712 (w), 1642 (s), 1582 (m), 1572 (), 1537 (s), 1500 
(w), 1462 (w), 1448 (w), 1437 (w), 1391 (m), 1368 (m), 1337 (s), 1303 (m), 1260 (m), 1240 (s), 
1213 (s), 1196 (m), 1180 (m), 1159 (m), 1124 (s), 1109 (s), 1098 (s), 1047 (s), 997 (m), 961 (w), 
925 (m), 853 (m), 842 (w), 821 (m), 786 (m), 745 (m), 719 (w), 686 (s), 655 (w) cm-1 
HRMS (ESI): calc. for C16H13O3 [M-ClO4]
+: 253.0860, found: 253.0857. 
 
 
Flavanol 1 Nordracorhodin perchlorate 24 (556 mg, 1.58 mmol, 1.0 eq) was dissolved in MeOH 
(80 mL). The flask was capped, purged with nitrogen for 5 min and heated in an oil bath at 40 °C. 
When the temperature was reached, triethylsilane (1.83 g, 2.52 mL, 15.8 mmol, 10 eq) was added 
und vigorous stirring, followed by a suspension of Raney-Nickel in water (1 mL, excess). A strong 
gas evolution was observed accompanied by a decolorization of the orange solution. The reaction 
was stirred for 15 min at 40 °C and filtered over a plug of celite (Attention: Raney-Ni is pyrophoric!) 
and washed with ethylacetate. The solvents were removed under reduced pressure and the crude 
product was purified by FCC (hexanes:ethyl acetate, 3:1) to afford 5-methoxyflavan-7-ol 1 
(307 mg, 75%) as a colorless sticky oil. Storage under air reddens the compound due to 
rearomatizative oxidation. Trituration under hexanes leads to crystallization of the oil affording a 
colorless solid. 
 
Rf: 0.28 (hexanes:EtOAc 3:1), m.p. 95.5–96.7 °C (Lit: 94 °C) 
1
H NMR (400 MHz, CDCl3) δ 7.45 – 7.37 (m, 4H), 7.36 – 7.30 (m, 1H), 6.07 (d, J = 2.3 Hz, 1H), 
6.04 (d, J = 2.3 Hz, 1H), 5.17 (s, 1H), 4.99 (dd, J = 10.3, 2.2 Hz, 1H), 3.78 (s, 3H), 2.75 (ddd, J = 
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16.7, 5.8, 3.2 Hz, 1H), 2.64 (ddd, J = 16.8, 11.0, 6.1 Hz, 1H), 2.20 (ddt, J = 13.6, 5.8, 2.9 Hz, 1H), 
2.01 (dtd, J = 13.7, 10.7, 5.9 Hz, 1H) ppm. 
13
C NMR (101 MHz, CDCl3) δ 158.78, 156.33, 155.12, 141.67, 128.61, 127.95, 126.15, 103.52, 
96.21, 91.60, 77.84, 55.60, 29.59, 19.30 ppm. 
IR (ATR): ?̃?𝒎𝒂𝒙= 3384 (w br), 2935 (w), 2847 (w), 1601 (s), 1497 (s), 1468 (s), 1366 (w), 1341 
(w), 1308 (w), 1267 (w), 1198 (m), 1177 (m), 1138 (s), 1106 (s), 1068 (m) 1045 (m), 1029 (w), 
1013 (m), 984 (w), 964 (w), 907 (m), 889 (w), 817 (m), 759 (m), 733 (m), 699 (m) cm-1 
HRMS (EI): calc. for C16H16O3 [M]
+: 256.1094, found: 256.1089. 
The reported data match those previously reported.112  
Nordracorhodin hexafluorophosphate, that was obtained in 61% yield by a similiar procedure as 
Nordracorhodin perchlorate 24 (41%) afforded under the same reductive conditions only 21% of 
the flavanol 1. 
Flavanol 1 could also be obtained by an unoptimized procedure starting with commercially 
available chrysin in only two steps.  
 
 
Protected Chrysin S5 To a suspension of chrysin (26) (10.2 g, 40.0 mmol, 1.0 eq) and K2CO3 
(16.6 g, 120 mmol, 3.0 eq) in acetone (120 mL) was added benzyl bromide (6.84 g, 4.75 mL, 
40.0 mmol, 1.0 eq). The reaction mixture was stirred for 3 h at 60 °C. After TLC indicated complete 
consumption of the starting material, the reaction mixture was cooled to 40 °C and dimethyl sulfate 
(11.38 mL, 15.14 g, 120 mmol, 3.0 eq) was added. The reaction mixture was stirred for 1 day before 
the temperature was risen to 70 °C. It was stirred for another 3 days at this temperature. The 
suspension was filtered and the filtrate was concentrated under reduced pressure. The filter cake 
was combined with the residue and stirred with a mixture of DCM and water. The aqueous phase 
was acidified with HCl(aq) (2 M) till the pH value was around 2 and extracted after phase separation 
with DCM (2 × 50 mL). The combined organic phases were washed with brine, dried over Na2SO4 
and concentrated under reduced pressure. The crude product was purified by FCC (1. DCM/MeOH 
97/3; 2. Ethyl acetate) to afford the product S5 (8.44 g, 23.6 mmol, 59%) as a colorless solid.  
                                                   
112 A. Robertson, W. B. Whalley, J. Yates, J. Chem. Soc., 1950, 0, 3117–3123. 
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Rf: 0.25 (EtOAc ), m.p. 183.2–185.6 °C (Lit: 178–180 °C) 
1
H NMR (400 MHz, Chloroform-d) δ 7.92 – 7.84 (m, 2H), 7.56 – 7.33 (m, 8H), 6.73 (s, 1H), 6.67 
(d, J = 2.1 Hz, 1H), 6.47 (d, J = 2.0 Hz, 1H), 5.16 (s, 2H), 3.95 (s, 3H) ppm. 
13
C NMR (101 MHz, CDCl3) δ 177.77, 163.29, 161.08, 160.89, 160.00, 135.75, 131.61, 131.37, 
129.08, 128.95, 128.65, 127.80, 126.11, 109.54, 109.17, 96.92, 93.86, 70.69, 56.64 ppm. 
IR (ATR): ?̃?𝒎𝒂𝒙= 2063 (w br), 2363 (w), 1644 (s), 1606 (s), 1578 (m), 1488 (m), 1463 (m), 1449 
(m), 1422(w), 1389 (w), 1346 (s), 1303 (w), 1262 (w), 11213 (m), 1190 (m), 1164 (s), 1119 (s), 
1101 (m), 1016 (w), 1032 (w), 906 (w), 847 (w), 823 (w), 766 (m), 695 (m) cm-1 
HRMS (EI): calc. for C23H18O4 [M]
+: 358.1200, found: 358.1202. 
The reported data match those previously reported.113  
 
 
 
Flavanol 1 Protected Chrysin S5 (2.84 g, 7.92 mmol, 1.0 eq) and Pd/C 10% (211 mg, 0.198 mmol, 
0.025 eq) were suspended in EtOAc (32 mL). The suspension was placed in a steel autoclave that 
was pressurized to 20 bar H2 after purging and releasing with hydrogen (10 bars × 3). The 
suspension was stirred at RT for 18 h. The pressure was released, the solvent was removed under 
reduced pressure and the crude mixture was resuspended in EtOH (30 mL). The reaction mixture 
was placed back in the steel reactor and pressurized to 20 bar H2 according the same procedure as 
before. The mixture was stirred for 24 h at RT. The pressure was released, the crude solution filtered 
over a plug of celite and concentrated under reduced pressure. The crude product was purified by 
FCC (DCM/MeOH; 97:3) to afford flavan-7-ol 4 (558 mg, 28%) as a colorless sticky oil. Storage 
under air reddens the compound due to rearomatizative oxidation. Trituration under hexanes leads 
to crystallization of the oil affording a colorless solid. 
See previous experiments for analytical data. 
 
                                                   
113 T. E. Adams, M. El Sous, B. C. Hawkins, S. Hirner, G. Holloway, M. L. Khoo, D. J. Owen, G. P. Savage, 
P. J. Scammells, M. A. Rizzacasa, J. Am. Chem. Soc., 2009, 131, 1607–1616. 
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TBS ether S6 Chrysin (26) (0.76 g, 3.00 mmol, 1.0 eq), imidazole (266 mg, 3.9 mmol, 1.3 eq) and 
4-dimethylaminopyridine (3.7 mg, 0.03 mmol, 0.01 eq) were dissolved in dry DMF (15 mL). To the 
clear solution was added tert-butyldimethylsilyl chloride (0.59 g, 3.9 mmol, 1.3 eq) under argon. 
The solution was stirred for 1 h at RT. After complete conversion monitored by TLC, the reaction 
was quenched by addition of diethyl ether (100 mL) and water (15 mL). The aqueous phase was 
disposed and the organic phase was washed with water (5 × 5 mL) and brine (10 mL). The organic 
phase was dried over Na2SO4 and concentrated under reduced pressure. Purification by FCC 
(hexanes:ethyl acetate, 6:1) afforded TBS ether S6 (1.08 g, 98%) as a yellow crystalline solid.  
Rf: 0.82 (hexanes:EtOAc 3:1), m.p. 146.8 - 147.5 °C  
1
H NMR (400 MHz, Chloroform-d) δ 12.69 (s, 1H), 7.92 – 7.85 (m, 3H), 7.58 – 7.48 (m, 3H), 
6.67 (s, 1H), 6.46 (d, J = 1.9 Hz, 1H), 6.31 (d, J = 1.9 Hz, 1H), 1.00 (s, 9H), 0.28 (s, 6H) ppm. 
13
C NMR (101 MHz, CDCl3) δ 182.72, 164.12, 162.51, 162.20, 157.76, 131.97, 131.48, 129.21, 
126.45, 106.36, 105.99, 104.09, 98.96, 25.68, 18.39, −4.19 ppm. 
HRMS (ESI): calc. for C21H25O4Si
+ [M+H]+: 369,15166, found: 369,15145. 
 
 
 
Methylated chrysin 27 NaH (60% in mineral oil, 60 mg, 1.5 mmol, 1.5 eq) was suspended in a 
flame-dried flask in dry hexane (3 mL) under argon. After stirring for 15 minutes, the organic phase 
was carefully removed. To the washed sodium hydride was added dry THF (10 mL). The 
suspension was cooled to 0 °C and TBS protected chrysin S6 (369 mg, 1.0 mmol, 1.0 eq) was added. 
The reaction mixture was stirred for 15 minutes at RT before methyl iodide (426 mg, 187 µL, 
3.0 mmol, 3.0 eq) was added. The ice bath was removed and the solution was stirred at RT for 72 h 
before the reaction was quenched by addition of saturated NH4Cl(aq) solution. The mixture was 
extracted with ethyl acetate (3 × 10 mL). The combined organic phases were washed with brine, 
dried over Na2SO4 and concentrated under reduced pressure. Purification by FCC (1. DCM/MeOH, 
97:3, 2. Ethyl acetate) afforded the title compound 27 (166 mg, 44%) as a colorless solid.  
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Rf: 0.41 (EtOAc), m.p. 151.6–152.2 °C  
1
H NMR (400 MHz, Chloroform-d) δ 7.80 (dd, J = 6.5, 2.7 Hz, 2H), 7.46 – 7.38 (m, 3H), 6.60 (s, 
1H), 6.48 (d, J = 1.9 Hz, 1H), 6.26 (d, J = 1.9 Hz, 1H), 3.90 (s, 3H), 0.96 (s, 9H), 0.25 (s, 
6H) ppm. 
13
C NMR (101 MHz, CDCl3) δ 177.56, 160.93, 160.61, 160.53, 159.35, 131.40, 131.09, 128.81, 
125.85, 109.59, 108.81, 100.41, 100.21, 56.34, 25.51, 18.18, −4.34 ppm. 
IR (ATR): ?̃?𝒎𝒂𝒙= 2954 (m), 2930 (m), 2858 (m), 1643 (s), 1604 8s9, 1578 (w), 1566 (w), 1462 
8w9, 1448 (m), 1416 (m), 1383 (w), 1343 (s), 1310 (w), 1285 (w), 1258 (m), 1212 (m), 1165 (s), 
1117 (s), 1098 (w), 1051 (m), 1032 (w), 999 (m), 958 (w), 837 (s), 783 8m), 767 (m), 690 (m), 
676 (w) cm-1.  
HRMS (ESI): calc. for C22H27O4Si
+ [M+H]+: 383,16731, found: 383,16672. 
 
 
Flavan-4-ol 28 To a flame-dried Schlenk tube equipped with a magnetic stirring bar was added 
bis(2-methylallyl)(1,5-cyclooctadiene)ruthenium(II) (9.6 mg, 0.03 mmol, 0.1 eq), (R,R)-
SINpEt·HBF4 (29.8 mg, 0.064 mmol, 0.12 eq) and potassium t-butanolate (10.0  mg; 0.090 mmol, 
0.27 eq) in a glove box. The mixture was suspended in dry hexane (1 mL) and stirred at 70 °C for 
14 h under argon. The afforded yellow catalyst suspension was transferred to a flame-dried vial 
equipped with a magnetic stirring bar and protected chrysin 27 (115 mg, 0.30 mmol, 1.0 eq). The 
suspension was diluted with dry hexane (2 mL) and dry toluene (3 mL) and placed in a high-
pressure stainless-steel autoclave filled with argon. The autoclave was closed and carefully 
pressurized/depressurized with hydrogen gas thrice before the reaction pressure of 150 bar was 
adjusted. The reaction mixture was stirred for 48 h in a tempered metal block at 25 °C before the 
pressure was carefully released. The crude mixture was filtered over a plug of silica and flushed 
with diethyl ether. Purification by FCC (hexanes:ethyl acetate, 6:1) afforded compound 28 
(25.6 mg, 22%) as a colorless oil with a dr of 2.7:1.  
Rf: 0.54 (cis), 0.49 (trans) (hexanes:EtOAc 3:1),  
For the major product (Cis-product) 
1
H NMR (400 MHz, Chloroform-d) δ 7.50 – 7.31 (m, 5H), 
6.08 (d, J = 1.8 Hz, 1H), 6.04 (d, J = 2.0 Hz, 1H), 5.29 – 5.22 (m, 1H), 5.01 (s, 1H), 3.94 (s, 1H), 
3.86 (s, 3H), 2.51 (dd, J = 13.4, 7.2 Hz, 1H), 2.30 – 2.16 (m, 1H), 0.98 (s, 9H), 0.21 (s, 6H) ppm. 
For the major product (Cis-product) 
13
C NMR (101 MHz, CDCl3) δ 159.24, 156.74, 156.45, 
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140.49, 128.74, 128.34, 126.45, 108.01, 101.47, 96.93, 77.22, 63.57, 55.75, 37.98, 25.80, 18.31, 
−4.27 ppm. 
IR (ATR): ?̃?𝒎𝒂𝒙= 3562 (m), 2956 (m), 2930 (m), 2886 (m), 2858 (m),  1613 (s), 1584 (s), 1490 
(m), 1429 (m), 1452 (m), 1390 (w), 1363 (m), 1342 (w), 1318 (w), 1283 (w), 1254 8m), 1209 (m), 
1187 (m), 1153 (s), 1114 (w), 1045 (m), 1016 (w), 957 (w), 840 (s), 782 (m), 759 (w), 
699 (m) cm-1. 
HRMS (EI): calc. for C22H30O4Si
+ [M]+: 386,1908, found: 386,1903. 
 
 
Chromane S7 Flavan-4-ol 28 (10.8 mg, 27.9 µmol, 1.0 eq) was dissolved under nitrogen in dry 
DCM (280 µL). The solution was cooled to 0 °C and triethyl silane (13.5 µL, 84 µmol, 3.0 eq) was 
added. Titanium tetrachloride (1 M in DCM, 84 µL, 84 µmol, 3.0 eq) was added dropwise and the 
orange-red solution was stirred for 10 minutes. The reaction was quenched by addition of saturated 
NaHCO3(aq) solution (0.5 mL). The reaction mixture was extracted with EtOAc (3 × 1 mL). The 
organic phases were combined, filtered through celite and dried over Na2SO4. Purification by FCC 
(hexanes: ethyl acetate, 9:1) afforded chromane S7 (7.7 mg, 74%) as a colorless oil.  
Rf: 0.52 (hexanes:EtOAc, 9:1),  
1
H NMR (400 MHz, Chloroform-d) δ 7.47 – 7.28 (m, 5H), 6.09 (d, J = 1.9 Hz, 1H), 6.00 (d, J = 
1.9 Hz, 1H), 4.97 (dd, J = 10.3, 1.6 Hz, 1H), 3.78 (s, 3H), 2.74 (ddd, J = 16.7, 5.7, 3.0 Hz, 1H), 
2.64 (ddd, J = 16.8, 11.0, 6.1 Hz, 1H), 2.19 (ddt, J = 12.9, 5.4, 2.4 Hz, 1H), 2.07 – 1.94 (m, 1H), 
0.98 (s, 9H), 0.21 (s, 6H) ppm. 
13
C NMR (101 MHz, CDCl3) δ 158.43, 156.20, 155.20, 141.88, 128.62, 127.93, 126.21, 104.18, 
100.91, 96.07, 77.80, 55.56, 29.73, 25.86, 19.47, 18.34, −4.25 ppm. 
IR (ATR): ?̃?𝒎𝒂𝒙= 2954 (m), 2930 (m), 2857 (m), 1613 (s), 1590 (s), 1494 (m), 1450 (m), 1422 
(w), 1363 (w), 1254 (w), 1201 (m), 1177 (m), 1151 (s), 1114 8s), 1048 (w), 1019 (w), 967 (w), 
854 (s), 841 (s), 780 (m), 758 (w), 699 (m) cm-1. 
HRMS (EI): calc. for C22H30O3Si
+ [M]+: 370,19587, found: 370,1954 
[α]D
20
 = −10.1 (c = 0.375, CHCl3) 
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(−)-Methoxyflavanol 1 To a solution of chromane S7 (7.4 mg, 20 µmol, 1.0 eq) in acetonitrile 
(200 µL) and water (20 µL) was added DBU (3.0 µL, 20 µmol, 1.0 eq) and the reaction mixture was 
stirred at RT for 20 h. The reaction was quenched by addition of saturated NH4Cl(aq) solution and 
extracted with ethyl acetate (3 ×1 mL). The organic phases were combined, washed with brine, 
dried over Na2SO4 and concentrated under reduced pressure. Purification by FCC 
(hexanes:ethylacetate, 9:1) afforded 5-methoxy flavan-7-ol (1) (4.2 mg, 82%) as a colorless sticky 
oil. 
Analytical data was identical with racemic product. See racemic synthesis for details. 
82% ee (HPLC conditions: Chiralcel IA column, heptane/i-PrOH = 97/3, 1.0 mL/min, λ = 269 nm, 
tR(major) = 24.0 min, tR(minor) = 28.2 min),  
[α]D
20
 = −5.7 (c = 0.42, CHCl3)  
[Lit]114: −6.35 (c = 1.94, CHCl3) for natural (2S)-5-methoxyflavan-7-ol 
 
 
Dracoflavan C 10a/b To flavanol 1 (70.0 mg, 273 µmol, 6.0 eq) and dracorhodin perchlorate 22 
(16.7 mg, 45.5 µmol, 1.0 eq) was given water (200 µL), MeOH (400 µL) and phosphate buffer 5.8 
pH (0.1 M, 200 µL). The addition of the buffer lead to the formation of a red suspension. The vial 
was capped and placed in a metal block at 45 °C. The reaction mixture was heated up to 110 °C 
during 30 min and stirred at this temperature for 2 h. The deep-red suspension was cooled down, 
diluted with water and extracted with EtOAc (3 ×). The organic phase was dried over Na2SO4 and 
concentrated under reduced pressure. The reaction mixture was purified by four FCC purification 
steps (1. hexanes:ethyl acetate 9:16:1, 2./3. DCM:MeOH 98:1, 4. Toluene/EtOAc 10:1) to afford 
next to recovered flavanol 1 (47.4 mg, 4.1 eq) dracoflavan C (10a/b) (17.3 mg, 73%) as a colorless 
solid in a diastereomeric ratio of 56:44 (10a:10b). Storage under air leads to reddening of the 
product. 
                                                   
114 G. Cardillo, L. Merlini, G. Nasini, P. Salvadori, J. Chem. Soc., C, 1971, 3967–3970. 
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Rf: 0.42 (hexanes:EtOAc 3:1), m.p. ~130 °C (decomp. starts at 100 °C; Lit
115: 90–95 °C) 
1
H NMR (800 MHz, Acetone-d6) δ 8.24 (s, 1H), 8.20 (s, 1H), 7.73 – 7.70 (m, 6H), 7.62 – 7.60 
(m, 2H), 6.34 (s, 1H), 6.32 (s, 1H), 6.23 (s, 1H), 6.22 (s, 1H), 5.12 (dd, J = 10.4, 2.2 Hz, 1H), 5.02 
(dd, J = 10.6, 1.8 Hz, 1H), 4.77 (t, J = 3.1 Hz, 1H), 4.70 (t, J = 3.1 Hz, 1H), 3.78 (s, 3H), 3.77 (s, 
3H), 3.53 (s, 3H), 3.38 (s, 3H), 2.73 (ddd, J = 16.7, 5.8, 2.9 Hz, 1H), 2.70 – 2.62 (m, 4H), 2.60 (s, 
1H), 2.28 (dd, J = 13.1, 3.3 Hz, 1H), 2.26 (dd, J = 13.2, 3.2 Hz, 2H), 2.25 – 2.22 (m, 2H), 2.20 
(dd, J = 13.1, 3.0 Hz, 1H), 2.15 (dd, J = 13.2, 3.0 Hz, 1H) (m, 1H), 2.14 (s, 1H), 2.09 (s, 3H), 2.08 
(s, 3H), 1.98 (s, 3H), 2.00 – 1.93 (m, 2H) ppm. 
13
C NMR (201 MHz, Acetone) δ 157.80, 157.69, 157.66, 157.65, 156.07, 156.01, 153.11, 153.00, 
152.79, 152.46, 152.31, 152.06, 143.53, 143.29, 143.24, 142.95, 129.30, 129.11, 129.01, 128.97, 
128.34, 128.30, 127.34, 126.95, 126.57, 126.55, 112.48, 112.33, 111.46, 111.36, 108.93, 108.87, 
104.66, 104.45, 99.69, 99.68, 99.58, 99.57, 99.14, 99.02, 92.34, 92.29, 78.97, 78.18, 61.04, 60.65, 
55.82, 55.79, 35.42, 35.31, 30.62, 30.59, 30.51, 21.98, 21.95, 20.69, 20.20, 9.17, 9.14 ppm. 
IR (ATR): ?̃?𝒎𝒂𝒙= 3408 (w br), 2939 (w), 1612 (s), 1486 (m), 1464 (m), 1448 (m), 1426 (m), 
1336 (m), 1278 (w), 1196 (m), 1176 (w), 1114 (s), 1101 (s), 1027 (w), 1011 (w), 970 (w), 955 
(w), 910 (m), 808 (w), 762 (m), 732 (m), 699 (m) cm-1  
HRMS (ESI): calc. for C33H31O6
+ [M+H]+: 523.2115, found: 523.2117. 
Dracoflavan C was characterized as diastereomeric mixture.  
  
                                                   
115 A. Arnone, G. Nasini, O. Vajna de Pava, L. Merlini, J. Nat. Prod., 1997, 60, 971–975. 
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1H NMR comparison with isolated natural product116 
 
  
                                                   
116 A. Arnone, G. Nasini, O. Vajna de Pava, L. Merlini, J. Nat. Prod., 1997, 60, 971–975. 
No.  1H NMR Isolation 
(acetone-d6, 250 MHz) 
dracoflavan C1 (10a) 
1H NMR Synthetic 
(acetone-d6, 800 MHz) 
Δ ppm 1H NMR Isolation 
(acetone-d6, 250 MHz) 
dracoflavan C2 (10b) 
1H NMR Synthetic 
(acetone-d6, 800 MHz) 
Δ ppm 
6 (6.34) 6.34 (s, 1H) ±0.00 (6.32) 6.32 (s, 1H) ±0.00 
8 (8.31) 8.24 (s, 1H) −0.07 (8.27) 8.20 (s, 1H) −0.07 
9 3.52 3.53 (s, 3H) +0.01 3.37 3.38 (s, 3H) +0.01 
10 4.69 (J = 3.1 Hz) 4.70 (t, J = 3.1 Hz, 1H) +0.01 4.76 (J = 3.1 Hz) 4.77 (t, J = 3.1 Hz, 1H) +0.01 
11 2.24 (J = 13.2, 3.1 Hz), 
2.13 (J = 13.2, 3.1 Hz) 
2.26 (dd, J = 13.2, 
3.2 Hz, 2H), 2.15 (J = 
13.2, 3.0 Hz) 
+0.02, 
+0.02 
2.28 (J = 13.2, 3.1 Hz), 
2.19 (J = 13.2, 3.1 Hz) 
2.28 (dd, J = 13.1, 
3.3 Hz, 1H), 2.20 (dd, J 
= 13.1, 3.0 Hz, 1H) 
±0.00, 
+0.01 
14 7.72 7.73 – 7.70 n.d. 7.72 7.73 – 7.70 n.d. 
15 7.5 – 7.3 7.5 – 7.3 (m) n.d. 7.5 – 7.3 7.5 – 7.3 (m) n.d. 
16 7.5 – 7.3 7.5 – 7.3 (m) n.d. 7.5 – 7.3 7.5 – 7.3 (m) n.d. 
17 7.5 – 7.3 7.5 – 7.3 (m) n.d. 7.5 – 7.3 7.5 – 7.3 (m) n.d. 
18 7.72 7.73 – 7.70 (m) +0.01 7.72 7.73 – 7.70 +0.01 
19 2.09 2.09 (s, 3H) ±0.00 1.98 1.98 (s, 3H) ±0.00 
26 (6.23) 6.23 (s, 1H) ±0.00 (6.22) 6.22 (s, 1H) ±0.00 
28 4.99  
(J = 10.6, 2.2 Hz) 
5.02 (dd, J = 10.6, 
1.8 Hz, 1H) 
+0.03 5.11  
(J = 10.5, 2.4 Hz) 
5.12 (dd, J = 10.4, 
2.2 Hz, 1H) 
+0.01 
29 2.25 (J = 2.2 Hz), 1.96 
(J = 10.6 Hz) 
2.25 – 2.22 (m), 2.00 – 
1.93 (m) 
n.d. 2.25 (J = 6,1, 3.1, 
2.4 Hz), 1.96 
(J = 11.1, 10.5, 6.2 Hz) 
2.25 – 2.22 (m), 2.00 – 
1.93 (m) 
n.d. 
30 2.69, 2.66 2.70 – 2.62 (m) n.d. 2.72 (J = 16.8, 6.2, 
3.1 Hz), 2.65 (J = 16.8, 
11.1, 6.1 Hz) 
2.73 (ddd, J = 16.7, 5.8, 
2.9 Hz, 1H), 2.66 – 2.62 
(m) 
+0.01, 
n.d. 
32 7.70 7.73 – 7.70 (m) n.d. 7.61 7.62 – 7.60 (m, 2H) n.d. 
33 7.5 – 7.3 7.5 – 7.3 (m) n.d. 7.5 – 7.3 7.5 – 7.3 (m) n.d. 
34 7.5 – 7.3 7.5 – 7.3 (m) n.d. 7.5 – 7.3 7.5 – 7.3 (m) n.d. 
35 7.5 – 7.3 7.5 – 7.3 (m) n.d. 7.5 – 7.3 7.5 – 7.3 (m) n.d. 
36 7.70 7.73 – 7.70 (m) n.d. 7.61 7.62 – 7.60 (m, 2H) n.d. 
37 (3.77) 3.78 (s, 3H) +0.01 (3.76) 3.77 (s, 2H) +0.01 
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13C NMR comparison with isolated natural product[9] 
 
13C NMR Isolation [ppm]  
(Acetone-d6; 62.9 MHz)  
13C NMR Synthetic [ppm] 
(Acetone-d6, 201 MHz)  
Δ ppm 
157.77 157.80,  +0.03 
157.63 157.69,  
157.66,  
157.65 
+0.06, +0.03, 
+0.02 
156.07 156.07 ±0.00 
155.99 156.01 +0.02 
153.08 153.11 +0.03 
152.98 153.00 +0.02 
152.77 152.79 +0.02 
152.43 152.46 +0.03 
152.28 152.31 +0.03 
152.04 152.06 +0.02 
143.50 143.53 +0.03 
143.21 143.29,  
143.24 
+0.08, +0.03 
142.92 142.95 +0.03 
129.30 129.30 ±0.00 
129.11 129.11 ±0.00 
128.99 129.01,  
128.97 
+0.02,  
−0.02 
128.33 128.34,  
128.30 
+0.01,  
−0.03 
127.31 127.34 +0.03 
126.93 126.95 +0.02 
126.54 126.55 +0.01 
112.42 112.48 +0.06 
112.28 112.33 +0.05 
111.45 111.46 +0.01 
111.28 111.36 +0.08 
108.90 108.93 +0.03 
108.83 108.87 +0.04 
104.63 104.66 +0.03 
104.48 104.45 +0.03 
99.66 99.69,  
99.68 
+0.03 
+0.02 
99.56 99.58,  
99.57 
+0.02,  
+0.01 
99.12 99.14 +0.02 
98.98 99.02 +0.04 
92.31 92.34 +0.03 
92.26 92.29 +0.03 
78.93 78.97 +0.04 
78.14 78.18 +0.04 
61.04 61.04 ±0.00 
60.65 60.65 ±0.00 
55.78 55.82,  
55.79  
+0.04,  
+0.01 
35.37 35.42 +0.05 
35.27 35.31 +0.04 
30.62 30.62,  
30.59,  
30.51 
±0.00,  
−0.03,  
−0.11 
21.92 21.98,  
21.95 
+0.06,  
+0.03 
20.68 20.69 +0.01 
20.19 20.20 +0.01 
9.16 9.17, 
9.14 
+0.01,  
−0.02 
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Benzopyran 15a/b To a solution of flavanol 1 (103 mg, 400 µmol, 4.0 eq) and dracorhodin 
perchlorate 22 (36.7 mg, 100 µmol, 1.0 eq) in acetonitrile (1.50 mL) under N2 was given aqueous 
phosphate buffer 5.8 pH (0.1 M, 0.5 mL) under vigorous stirring whereupon the color of the solution 
reddened. The reaction mixture was stirred for 21 h at 38 °C. Approximately ¾ of the organic 
solvent was removed by a stream of nitrogen what caused a phase separation. The mixture was 
extracted with EtOAc (3×), washed with brine, dried over Na2SO4 and concentrated under reduced 
pressure. Purification by FCC (hexanes:ethyl acetate, 3:1, loading:toluene) afforded next to 
recovered flavanol 1 (90 mg, 3.5 eq), benzopyran 15a/b (29.9 mg, 76%) as an colorless –fast 
reddening, air sensitive solid in a diasteromeric ratio of 51:49. Concentration after purification by 
chromatography is carried out at 0°C under reduced pressure. 
Rf: 0.25 (hexanes:EtOAc 3:1), m.p. 135 °C (decomp.) 
1
H NMR (599 MHz, DMSO-d6) δ 9.73 (s, 1H), 9.62 (s, 1H), 9.28 (s, 1H), 9.28 (s, 1H), 7.82 – 
7.77 (m, 4H), 7.62 – 7.57 (m, 4H), 7.53 – 7.48 (m, 2H), 7.42 – 7.36 (m, 4H), 7.31 (dd, J = 18.8, 
7.8 Hz, 4H), 7.23 (q, J = 6.1 Hz, 2H), 7.16 (dt, J = 16.3, 7.7 Hz, 6H), 6.98 – 6.94 (m, 4H), 6.43 (s, 
1H), 6.43 (s, 1H), 6.43 (s, 1H), 6.36 (s, 1H), 6.15 (s, 1H), 6.13 (s, 1H), 5.29 (d, J = 5.5 Hz, 1H), 
5.27 (d, J = 5.4 Hz, 1H), 5.02 (d, J = 10.2 Hz, 1H), 4.75 (d, J = 10.8 Hz, 1H), 4.33 (s, 1H), 4.21 
(s, 1H), 3.69 (s, 3H), 3.67 (s, 3H), 3.48 (ddd, J = 7.1, 5.5, 1.8 Hz, 2H), 2.96 (s, 3H), 2.89 (s, 3H), 
2.87 (s, 3H), 2.86 (s, 3H), 2.58 – 2.51 (m, 6H), 2.26 – 2.20 (m, 1H), 2.12 – 2.07 (m, 1H), 1.94 (s, 
3H), 1.89 (s, 3H), 1.88 – 1.81 (m, 1H), 1.67 – 1.60 (m, 1H), 1.59 (s, 3H), 1.57 (s, 3H) ppm. 
13
C NMR (151 MHz, DMSO-d6) δ 156.24, 156.05, 155.99, 155.77, 155.68, 155.02, 152.21, 
151.88, 150.70, 150.62, 150.37, 149.79, 149.59, 148.95, 148.54, 148.33, 142.25, 140.57, 140.25, 
140.15, 133.58, 128.65, 128.31, 128.20, 128.05, 127.64, 127.02, 126.58, 126.35, 124.86, 124.30, 
112.86, 111.70, 111.66, 111.33, 111.19, 110.06, 109.90, 105.84, 105.65, 103.21, 102.69, 100.99, 
100.71, 98.78, 98.69, 98.15, 98.08, 97.99, 91.09, 76.35, 75.51, 59.52, 58.69, 58.52, 55.41, 47.88, 
47.33, 40.06, 29.55, 29.53, 29.44, 26.34, 21.72, 21.55, 19.31, 18.72, 8.88, 8.67, 8.61 ppm. 
IR (ATR): ?̃?𝒎𝒂𝒙= 3413 (br m), 2939 (m), 2362 (w), 1613 (s), 1493 (m), 1464 (m), 1450 (m), 
1425 (m), 11344 (w), 1321 (m), 1300 (m), 1242 (m), 1195 (m), 1120 (s), 1102 (s), 1032 (w), 1006 
(w), 964 (m), 901 (w), 828 (w), 765 (m), 763 (m), 699 (m) cm-1   
HRMS (EI): calc. for C50H44O9 [M]
+: 788.2985, found: 788.3004. 
 
86   Supporting information to chapter I – 2.1 
 
 
 
Dragonbloodin Peroxide 18a/b A solution of benzopyran 15a/b (16.8 mg, 21.3 µmol, 1.0 eq) in 
DCM/MeOH (97:3, 2.1 mL) was stirred under air at RT in a capped vial until TLC indicated 
complete consumption of the starting material. After 5 h, the solvent was blown off by a stream of 
nitrogen. The crude product was purified by FCC (DCM/MeOH 97:3) to afford 18a/b (13.1 mg, 
75%) as a colorless solid with a dr of 53:47. A crystal suitable for X-Ray analysis was obtained 
from CDCl3/hexanes.  
Attempted separation by HPLC (acetonitrile/water: 80/20) directly affords dragonbloodin A 
(11a/b) due to hydrolysis.  
 
Rf: 0.26 (hexanes:EtOAc 1:1), m.p. >200 °C (decomposition) 
1
H NMR (800 MHz, Acetone-d6**) δ 10.28 (s, 1H), 10.24 (s, 1H), 8.54 (s, 1H), 8.54 (s, 1H), 7.91 
– 7.88 (m, 4H), 7.66 – 7.62 (m, 4H), 7.56 (tq, J = 7.2, 1.2 Hz, 2H), 7.30 – 7.15 (m, 18H), 7.05 (d, 
J = 7.2 Hz, 2H), 6.47 (s, 1H), 6.46 (s, 1H), 6.11 (s, 1H), 6.08 (s, 1H), 5.43 (s, 1H), 5.43 (s, 1H), 
5.32 (t, J = 4.0 Hz, 1H), 5.06 (dd, J = 9.3, 2.9 Hz, 1H), 3.99 (d, J = 4.5 Hz, 1H), 3.86 (d, J = 4.5 
Hz, 1H), 3.85 (d, J = 9.0 Hz, 1H), 3.79 (d, J = 9.1 Hz, 1H), 3.72 (s, 6H), 3.61 (d, J = 8.8 Hz, 1H), 
3.59 (d, J = 8.8 Hz, 1H), 3.26 (d, J = 4.6 Hz, 1H), 3.25 (s, 3H), 3.24 (d, J = 4.6 Hz, 1H), 2.94 (s, 
3H), 2.93 (s, 3H), 2.87 (s, 3H), 2.55 – 2.43 (m, 3H), 2.10 – 2.03 (m, 2H), 2.03 (s, 3H), 2.00 (s, 
3H), 2.00 – 1.98 (m, 1H), 1.98 – 1.96 (m, 1H), 1.77 – 1.69 (m, 1H), 1.19 (s, 3H), 0.71 (s, 3H) 
ppm. 
13
C NMR (201 MHz, Acetone) δ 187.99, 187.77, 171.78, 171.61, 163.82, 163.24, 158.59, 158.54, 
157.67, 157.55, 156.54, 154.46, 154.10, 153.30, 153.16, 151.77, 151.67, 143.33, 141.77, 139.92, 
139.90, 138.18, 137.70, 129.94, 129.91, 129.21, 129.18, 129.14, 129.05, 128.93, 128.17, 127.90, 
127.51, 127.46, 126.64, 126.36, 113.53, 112.86, 112.45, 112.43, 109.18, 109.10, 106.74, 106.09, 
105.13, 104.89, 104.84, 104.72, 104.43, 104.35, 101.04, 100.94, 100.81, 100.75, 91.95, 91.89, 
78.04, 77.46, 59.49, 58.86, 55.75, 55.28, 55.03, 50.12, 49.72, 48.93, 48.32, 38.84, 38.71, 36.09, 
35.80, 32.63, 30.19*, 26.92, 23.32, 19.06, 16.21, 14.35, 9.57, 9.52, 8.79, 8.76 ppm. 
IR (ATR): ?̃?𝒎𝒂𝒙= 3250 (m br), 2923 (m), 2853 (w), 1675 (m), 1602 (s), 1581 (s), 1462 (w), 
1446(m), 1344 (m), 1313 (w), 1238 (m), 1198 (w), 1176 (m), 1123 (s), 1089 (s), 1001 (m), 956 
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(m), 910 (w), 832 (w), 748 (m), 697 (s) cm-1  
HRMS (ESI): calc. for C50H45O11 [M+H]
+: 821.2956, found: 821.2964 
 
*assigned by HSQC data 
**solubility in acetone-d6 is very low compared to dragonbloodin A (11a/b). 
 
 
Proposed autoxidation mechanism of the formation of 18a/b. 
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Dragonbloodin A 11a/b To a solution of peroxy compound 18a/b (2.0 mg, 2.4 µmol, 1.0 eq) in 
DCM/MeOH (97/3, 250 µL) was added dimethylsulfide (0.9 µL, 12 µmol, 5.0 eq). The solution was 
stirred at RT for 1 h. The organic solvents were removed under reduced pressure to afford 
dragonbloodin A 11a/b (2.0 mg, quantitative crude) as a colorless solid that reddens slowly under 
air. 
Rf: 0.28 (hexanes:EtOAc 1:1), m.p. >200 °C (decomposition) 
1
H NMR (400 MHz, Acetone-d6) δ 8.44 (s, 1H), 8.43 (s, 1H), 7.93 – 7.88 (m, 4H), 7.67 – 7.61 
(m, 4H), 7.59 – 7.52 (m, 2H), 7.33 – 7.14 (m, 18H), 7.08 – 7.03 (m, 2H), 6.42 (s, 2H), 6.11 (s, 
1H), 6.08 (s, 1H), 5.45 (s, 1H), 5.45 (s, 1H), 5.44 (s, 1H), 5.44 (s, 1H), 5.31 (t, J = 3.4 Hz, 1H), 
5.03 (dd, J = 9.4, 2.7 Hz, 1H), 4.04 (d, J = 4.6 Hz, 1H), 3.91(d, J = 8.5 Hz, 1H), 3.91 (d, J = 
5.0 Hz, 1H), 3.88 (d, J = 8.8 Hz, 1H), 3.77 (d, J = 8.8 Hz, 1H), 3.75 (d, J = 9.2 Hz, 1H), 3.72 (s, 
3H), 3.71 (s, 3H), 3.23 (d, J = 4.7 Hz, 1H), 3.22 (d, J = 4.9 Hz, 1H), 3.21 (s, 3H), 2.93 (s, 3H), 
2.90 (s, 6H), 2.62 – 2.40 (m, 3H), 2.02 (s, 3H), 1.99 (s, 3H), 2.11 – 1.95 (m, 4H), 1.77 – 1.65 (m, 
1H), 1.19 (s, 3H), 0.72 (s, 3H) ppm. 
13
C NMR (201 MHz, Acetone) δ 188.18, 187.93, 172.33, 172.18, 164.60, 163.89, 158.53, 158.50, 
157.88, 157.74, 156.44, 154.47, 154.14, 153.34, 153.20, 152.76, 152.67, 143.40, 142.54, 142.22, 
141.82, 140.12, 140.09, 129.86, 129.84, 129.15, 129.12, 128.71, 128.61, 128.06, 127.88, 127.55, 
127.50, 126.69, 126.38, 113.40, 112.94, 111.76, 111.75, 109.90, 109.80, 106.63, 105.94, 105.05, 
104.98, 104.92, 104.63, 101.37, 101.20, 100.96, 100.76, 97.28, 97.23, 91.95, 91.89, 78.02, 77.43, 
59.52, 59.45, 58.86, 55.75, 55.73, 55.09, 54.85, 52.91, 52.26, 49.93, 49.58, 38.91, 38.80, 36.21, 
35.88, 30.43, 26.94, 19.21, 16.35, 9.61, 9.60, 8.78, 8.74 ppm. 
IR (ATR): ?̃?𝒎𝒂𝒙= 3332 (w, br), 2958 (m), 2363 (w), 2333 (w), 1670 (s), 1617 (s), 1595 (s), 1492 
(m), 1463 (w) 1449 8m), 1424 (w), 1367 (w), 1349 (m), 1312 (w), 1264 (w), 1239 (m), 1211 (m), 
1200 (m9, 1178 (m), 1121 (s), 1091 (s), 1011 (m), 978 (w9, 954 8m), 916 (w), 892 (w), 806 (w), 
760 (w), 699 (m), 668 (w) cm-1  
HRMS (ESI): calc. for C50H45O10 [M+H]
+: 805.30072, found: 805.30136 
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The reduction of 18a/b towards dragonbloodin A (11a/b) can be conducted in the same step as the 
oxidation of 15a/b towards 18a/b without any significant drop in yield. Yet this is not 
recommendable as dragonbloodin A proved to be less column stable than 18a/b.  
 
 
 
Dragonbloodin A 11a/b To a suspension of benzopyran 15a/b (24.3 mg, 30.8 µmol, 1.0 eq) in 
DCM/HFIP (hexafluoro-iso-propanol) (3/5, 1.60 mL) was added (Diacetoxyiodo)benzene 
(10.9 mg, 33.9 µmol, 1.1 eq) as a solution in HFIP (600 µL) at -18 °C. The solution was stirred for 
5 minutes and quenched by the addition of acetone. The solvents were removed under reduced 
pressure and the crude mixture was purified by FCC (DCM/MeOH: 99/1) to afford the title 
compound 11a/b (6.2 mg. 25%) as a reddish solid.  
 
See previous experiments for analytical data.  
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1H- NMR comparison with isolated natural product117 
 
 
                                                   
117 W.-K. Du, H.-Y. Hung, P.-C. Kuo, T.-L. Hwang, L.-C. Shiu, K.-B. Shiu, E.-J. Lee, S.-H. Tai, T.-S. Wu, 
Org. Lett., 2016, 18, p. 3042. 
No.  1H NMR Isolation 
(400 MHz, Acetone-
d6) 
Dragonbloodin A1 
(11a) [ppm] 
1H NMR synthetic 
(400 MHz,  
Acetone-d6) 
[ppm] 
Δ ppm 1H NMR Isolation  
(400 MHz, Acetone-
d6) 
Dragonbloodin A2 
(11b) [ppm] 
1H NMR synthetic 
(400 MHz,  Acetone-
d6) 
[ppm] 
Δ ppm 
3 3.90(d, J = 9.1 Hz) 3.91 (d, J = 8.8 Hz) +0.01 3.86 (d, J = 9.1 Hz) 3.87 (d, J = 9.1 Hz) +0.01 
4 3.75(d, J = 9.1 Hz) 3.76 (d, J = 8.9 Hz) +0.01 3.74 (d, J = 9.1 Hz) 3.75 (d, J = 8.9 Hz) +0.01 
8 6.40(s) 6.41 (s) +0.01 6.40 (s) 6.41 (s) +0.01 
10 7.30 – 7.25 (m) 7.33 – 7.19 (m) n.d. 7.18 – 7.14 (m) 7.30 – 7.12 (m) n.d. 
11 7.30 – 7.25 (m) 7.33 – 7.19 (m) n.d. 7.18 – 7.14 (m) 7.30 – 7.12 (m) n.d. 
12 7.30 – 7.25 (m) 7.33 – 7.19 (m) n.d. 7.18 – 7.14 (m) 7.30 – 7.12 (m) n.d. 
13 7.30 – 7.25 (m) 7.33 – 7.19 (m) n.d. 7.18 – 7.14 (m) 7.30 – 7.12 (m) n.d. 
14 7.30 – 7.25 (m) 7.33 – 7.19 (m) n.d. 7.18 – 7.14 (m) 7.30 – 7.12 (m)j n.d. 
2-OH 5.41(s) 5.44 (s) +0.03 5.41 (s) 5.43 (s) +0.02 
5-
OMe 
2.93(s) 2.94 (s) +0.01 2.92 (s) 2.93 (s) +0.01 
6-Me 2.01(s) 2.02 (s) +0.01 1.98 (s) 1.99 (s) +0.01 
7-OH 8.33(s) 8.44 (s) +0.11 8.28 (s, br) 8.49 (s) +0.21 
2′ 3.21(d, J = 4.6 Hz) 3.22 (d, J = 4.6 Hz) +0.01 3.21 (d, J = 4.9 Hz) 3.22 (d, J = 5.3 Hz) +0.01 
3′ 4.03(d, J = 4.6 Hz) 4.03 (d, J = 4.6 Hz) +0.01 3.90 (d, J = 4.9 Hz) 3.90 (d, J = 4.7 Hz) ±0.00 
8′ 5.42(s) 5.44 (s) +0.02 5.42 (s) 5.45 (s) +0.03 
11′ 7.89(d, J = 7.4 Hz) 7.90 (d, J = 7.7 Hz) +0.01 7.90 (d, J = 7.4 Hz) 7.90 (d, J = 7.4 Hz) ±0.00 
12′ 7.63 (t, J = 7.7 Hz) 7.64 (t, J = 7.6 Hz) +0.01 7.64 (t, J = 7.7 Hz) 7.65 (t, J = 7.6 Hz) +0.01 
13′ 7.55(t, J = 7.7 Hz) 7.56 (t, J = 7.3 Hz) +0.01 7.55 (t, J = 7.7 Hz) 7.56 (t, J = 7.3 Hz) +0.01 
14′ 7.63(t, J = 7.7 Hz) 7.64 (t, J = 7.6 Hz) +0.01 7.64 (t, J = 7.7 Hz) 7.65 (t, J = 7.6 Hz) +0.01 
15′ 7.89(d, J = 7.4 Hz) 7.90 (d, J = 7.7 Hz) +0.01 7.90 (d, J = 7.6 Hz) 7.90 (d, J = 7.4 Hz) ±0.00 
5′-
OMe 
2.89(s) 2.90 (s),  
(assigned by 
HSQC) 
 
+0.01 3.20 (s) 3.21 (s) +0.01 
6′-Me 1.17(s) 1.18 (s) +0.01 0.70 (s) 0.71 (s) +0.01 
2′′ 5.02(dd, J = 9.2, 
2.6 Hz) 
5.03 (dd, J = 9.4, 
2.2 Hz) 
+0.01 5.31 (dd, J = 5.2, 
4.0 Hz) 
5.31 (t, J = 3.3 Hz) ±0.00 
3′′ 2.05 – 2.01(m) 
1.71(m) 
2.12 – 2.00 (m) 
(assigned by 
HSQC) 
1.79 – 1.64 (m) 
n.d. 2.05 – 1.98 (m) 
2.05 – 1.98 (m) 
2.11 – 1.95 (m) 
(assigned by HSQC) 
 
n.d. 
4′′ 2.53 (ddd, J = 16.0, 
5.7, 4.6 Hz) 
2.45(ddd, J = 
17.2,10.5, 5.9 Hz) 
2.58 – 2.41 (m) n.d. 2.50 (ddd, J = 16.8, 
6.2, 4.9 Hz), 
1.94-1.98 (m) 
2.55 – 2.47 (m) 
2.02 – 1.93 (m) 
n.d. 
6′′ 6.07(s) 6.08 (s) +0.01 6.10 (s) 6.11 (s) +0.01 
10′′ 7.23 – 7.20(m) 7.33 – 7.19 (m) n.d. 7.05 (d, J = 7.1 Hz) 7.06 (d, J = 6.8 Hz) +0.01 
11′′ 7.23 – 7.20(m) 7.33 – 7.19 (m) n.d. 7.24 – 7.19 (m) 7.30 – 7.12 (m) n.d. 
12′′ 7.25 – 7.24(m) 7.33 – 7.19 (m) n.d. 7.24 – 7.19 (m) 7.30 – 7.12 (m) n.d. 
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13″ 7.23 – 7.20 (m) 7.33 – 7.19 (m) n.d. 7.24 – 7.19 (m) 7.30 – 7.12 (m) n.d. 
14″ 7.23 – 7.20(m) 7.33 – 7.19 (m) n.d. 7.05 (d, J = 7.1 Hz) 7.06 (d, J = 6.8 Hz) +0.01 
5′′-
OMe 
3.71 (s) 3.72 (s) +0.01 3.71 (s) 3.71 (s) ±0.00 
No.  13C NMR Isolation 
(100 MHz, Acetone-
d6) Dragonbloodin 
A1 (11a) [ppm] 
13C NMR 
(201 MHz) 
synthetic [ppm] 
Δ ppm 1H NMR Isolation 
(100 MHz, Acetone-
d6) Dragonbloodin A2 
(11b) [ppm] 
13C NMR 
(201 MHz) 
synthetic [ppm] 
Δ ppm 
2 96.91 (s) 97.24 +0.35 96.85 (s) 97.18 +0.33 
3 51.85 (d) 52.21 +0.36 52.52 (d) 52.87 +0.35 
4 35.81 (d) 36.17 +0.36 35.49 (d) 35.83 +0.34 
4a 109.59 (s) 109.86 +0.27 109.49 (s) 109.70 +0.21 
5 157.37 (s) 157.69 +0.32 157.51 (s) 157.81 +0.30 
6 111.36 (s) 111.71 +0.35 111.38 (s) 111.72 +0.34 
7 156.04 (s) 156.43 +0.39 156.03 (s) 156.44 +0.41 
8 100.37 (d) 100.72 +0.35 100.57 (d) 100.92 +0.35 
8a 152.40 (d) 152.73 +0.33 152.31 (d)  152.63 +0.32 
9 143.04 (s) 143.36 +0.32 141.45 (s) 141.78 +0.33 
10 128.76 (d) 126.36, 128.11, 
129.10 
+0.34, 
n.d. 
128.80 126.35, 128.03, 
129.14 
+0.34, 
n.d. 
11 128.76 (d) 126.36, 128.11, 
129.10 
+0.34, 
n.d. 
128.80 126.35, 128.03, 
129.14 
+0.34, 
n.d. 
12 128.76 (d) 126.36, 128.11, 
129.10 
+0.34, 
n.d. 
128.80 126.35, 128.03, 
129.14 
+0.34, 
n.d. 
13 128.76 (d) 126.36, 128.11, 
129.10 
+0.34, 
n.d. 
128.80 126.35, 128.03, 
129.14 
+0.34, 
n.d. 
14 128.76 (d) 126.36, 128.11, 
129.10 
+0.34, 
n.d. 
128.80 126.35, 128.03, 
129.14 
+0.34, 
n.d. 
5-OMe 59.08 (q) 59.42 +0.34 59.08 59.41 +0.33 
6-Me 8.42 (q) 8.77 +0.35 8.38 8.73 +0.35 
1′ 104.58 (s) 104.94 +0.36 104.52 (s) 104.90 +0.38 
2′ 49.20 (d) 49.55 +0.35 49.56 (s) 49.91 +0.35 
3′ 38.49 (d) 38.86 +0.37 38.40 (d) 38.76 +0.36 
4′ 54.68 (s) 55.05 +0.37 54.42 (s) 54.80 +0.38 
5′ 164.17 (s) 164.60 +0.43 163.43 (s) 163.91 +0.48 
6′ 112.55 (s) 112.90 +0.35 113.02 (s) 113.35 +0.33 
7′ 187.71 (s) 188.16 +0.45 187.43 (s) 187.97 +0.54 
8′ 106.30 (d) 106.60 +0.30 105.60 (d) 105.87 +0.27 
9′ 171.74 (s) 172.16 +0.42 171.89 (s) 172.35 +0.46 
10′ 139.72 (s) 140.05 +0.33 139.75 (s) 140.06 +0.31 
11′ 127.15 (d) 127.49 +0.34 127.20 (d) 127.53 +0.33 
12′ 128.80 (d) 129.10 +0.30 128.80 (d) 129.14 +0.34 
13′ 129.49 (d) 129.83 +0.34 129.52 (d) 129.86 +0.34 
14′ 128.80 (d) 129.10 +0.30 128.80 (d) 129.14 +0.34 
15′ 127.15 (d) 127.49 +0.34 127.20 (d) 127.53 +0.33 
5′-OMe 59.16 (q) 59.51 +0.35 58.50 (q) 58.85 +0.35 
6′-Me 9.24 (q) 9.59 +0.35 9.24 (q) 9.58 +0.34 
2′′ 77.64 (d) 77.99 +0.35 77.02 (d) 77.37 +0.35 
3′′ 29.97 (t) 30.4 (assigned by 
HSQC) 
+0.4 26.56 (t) 26.91 +0.35 
4′′ 18.85 (t) 19.19 +0.34 15.92 (t) 16.25 +0.33 
4′′a 104.22 (s) 104.58 +0.36 104.64 (s) 104.90 +0.26 
5′′ 158.11 (s) 158.46 +0.35 158.15 (s) 158.48 +0.33 
6′′ 91.56 (d) 91.91 +0.35 91.50 (d) 91.84 +0.34 
7′′ 152.83 (s) 153.16 +0.33 152.97 (s) 153.29 +0.32 
8′′ 100.97 (s) 101.32 +0.35 100.80 (s) 101.14 +0.34 
8′′a 153.77 (s) 154.11 +0.34 154.07 (s) 154.41 +0.34 
9′′ 141.84 (s) 142.19 +0.36 142.17 (s) 142.51 +0.34 
10′′ 126.03 (d) 126.42 +0.39 126.29 (d) 126.62 +0.33 
11′′ 127.70 (d) 128.03 +0.33 127.50 (d) 127.85 +0.35 
12′′ 128.36 (d) 128.70 +0.34 128.25 (d) 128.58 +0.33 
13″ 127.70 (d) 128.03 +0.33 127.50 (d) 127.85 +0.35 
14″ 126.03 (d) 126.42 +0.39 126.29 (d) 126.62 +0.33 
5′′-
OMe 
55.38 (q) 55.73 +0.35 55.36 (q) 55.71 +0.35 
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1.2 NMR spectra 
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HSQC 18a/b 
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HSQC 11a 
 
HMBC 11a 
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COSY 11a 
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HSQC 11b 
 
HMBC 11b  
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COSY 11b
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1.3 X-Ray crystallographic analysis data 
 
 
 
Dragonbloodin peroxide (18a/b)  
net formula C50H44O11 
Mr/g mol−1 820.85 
crystal size/mm 0.100 × 0.090 × 0.020 
T/K 100(2) 
radiation MoKα 
diffractometer 'Bruker D8 Venture TXS' 
crystal system orthorhombic 
space group 'P b c a' 
a/Å 18.3069(8) 
b/Å 20.2298(7) 
c/Å 26.5416(10) 
α/° 90 
β/° 90 
γ/° 90 
V/Å3 9829.5(7) 
Z 8 
calc. density/g cm−3 1.109 
μ/mm−1 0.078 
absorption correction Multi-Scan 
transmission factor range 0.8689–0.9593 
refls. measured 68880 
Rint ? 
mean σ(I)/I 0.0657 
θ range 3.255–26.37 
observed refls. 6328 
x, y (weighting scheme) 0.1195, 0.0000 
hydrogen refinement constr 
refls in refinement 10043 
parameters 576 
restraints 0 
R(Fobs) 0.0671 
Rw(F2) 0.2048 
S 1.045 
shift/errormax 0.001 
max electron density/e Å−3 0.330 
min electron density/e Å−3 −0.286 
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Figure 1-1: Crystal structure of dragonbloodin A1 and the unnatural A2 enantionmer with structural disorder on the 
flavan moiety.  
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1.4 Chiral HPLC data 
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2 Supporting information for chapter II – 2.1 
 
2.1 General experimental details  
 
All reactions were carried out with magnetic stirring, and if moisture or air sensitive, under nitrogen 
or argon atmosphere using standard Schlenk techniques in oven-dried glassware (100 °C oven 
temperature). If required glassware was further dried under vacuum with a heat-gun at 650 °C. 
External bath thermometers were used to record all reaction temperatures. Low temperature 
reactions were carried out in a Dewar vessel filled with acetone/dry ice (T between –78 °C and 
0 °C) or distilled water/ice (0 °C). High temperature reactions were conducted using a heated silicon 
oil bath or a metal block in reaction vessels equipped with a reflux condenser or in a pressure tube. 
Tetrahydrofuran (THF) was distilled over sodium/potassium alloy prior to use. All other solvents 
were purchased from Acros Organics as ‘extra dry’ reagents. All other reagents with a purity > 95% 
were obtained from commercial sources (Sigma Aldrich, Acros, Alfa Aesar and others) and used 
without further purification unless otherwise stated.  
Flash column chromatography (FCC) was carried out with Merck silica gel 60 (0.040–
0.063 mm). Analytical thin layer chromatography (TLC) was carried out using Merck silica gel 60 
F254 glass-backed plates or aluminum foils and visualized under UV light at 254 nm. Staining was 
performed with ceric ammonium molybdate (CAM) or by staining with an aqueous anisaldehyde 
solution and subsequent heating.  
NMR spectra (1H NMR and 13C NMR) were recorded in deuterated chloroform (CDCl3) or 
methanol (MeOD-d4) on a Bruker Avance III HD 400 MHz spectrometer equipped with a 
CryoProbe™, a Bruker Avance Neo 400 MHz spectrometer, an Agilent 500 DD2 500 MHz 
spectrometer or a Bruker Avance II 600 MHz spectrometer and are reported as follows: chemical 
shift δ in ppm (multiplicity, coupling constant J in Hz, number of protons) for 1H NMR spectra and 
chemical shift δ in ppm for 13C NMR spectra. Multiplicities are abbreviated as follows: s = singlet, 
d = doublet, t = triplet, q = quartet, p = quintet, br = broad, m = multiplet, or combinations thereof. 
Residual solvent peaks of CDCl3 (δH = 7.26 ppm, δC = 77.16 ppm) and MeOD-d4 (δH = 3.31 ppm, 
δC = 49.00 ppm) were used as internal reference. NMR spectra were assigned using information 
ascertained from COSY, HMBC, HSQC and NOESY experiments.  
High resolution mass spectra (HRMS) were recorded on a Varian MAT CH7A or a Varian MAT 
711 MS instrument by electron impact (EI) or electrospray ionization (ESI) techniques at the 
Department of Chemistry, Ludwig-Maximilians-University Munich or a Thermo Scientific™ LTQ 
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Orbitrap XL™ Hybrid Ion Trap-Orbitrap Mass Spectrometer at the Institute of Organic Chemistry 
and Center for Molecular Biosciences, University of Innsbruck. 
Infrared spectra (IR) were recorded from 4000 cm−1 to 450 cm−1 on a Bruker™ ALPHA FT-IR 
Spectrometer from Bruker. Samples were prepared as a neat film or a film by evaporation of a 
solution in CDCl3. IR data in frequency of absorption (cm
−1) is reported as follows: w = weak, m = 
medium, s = strong, br = broad or combinations thereof.  
Melting Points were measured with a SRS MPA120 EZ-Melt Melting Point Apparatus in open 
glass capillaries and are uncorrected. 
Optical rotation values were recorded on a Schmidt+Haensch UniPol L1000 Peltier polarimeter. 
The specific rotation is calculated as follows: [𝛼]𝜆
𝑇 = 
∝ × 100
𝑐 × 𝑑
. Thereby, the wavelength λ is reported 
in nm and the measuring temperature in °C. α represents the recorded optical rotation, c the 
concentration of the analyte in 10 mg/mL and d the length of the cuvette in dm. Thus, the specific 
rotation is given in 10−1·deg·cm2 g−1. Use of the sodium D line (λ = 589 nm) is indicated by D 
instead of the wavelength in nm. The sample concentration as well as the solvent is reported in the 
relevant section of the experimental part. 
 
X-ray diffraction analysis was carried out by Prof. Dr. Klaus Wurst at the Institute of Inorganic 
and Theoretical Chemistry and Center for Molecular Biosciences, University of Innsbruck. The 
data collections were performed on a Bruker D8Quest using MoKα-radiation (λ = 0.71073 Å, 
Incoatec Microfocus). The Bruker Apex III software was applied for the integration, scaling and 
multi-scan absorption correction of the data. The structures were solved by direct methods with 
SHELXTL-XT-2014 and refined by least-squares methods against F2 with SHELXL-2014/7. All 
non-hydrogen atoms were refined anisotropically. The hydrogen atoms were placed in ideal 
geometry riding on their parent atoms. Further details are summarized in the tables at the different 
sections. Plotting of thermal ellipsoids in this document and in the main text was carried out using 
MERCURY for Windows. 
All yields are isolated, unless otherwise specified. 
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1-(3-methoxyphenyl)-4,4-dimethylpentan-3-one (11) 
 
 
 
To a solution of m-anisaldehyde (8) (8.95 mL, 73.4 mmol, 1 equiv) and pinacolone (9) (13.8 mL, 
110 mmol, 1.50 equiv) in ethanol (37 mL) under argon was added finely grinded barium hydroxide 
monohydrate (C-200, 1.89 g, 11.0 mmol, 0.150 equiv), which was prepared by drying barium 
hydroxide octahydrate at 200 °C in an oven for 3 h. The mixture was heated to 90 °C and after 2 h, 
the reaction mixture was cooled to 23 °C, concentrated under reduced pressure, diluted with ethyl 
acetate (460 mL) and filtered over a short pad of Celite®. To this solution was added palladium on 
charcoal (10% palladium on activated charcoal, 0.781 g, 0.734 mmol, 1.00 mol%) and the resulting 
suspension was sparged with hydrogen gas for 20 min. Stirring under hydrogen atmosphere was 
continued for 15 h, then Celite® was added and the mixture was filtered through a pad of Celite®. 
The filtrate was concentrated under reduced pressure and the crude residue was purified by flash 
column chromatography on silica gel (5% ethyl acetate in hexanes) to yield saturated ketone 11 
(13.3 g, 82% over 2 steps) as a colorless oil.  
 
The same reaction was conducted also on larger scale: m-anisaldehyde (26.0 g, 191 mmol). Hereby 
the amount of palladium was reduced to 0.20 mol% (10% palladium on activated charcoal, 0.41 g), 
that afforded the ketone 11 (32.0 g) in 76% yield. 
 
TLC (20% ethyl acetate in hexanes): Rf: 0.54 (UV) 
mp: 15.1 °C 
1
H NMR (400 MHz, CDCl3) δ 7.23 – 7.16 (m, 1H), 6.78 (dt, J = 7.7, 1.2 Hz, 1H), 6.76 – 6.72 (m, 
2H), 3.79 (s, 3H), 2.88 – 2.76 (m, 4H), 1.11 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ: 215.0, 159.7, 143.3, 129.5, 120.8, 114.2, 111.4, 55.2, 44.2, 38.5, 
30.2, 26.4. 
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IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3315 (m), 3297 (m), 3256 (m), 3183 (m), 3106 (m), 2957 (m), 2835 (m), 2707 
(m), 2617 (m), 2125 (w), 1703 (w), 1651 (m), 1584 (s), 1517 (s), 1476 (vs), 1394 (s), 1364 (s), 1317 
(w), 1226 (s), 1151 (vs), 1125 (s), 1099 (s), 1025 (s), 978 (s), 928 (s), 787 (s), 762 (s), 723 (s) cm−1.  
HRMS (EI): calcd for C14H20O2 [M]
+: 220.1458; found: 220.1459. 
 
2-(tert-butyl)-2-(3-methoxyphenethyl)oxirane (7) 
 
 
 
Sodium hydride (60% in mineral oil, 7.40 g, 184 mmol, 1.60 equiv) was washed with n-hexane 
(20 mL) in a dry 1-liter three-neck bottom flask equipped with a mechanical stirrer for 10 min. The 
solvent was removed via syringe and dry dimethyl sulfoxide (90 mL) was added. The suspension 
was heated under strong hydrogen evolution at 70 °C for 80 min. The green-brownish solution was 
cooled to 23 °C, diluted with tetrahydrofuran (95 mL) and the solution was then cooled in an 
aceton/dry ice bath to −15 °C. A stirred suspension of trimethylsulfonium iodide (35.2 g, 172 mmol, 
1.50 equiv) in dimethylsulfoxide (90 mL) was added via canula at a rate that the temperature did 
not exceed 0 °C. The reaction was stirred for 2 min and a solution of ketone 11 (25.3 g, 115 mmol, 
1 equiv) in tetrahydrofuran (18 mL) was added slowly via syringe. The flask of the ketone was 
rinsed with tetrahydrofuran (3 × 7 mL) and the reaction solution was stirred for 15 min at 0 °C and 
1 h at 23 °C. Excess base was quenched by addition of water (900 mL) and the layers were 
separated. The aqueous layer was extracted with diethyl ether (4 × 200 mL), the combined organic 
layers were washed with saturated aqueous sodium chloride solution (3 × 200 mL) and the washed 
solution was dried over sodium sulfate. The filtrate was concentrated under reduced pressure and 
the crude product (26.7 g) was used without further purification in the next step assuming full 
conversion. An analytically pure sample of the colorless oil was received by purification by flash 
column chromatography on silica gel (5% ethyl acetate in hexanes).  
 
TLC (20% ethyl acetate in hexanes): Rf: 0.57 (CAM) 
1H NMR (400 MHz, CDCl3) δ: 7.23 – 7.17 (m, 1H), 6.78 (d, J = 7.5 Hz, 1H), 6.76 – 6.71 (m, 2H), 
3.80 (s, 3H), 2.78 (d, J = 4.2 Hz, 1H), 2.67 (d, J = 4.2 Hz, 1H), 2.54 (ddd, J = 13.5, 11.5, 5.1 Hz, 
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1H), 2.44 (ddd, J = 13.5, 11.6, 5.8 Hz, 1H), 2.13 (ddd, J = 14.6, 11.6, 5.8 Hz, 1H), 2.02 (ddd, J = 
14.6, 11.7, 5.1 Hz, 1H), 0.97 (s, 9H). 
13C NMR (101 MHz, CDCl3) δ: 159.8, 144.0, 129.5, 120.8, 114.3, 111.2, 63.5, 55.3, 48.1, 34.1, 
31.4, 30.8, 26.2. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2958 (m), 2872 (w), 2835 (w), 1602 (s), 1585 (s), 1490 (s), 1465 (s),1455 (s), 
1436 (m), 1394 (w), 1364 (w), 1284 (w), 1261 (vs), 1166 (s), 1153 (vs), 1055 (s), 1039 (vs),910 (m), 
836 (m), 777 (vs), 745 (m), 696 (vs) cm−1. 
HRMS (ESI): calcd for C15H22O2 [M]
+: 234.1614; found: 234.1621. 
 
(6-methoxy-1,1,2-trimethyl-1,2,3,4-tetrahydronaphthalen-2-yl)methanol (12) 
 
 
 
The crude epoxide 7 (26.7 g, 114 mmol, 1 equiv) was divided into three equal batches and 
sequentially subjected to the reaction conditions.  
To a vigorously stirred solution of sulfuric acid (0.20 mL, 3.8 mmol, 10 mol%) in 1,1,1,3,3,3-
hexafluoro-2-propanol (485 mL) was added dropwise crude epoxide 7 (8.9 g, 38 mmol, 1 equiv) 
over a period of 5 min. The colorless liquid turned instantly yellow on the addition of the first drops 
and became finally burgundy. The reaction solution was stirred for further 5 min whereupon excess 
acid was quenched by addition of potassium carbonate (2.0 g, 14 mmol, 0.35 equiv), what caused a 
color change over red to grey. The reaction mixture was stirred for 5 min and concentrated under 
reduced pressure (250 mbar, 40 °C water bath temperature) to recover 1,1,1,3,3,3-hexafluoro-2-
propanol (450 ml). The turquoise crude product was combined with the crude products from the 
other two batches, water (500 mL) was added and the mixture was extracted with ethyl acetate 
(3 × 300 mL). The combined organic layers were washed with saturated aqueous sodium chloride 
solution (300 mL) and the washed solution was dried over sodium sulfate. The filtrate was 
concentrated under reduced pressure and the crude product was purified by flash column 
chromatography on silica gel (10% ethyl acetate in hexanes) to afford tetraline 12 (10.9 g, 41% over 
2 steps) as colorless viscous oil that slowly solidified upon storage. Besides the para-product 12, 
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ortho-product 13 (1.36 g, 5% over 2 steps) was afforded as a colorless viscous oil that slowly 
solidified upon storage.  
 
Analytical data of 12: 
 
TLC (25% ethyl acetate in hexanes): Rf: 0.37 (CAM) 
mp: 80.5 – 81.4 °C 
1
H NMR (400 MHz, CDCl3) δ: 7.25 (d, J = 8.9 Hz, 1H), 6.74 (dd, J = 8.7, 2.9 Hz, 1H), 6.58 (d, J 
= 2.7 Hz, 1H), 3.78 (s, 3H), 3.57 (d, J = 10.8 Hz, 1H), 3.54 (d, J = 10.8 Hz, 1H), 2.88 – 2.68 (m, 
2H), 1.87 – 1.65 (m, 2H), 1.45 (s, 1H), 1.23 (s, 3H), 1.20 (s, 3H), 0.99 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ: 157.0, 138.3, 136.7, 128.0, 112.9, 112.6, 67.3, 55.2, 39.2, 38.7, 
27.9, 27.2, 26.6, 25.4, 19.1. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3358 (m), 2973 (m), 2956 (m), 2929 (m), 1609 (s), 1500 (s) 1459 (s), 1448 
(s), 1432 (m), 1361 (m), 1317 (s), 1246 (s), 1232 (s), 1198 (m), 1164 (m), 1084 (m), 1047 (s), 1033 
(vs), 1022 (vs), 993 (s), 948 (m), 889 (m), 848 (s), 823 (vs), 754 (m), 714 (m) cm−1.  
HRMS (EI): calcd for C15H22O2 [M]
+: 234.1614; found: 234.1617.  
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Figure 2-1: A = Addition of substrate (7) to HFIP/H2SO4; B =After complete addition of the substrate and 5 
minutes of stirring; C = 10 seconds after addition of K2CO3, D = 5 minutes after K2CO3 addition; E = crude 
product after removal of HFIP at 250 mbar, 40 °C. 
 
Analytical data of 13:  
 
TLC (25% ethyl acetate in hexanes): Rf: 0.47 (CAM) 
mp: 71.5 – 74.4 °C 
1
H NMR (400 MHz, CDCl3) δ: 7.08 (t, J = 7.8 Hz, 1H), 6.74 – 6.68 (m, 2H), 3.80 (s, 3H), 3.59 (s, 
2H), 2.92 – 2.70 (m, 3H), 1.80 – 1.61 (m, 2H), 1.35 (s, 3H), 1.32 (s, 3H), 0.99 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ: 159.5, 138.1, 133.9, 126.1, 122.1, 109.5, 66.9, 55.2, 40.5, 39.3, 
27.2, 26.9, 23.5, 21.9, 18.9. 
A B 
C D E 
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IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3384 (w), 2969 (m), 2938 (m), 1576 (m), 1452 (s), 1436 (s), 1362 (m), 1248 
(vs), 1191 (m), 1109 (m), 1074 (s), 1058 (s), 1022 (vs), 1005 (s), 953 (m), 880 (m), 811 (m), 779 
(s), 754 (s), 740 (vs) cm−1.  
HRMS (EI) calcd for C15H22O2 [M]
+: 234.1614; found: 234.1616. 
tert-butyl((6-methoxy-1,1,2-trimethyl-1,2-dihydronaphthalen-2-yl)methoxy)- 
diphenylsilane (14) 
 
 
 
To a solution of alcohol 12 (8.92 g, 38.1 mmol, 1 equiv), N,N-dimethyl-4-aminopyridine (93 mg, 
0.76 mmol, 2.0 mol%) and imidazole (4.66 g, 68.5 mmol, 1.80 equiv) in N,N-dimethylformamide 
(95 mL) was added dropwise tert-butyl(chloro)diphenylsilane (15.4 mL, 57.1 mmol, 1.50 equiv). 
The solution was stirred at 23 °C for 16 h and then excess tert-butyl(chloro)diphenylsilane was 
hydrolyzed by the addition of water (50 mL). The mixture was extracted with diethyl ether 
(500 mL). The organic layer was washed with water (2 × 50 mL) and saturated aqueous sodium 
chloride solution (2 × 50 mL). The organic layer was dried over sodium sulfate and the filtrate was 
concentrated under reduced pressure. The crude product S1 was used without further purification 
in the next step.  
To the solution of crude silyl ether S1 in dry 1,4-dioxane (95 mL) was added 2,3-dichloro-4,5-
dicyano-1,3-benzoquinone (13.0 g, 57.2 mmol, 1.50 equiv). The dark solution was stirred at 93 °C 
for 48 h. An additional portion of 2,3-dichloro-4,5-dicyano-1,3-benzoquinone (4.3 g, 19.1 mmol, 
0.5 eq) was added and the reaction was stirred for further 24 h at 93 °C. Subsequently the solution 
was cooled to 23 °C and poured into cyclohexane (900 mL). The resulting suspension was filtered 
through a plug of Celite® and concentrated under reduced pressure. Purification by flash column 
chromatography on silica gel (1% ethyl acetate in cyclohexane) afforded dihydronaphthalene 14 
(16.3 g, 91%) as a colorless liquid.  
 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.61 (CAM) 
mp: 99.2 – 100.6 °C 
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1
H NMR (400 MHz, CDCl3) δ: 7.66 – 7.59 (m, 4H), 7.45 – 7.31 (m, 6H), 7.16 (d, J = 8.5 Hz, 1H), 
6.71 (dd, J = 8.5, 2.8 Hz, 1H), 6.59 (d, J = 2.8 Hz, 1H), 6.38 (d, J = 9.6 Hz, 1H), 5.84 (d, J = 9.6 Hz, 
1H), 3.81 (s, 3H), 3.65 (d, J = 9.6 Hz, 1H), 3.57 (d, J = 9.6 Hz, 1H), 1.19 (s, 6H), 1.13 (s, 3H), 1.03 
(s, 9H). 
13
C NMR (101 MHz, CDCl3) δ: 157.9, 137.4, 137.0, 135.9, 135.8, 133.9, 133.8, 133.7, 129.6, 
129.6, 127.7, 127.7, 125.9, 125.1, 112.4, 112.0, 67.8, 55.4, 43.4, 38.9, 27.0, 24.7, 22.9, 19.5, 17.9. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3071 (w), 3031 (w), 2961 (s), 2931 (s), 2857 (m), 1603 (m), 1572 (m), 1489 
(m), 1471 (m), 1428 (m), 1390 (w), 1361 (m), 1309 (m), 1282 (m), 1261 (s), 1228 (w), 1192 (w), 
1153 (m), 1111 (s), 1073 (s), 1038 (m), 1007 (w), 976 (w), 936 (w), 872 (w), 855 (w), 821 (s) 790 
(w), 775 (w), 740 (m), 702 (s), 658 (w), 612 (m), 560 (w), 504 (s), 490 (m), 433 (w) cm−1. 
HRMS (ESI) calcd for C31H38NaO2Si [M+Na]
+: 493.2533; found: 493.2481. 
 
6-(((tert-butyldiphenylsilyl)oxy)methyl)-5,5,6-trimethyl-5,6-dihydronaphthalen-2-ol (S2) 
 
 
 
To a solution of diphenylphosphane (17.8 mL, 103 mmol, 3.00 equiv) in dry tetrahydrofuran 
(170 mL) was added dropwise n-butyllithium (2.5 M in hexane, 41 mL, 103 mmol, 3.00 equiv) at 
0 °C. The deep red solution was stirred for 30 minutes at 0 °C and then warmed up to 23 °C. The 
red solution was transferred to a flask containing methyl ether 14 (16.1 g, 34.2 mmol, 1 equiv) and 
the flask was equipped with a reflux condenser. The reaction was heated at reflux at 75 °C for 2.5 h 
and was then stirred for 16 h at 23 °C. Excess phosphide was quenched by the addition of saturated 
aqueous ammonium chloride solution (100 mL). The mixture was extracted with diethyl ether 
(3 × 200 mL). The combined organic layers were washed with saturated aqueous sodium chloride 
solution (200 mL). The washed solution was dried over sodium sulfate and the filtrate was 
concentrated under reduced pressure. Purification by flash column chromatography on silica gel 
(10% ethyl acetate in cyclohexane) afforded the title compound S2 (15.7 g, quant.) as a colorless 
viscous oil.  
TLC (10% ethyl acetate in cyclohexane): Rf: 0.28 (CAM) 
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1
H NMR (400 MHz, CDCl3) δ: 7.64 (m, 4H), 7.46 – 7.32 (m, 6H), 7.11 (d, J = 8.3 Hz, 1H), 6.63 
(dd, J = 8.3, 2.8 Hz, 1H), 6.52 (d, J = 2.7 Hz, 1H), 6.35 (d, J = 9.7 Hz, 1H), 5.84 (d, J = 9.6 Hz, 1H), 
4.74 (s, 1H), 3.65 (d, J = 9.6 Hz, 1H), 3.58 (d, J = 9.6 Hz, 1H), 1.19 (s, 6H), 1.13 (s, 3H), 1.04 (s, 
9H). 
13
C NMR (101 MHz, CDCl3) δ: 153.6, 137.6, 137.1, 135.9, 135.8, 133.9, 133.9, 133.7, 129.6, 
129.6, 127.7, 127.7, 125.6, 125.3, 113.9, 113.3, 67.8, 43.4, 38.9, 27.0, 24.7, 22.9, 19.5, 17.9. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3339 (m br), 2962 (m), 2930 (m), 2857 (m), 1605 (m), 1576 (m), 1471 (m), 
1427 (m), 1387 (m), 1361 (m), 1287 (w), 1265 (m), 1155 (m), 1105 (s), 1069 (s), 1007 (w), 958 (w), 
908 (m), 867 (m), 819 (s), 790 (m), 732 (s), 700 (s), 659 (m), 612 (s), 543 (w), 503 (s), 489 (s), 434 
(w) cm-1. 
HRMS (ESI) calcd for C30H37O2Si [M+H]
+: 457.2557; found: 457.2553. 
 
6-(((tert-butyldiphenylsilyl)oxy)methyl)-5,5,6-trimethyl-5,6-dihydronaphthalen-2-yl 
trifluoromethanesulfonate (15) 
 
 
 
To a solution of phenol S2 (15.6 g, 34.2 mmol, 1 equiv) and N,N-dimethylpyridin-4-amine (0.42 g, 
3.4 mmol, 0.10 equiv) in dichloromethane (70 mL) was added triethylamine (6.67 mL, 47.8 mmol, 
1.40 equiv) and N-Phenyl-bis(trifluoromethanesulfonimide) (14.65 g, 41.0 mmol, 1.2 equiv). The 
solution was stirred at 23 °C for 16 h. Excess amine was quenched by addition of saturated aqueous 
ammonium chloride solution (100 mL) and the mixture was extracted with dichloromethane 
(3 × 150 mL). The combined organic layers were dried over sodium sulfate and the filtrate was 
concentrated under reduced pressure. The crude product was purified by flash column 
chromatography on silica gel (1% ethyl acetate in cyclohexane initially, grading to 3% ethyl acetate 
in cyclohexane) to afford the title compound 15 (20.2 g, 99% over 2 steps) as a colorless wax, that 
crystallized upon storage at 23 °C after several days.  
 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.62 (CAM) 
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mp: 94.7 – 96.2 °C 
1
H NMR (400 MHz, CDCl3) δ 7.66 – 7.57 (m, 4H), 7.47 – 7.33 (m, 6H), 7.30 (d, J = 8.6 Hz, 1H), 
7.05 (dd, J = 8.6, 2.7 Hz, 1H), 6.91 (d, J = 2.7 Hz, 1H), 6.41 (d, J = 9.7 Hz, 1H), 5.90 (d, J = 9.7 Hz, 
1H), 3.62 (d, J = 9.8 Hz, 1H), 3.53 (d, J = 9.8 Hz, 1H), 1.27 (s, 3H), 1.20 (s, 3H), 1.13 (s, 3H), 1.00 
(s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 148.0, 145.6, 138.7, 135.8, 134.9, 133.6, 133.4, 129.7, 127.7, 125.8, 
124.8, 119.6, 118.9 (q, J = 320.9 Hz), 118.5, 67.9, 43.3, 39.4, 26.8, 25.0, 22.3, 19.3, 17.9. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3072 (w), 2964 (m), 2932 (m), 2858 (m), 1602 (w), 1574 (w), 1473 (m), 
1421 (s), 1363 (m), 1251 (m), 1212 (s), 1111 (s), 1074 (s), 1008 (w), 947 (s), 900 (m), 878 (s), 848 
(s), 819 (s), 789 (w), 777 (w), 736 (s), 700 (s), 646 (w), 603 (s), 574 (w), 502 (s), 488 (s) 435 (m) 
cm-1. 
HRMS (ESI) calcd for C31H35F3NaO4SSi [M+Na]
+: 611.1870; found: 611.1863. 
 
tert-butyl((6-ethyl-1,1,2-trimethyl-1,2-dihydronaphthalen-2-yl)methoxy)-diphenylsilane (S3) 
 
 
 
To a solution of triflate 15 (5.00 g, 8.49 mmol, 1 equiv) in dry dioxane (70 mL) was added [1,1′-
bis(diphenylphosphino)ferrocene]dichloropalladium(II) (124 mg, 0.17 mmol, 2 mol%). The orange 
suspension was cooled to 0 °C causing partial crystallization of the solvent. Diethylzinc (1 M in 
hexanes, 17.0 mL, 17.0 mmol, 2.00 equiv) was added and the ice bath was removed. When all 
dioxane was melted again, a yellow clear solution was formed. The reaction mixture was heated at 
70 °C for 1 h and was then cooled to 0 °C. Excess diethylzinc of the brownish solution was 
quenched by addition of methanol (10 mL), water (50 mL) and saturated aqueous ammonium 
chloride solution (50 mL). The mixture was extracted with ethyl acetate (3 × 50 mL). The combined 
organic layers were washed with saturated aqueous sodium chloride solution (50 mL) and the 
washed solution was dried over sodium sulfate. The filtrate was concentrated under reduced 
pressure. Purification by flash column chromatography on silica gel (1% ethyl acetate in 
cyclohexane) afforded the title compound S3 (3.65 g, 92%) as a colorless viscous oil.  
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TLC (10% ethyl acetate in cyclohexane): Rf: 0.68 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.74 – 7.66 (m, 4H), 7.50 – 7.37 (m, 6H), 7.23 (d, J = 7.9 Hz, 1H), 
7.07 (dd, J = 7.9, 1.9 Hz, 1H), 6.93 (d, J = 1.8 Hz, 1H), 6.48 (d, J = 9.6 Hz, 1H), 5.87 (d, J = 9.6 Hz, 
1H), 3.72 (d, J = 9.6 Hz, 1H), 3.64 (d, J = 9.6 Hz, 1H), 2.68 (q, J = 7.6 Hz, 2H), 1.32 (t, J = 7.6 Hz, 
3H), 1.28 (s, 3H), 1.28 (s, 3H), 1.20 (s, 3H), 1.10 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 142.4, 141.6, 136.0, 135.9, 135.8, 133.9, 133.8, 132.4, 129.6, 129.6, 
127.7, 127.6, 127.1, 126.2, 126.0, 124.0, 67.9, 43.3, 39.1, 28.4, 27.0, 24.7, 22.8, 19.4, 18.0, 15.6.  
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3070 (w), 3020 (w), 2962 (s), 2930 (s), 2857 (m), 1589 (w), 1503 (w), 1490 
(w), 1471 (w), 1462 (m), 1428 (w), 1390 (w), 1361 (w), 1247 (w), 1208 (w), 1111 (s), 1008 (s), 976 
(w), 938 (w), 888 (w), 824 (s), 792 (w), 740 (m), 701 (s), 650 (w), 612 (m), 504 (s), 490 (m), 436 
(w) cm-1. 
HRMS (ESI) calcd for C32H40NaOSi [M+Na]
+: 491.2741; found: 491.2741. 
 
(6-ethyl-1,1,2-trimethyl-1,2-dihydronaphthalen-2-yl)methanol (16) 
 
 
 
To a stirred solution of protected alcohol S3 (3.61 g, 7.70 mmol, 1 equiv) in tetrahydrofuran (50 mL) 
was added a solution of tetrabutylammonium fluoride (1 M in THF, 10.0 mL, 10.0 mmol, 
1.30 equiv) at 0 °C. The ice bath was removed after 15 min and the reaction was stirred at 23 °C for 
16 h. Excess fluoride was quenched by addition of water (50 mL). The reaction was extracted with 
ethyl acetate (3 × 50 mL). The combined organic layers were washed with saturated aqueous 
sodium chloride solution (50 mL) and the washed solution was dried over sodium sulfate. The 
filtrate was concentrated under reduced pressure. Purification by flash column chromatography (1% 
ethyl acetate in cyclohexane initially, grading to 5% ethyl acetate in cyclohexane) afforded the title 
compound 16 (1.78 g, 99%) as a colorless viscous oil.  
 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.17 (CAM) 
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1
H NMR (400 MHz, CDCl3) δ 7.19 (d, J = 7.9 Hz, 1H), 7.03 (dd, J = 7.9, 1.9 Hz, 1H), 6.86 (d, J = 
1.8 Hz, 1H), 6.49 (d, J = 9.6 Hz, 1H), 5.64 (d, J = 9.6 Hz, 1H), 3.62 (d, J = 10.8 Hz, 1H), 3.39 (d, J 
= 10.8 Hz, 1H), 2.60 (q, J = 7.6 Hz, 2H), 1.30 (s, 3H), 1.23 (t, J = 7.6 Hz, 3H), 1.14 (s, 3H), 1.10 (s, 
3H). 
13
C NMR (101 MHz, CDCl3) δ 142.4, 141.9, 134.5, 132.0, 127.6, 126.2, 124.1, 67.9, 42.9, 38.9, 
28.3, 25.7, 21.4, 17.7, 15.5.  
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3371 (br s), 3022 (w), 2964 (s), 2931 (m), 2874 (m), 1607 (w), 1491 (m), 
1461 (m), 1383 (m), 1361 (m), 1327 (w), 1285 (w), 1244 (w), 1154 (w), 1093 (w), 1078 (m), 1027 
(s), 972 (w), 951 (w), 888 (s), 825 (s), 782 (s), 741 (s), 701 (m), 575 (w), 519 (w), 486 (w), 418 (w) 
cm-1. 
HRMS (ESI) calcd for C16H22NaO [M+Na]
+: 253.1563; found: 253.1563. 
 
6-ethyl-1,1,2-trimethyl-1,2-dihydronaphthalene-2-carbaldehyde (S4) 
 
 
 
To a solution of alcohol 16 (1.77 g, 7.68 mmol, 1 equiv) in dry dichloromethane (80 mL) was added 
potassium carbonate (2.12 g, 15.4 mmol, 2.00 equiv) and Dess–Martin periodinane (6.52 g, 
15.4 mmol, 2.00 equiv) at 0 °C. The suspension was stirred at 0 °C for 15 min and at 25 °C for 3 h. 
Excess Dess–Martin periodinane was quenched by addition of saturated aqueous sodium 
bicarbonate solution (50 mL) and saturated aqueous sodium thiosulfate solution (30 mL). The 
organic layer was separated and the aqueous phase was extracted with dichloromethane 
(3 × 50 mL). The combined organic layers were dried over sodium sulfate and the filtrate was 
concentrated under reduced pressure. Purification by flash column chromatography (1% ethyl 
acetate in cyclohexane initially, grading to 5% ethyl acetate in cyclohexane) afforded aldehyde S4 
(1.69 g, 96%) as a colorless oil.  
 
TLC (5% ethyl acetate in cyclohexane): Rf: 0.48 (UV) 
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1
H NMR (400 MHz, CDCl3) δ 9.35 (s, 1H), 7.22 (d, J = 7.9 Hz, 1H), 7.08 (dd, J = 7.9, 1.9 Hz, 1H), 
6.90 (d, J = 1.8 Hz, 1H), 6.66 (d, J = 9.5 Hz, 1H), 5.46 (d, J = 9.5 Hz, 1H), 2.62 (q, J = 7.6 Hz, 2H), 
1.30 (s, 3H), 1.25 (t, J = 7.6 Hz, 3H), 1.21 (s, 3H), 1.19 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 202.7, 142.6, 140.6, 131.8, 130.8, 129.0, 128.3, 126.7, 124.4, 54.7, 
38.9, 28.3, 25.2, 22.3, 15.4, 14.3.  
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2967 (s), 2932 (m), 2872 (w), 2820 (w), 2715 (w), 1716 (s), 1606 (w), 1491 
(m), 1455 (m), 1386 (m), 1363 (m), 1328 (w), 1286 (w), 1246 (m), 1185 (w), 1159 (w), 1096 (m), 
1078 (m), 1011 (w), 983 (w), 889 (w), 873 (s), 826 (s), 792 (m), 778 (s), 754 (m), 732 (s), 701 (m), 
579 (m), 528 (m), 503 (m), 414 (w) cm-1. 
HRMS (ESI) calcd for C16H20NaO [M+Na]
+: 251.1406; found: 251.1408. 
 
ethyl (Z)-5-(6-ethyl-1,1,2-trimethyl-1,2-dihydronaphthalen-2-yl)pent-4-enoate (S5) 
 
 
 
To a stirred suspension of [3-(ethoxycarbonyl)propyl]triphenylphosphonium bromide (17) (5.08 g, 
11.1 mmol, 1.50 equiv) in tetrahydrofuran (44 mL) was added sodium bis(trimethylsilyl)amide 
(1.0 M in THF, 12.6 mL, 12.6 mmol, 1.70 equiv) at 0 °C. The yellow-orange mixture was stirred for 
30 min at 0 °C and was then cooled to −78 °C. A solution of aldehyde S4 (1.69 g, 7.41 mmol, 
1 equiv) in tetrahydrofuran (7 mL) was added slowly. After 15 min, the reaction was allowed to 
warm to 23 °C and stirred at 23 °C for 5 h. Excess amide was quenched by addition of saturated 
aqueous ammonium chloride solution (40 mL). The mixture was extracted with diethyl ether 
(3 × 150 mL). The combined organic layers were washed with saturated aqueous sodium chloride 
solution (100 mL) and the washed solution was dried over sodium sulfate. The filtrate was 
concentrated under reduced pressure and the crude product was purified by flash column 
chromatography on silica gel (5% ethyl acetate in cyclohexane) to afford the title compound S5 
(2.06 g, 85%) as a colorless oil. 
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TLC (5% ethyl acetate in cyclohexane): Rf: 0.19 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.22 (d, J = 7.9 Hz, 1H), 7.05 (dd, J = 7.8, 1.8 Hz, 1H), 6.88 (d, J = 
1.7 Hz, 1H), 6.37 (d, J = 9.6 Hz, 1H), 5.99 (d, J = 9.6 Hz, 1H), 5.50 (d, J = 12.0 Hz, 1H), 5.40 (dt, 
J = 12.0, 7.2 Hz, 1H), 4.17 (q, J = 7.1 Hz, 2H), 2.80 – 2.65 (m, 1H), 2.64 (q, J = 7.6 Hz, 2H), 2.61 
– 2.50 (m, 1H), 2.40 (t, J = 7.5 Hz, 2H), 1.33 (s, 3H), 1.29 (t, J = 7.2 Hz, 3H), 1.27 (t, J = 7.6 Hz, 
3H), 1.21 (s, 3H), 1.13 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 173.0, 141.6, 141.5, 138.0, 135.8, 132.0, 129.7, 127.0, 125.9, 124.7, 
124.1, 60.3, 45.0, 41.2, 34.7, 28.3, 26.0, 24.9, 22.5, 21.5, 15.4, 14.3. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2966 (s), 2932 (m), 2872 (m), 1736 (s), 1606 (w), 1491 (w), 1491 (w), 1458 
(m), 1372 (m), 1248 (m), 1161 (s), 1092 (w), 1079 (m), 1041 (w), 889 (w), 826 (m), 792 (w), 760 
(w), 739 (w), 700 (w) cm-1. 
HRMS (ESI) calcd for C22H31O2 [M+H]
+: 327.2319; found: 327.2324. 
 
(Z)-5-(6-ethyl-1,1,2-trimethyl-1,2-dihydronaphthalen-2-yl)-1-(pyrrolidin-1-yl)pent-4-en-1-one (6) 
 
 
 
The ester S5 (2.05 g, 6.28 mmol, 1 equiv) was dissolved in dry and colorless pyrrolidine (7.7 mL, 
94 mmol, 15 equiv) in a pressure tube under argon. The tube was sealed and heated at 100 °C. The 
reaction mixture was stirred for 45 h and then allowed to cool to 23 °C. Excess pyrrolidine was 
removed under reduced pressure. Purification by flash column chromatography on silica gel (50% 
ethyl acetate in cyclohexane) afforded the title compound 6 (2.23 g, 99%) as a pale yellow oil.  
 
TLC (50% ethyl acetate in cyclohexane): Rf: 0.24 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.18 (d, J = 7.9 Hz, 1H), 7.00 (dd, J = 7.8, 1.8 Hz, 1H), 6.83 (d, J = 
1.7 Hz, 1H), 6.31 (d, J = 9.6 Hz, 1H), 5.97 (d, J = 9.6 Hz, 1H), 5.47 – 5.36 (m, 2H), 3.46 (t, J = 
6.9 Hz, 2H), 3.39 (t, J = 6.8 Hz, 2H), 2.75 – 2.63 (m, 1H), 2.59 (q, J = 7.6 Hz, 2H), 2.60 – 2.47 (m, 
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1H), 2.31 (t, J = 7.7 Hz, 2H), 1.93 (p, J = 6.6 Hz, 2H), 1.83 (p, J = 6.6 Hz, 2H), 1.28 (s, 3H), 1.22 
(t, J = 7.6 Hz, 3H), 1.16 (s, 3H), 1.08 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 171.0, 141.7, 138.4, 135.3, 132.1, 130.6, 126.9, 125.9, 124.7, 124.2, 
46.7, 45.7, 45.0, 41.2, 35.2, 28.3, 26.2, 26.1, 25.0, 24.5, 22.5, 21.5, 15.4. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2965 (s), 2931 (m), 2870 (m), 1639 (s), 1490 (w), 1427 (s), 1380 (m), 1359 
(m), 1340 (m), 1252 (w), 1226 (m), 1192 (m), 1167 (m), 1117 (w), 1090 (w), 1078 (m), 1034 (w), 
986 (w), 986 (w), 913 (w), 888 (m), 857 (w), 825 (s), 781 (m), 763 (m), 725 (s), 699 (m), 628 (w), 
544 (w), 521 (m), 424 (w) cm-1.  
HRMS (ESI) calcd for C24H34NO [M+H]
+: 352.2635; found: 352.2635. 
 
7-ethyl-3,4,4-trimethyl-2a,3,4,8b-tetrahydro-3,1-prop[1]enocyclobuta[a]-naphthalen-2(1H)-one 
(5) 
 
 
 
To a vigorously stirred solution of freshly distilled trifluoromethanesulfonic anhydride (1.38 mL, 
8.25 mmol, 1.20 equiv) in dry 1,2-dichloroethane (80 mL) at 80 °C was added dropwise a solution 
of amide 6 (2.23 g, 6.34 mmol, 1 equiv) and 2,4,6-collidine (1.09 mL, 8.25 mmol, 1.2 equiv) in 1,2-
dichloroethane (80 mL) via a dropping funnel over a period of 5 h. The initial yellowish reaction 
mixture turned red-brownish, stirring was continued at 80 °C for 20 h and then the reaction mixture 
was concentrated under reduced pressure. To the crude iminium salt was added tetrachloromethane 
(30 mL) and water (30 mL) and the dark brown mixture was heated at reflux at 80 °C for 5 h under 
an atmosphere of argon. The organic layer was separated and the aqueous phase was extracted with 
dichloromethane (3 × 20 mL). The combined organic layers were dried over sodium sulfate and the 
filtrate was concentrated under reduced pressure. Purification by flash column chromatography on 
silica gel (10% ethyl acetate in cyclohexane) afforded cyclobutanone 5 (1.59 g, 89%) as a pale 
yellowish oil that solidified upon storage.  
 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.43 (CAM) 
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mp: 68.4 – 69.1 °C 
1
H NMR (400 MHz, CDCl3) δ 7.23 (d, J = 8.0 Hz, 1H), 7.06 (dd, J = 8.0, 1.6 Hz, 1H), 6.93 (d, J = 
1.6 Hz, 1H), 5.41 (ddt, J = 12.4, 2.5, 1.6 Hz, 1H), 5.18 (ddd, J = 12.5, 4.9, 2.6 Hz, 1H), 3.74 – 3.64 
(m, 2H), 3.54 (td, J = 7.4, 1.7 Hz, 1H), 2.64 (q, J = 7.6 Hz, 2H), 2.33 (dt, J = 18.4, 4.9 Hz, 1H), 1.99 
(dq, J = 18.2, 2.6 Hz, 1H), 1.43 (s, 3H), 1.32 (s, 3H), 1.26 (t, J = 7.6 Hz, 3H), 1.16 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ: 210.1, 144.1, 141.1, 135.9, 131.8, 128.4, 126.2, 125.8, 124.8, 64.4, 
61.0, 40.8, 40.8, 29.7, 28.3, 28.0, 27.0, 21.8, 21.6, 15.5. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2965 (m), 2936 (w), 2251 (w), 1772 (s), 1612 (w), 1496 (w), 1477 (w), 1462 
(w), 1418 (w), 1387 (w), 1371 (w) 1318 (w), 1240 (w), 1219 (w), 1184 (w), 1113 (w), 1087 (w), 
1063 (w), 1013 (w), 968 (w), 944 (w), 908 (s), 857 (w), 825 (m), 793 (w), 758 (m), 728 (s), 702 (w), 
687 (m), 647 (m), 608 (w), 590 (w), 562 (w), 512 (w), 480 (m), 447  
(w) cm-1. 
HRMS (ESI): calcd for C20H24NaO [M+Na]
+: 303.1719; found: 303.1717. 
The structure was validated by single crystal X-ray analysis (see X-ray section). 
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7-ethyl-11-hydroxy-3,4,4-trimethyl-2a,3,4,8b-tetrahydro-3,1-prop[1]enocyclobuta[a]naphthalen-
2(1H)-one (22) 
 
 
 
To finely grinded selenium dioxide (2.0 g, 18 mmol, 10 equiv) and oven-dried (100 °C) fine white 
quartz sand (2.0 g, 19 eq, particle size >230 mesh) in a flame-dried pressure tube (15 mL) equipped 
with a magnetic stirring bar was added cyclobutanone 5 (500 mg, 1.78  mmol, 1.0 eq). After 
sparging with nitrogen for 5 min, dry 1,4-dioxane (9 mL) was added. The tube was sealed and the 
vigorously stirred reaction mixture was heated at 115 °C (700 rpm) for 3 h. The temperature was 
raised to 120 °C. After 3 h, the reaction mixture was cooled to 23 °C and filtered through a pad of 
Celite®. The Celite® was washed with ethyl acetate (200 mL) and the filtrate was concentrated 
under reduced pressure. Purification by flash column chromatography (1% ethyl acetate in 
cyclohexane initially, grading to 10% ethyl acetate in cyclohexane, grading to 25% ethyl acetate in 
cyclohexane, grading to 50% ethyl acetate in cyclohexane) afforded slightly impure 22 (80 mg) as 
an orange oil. Cyclobutanone 5 (380 mg, 76%) was recovered and used in the next cycle. After five 
cycles, the product fractions were combined and collectively purified by flash column 
chromatography (10% ethyl acetate in dichloromethane) to afford the allylic alcohol 22 (252 mg, 
47%) as a colorless wax.  
cycle 1 2 3 4 5 
recovered SM 5 [mg] 380 261 180 125 85 
  
TLC (10% ethyl acetate in cyclohexane): Rf: 0.25 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.20 (d, J = 8.1 Hz, 1H), 7.03 (dd, J = 8.1, 1.5 Hz, 1H), 6.96 (d, J = 
1.4 Hz, 1H), 5.42 (dt, J = 12.7, 1.8 Hz, 1H), 5.33 (dt, J = 12.7, 2.2 Hz, 1H), 3.94 (s, 1H), 3.84 (dddd, 
J = 8.6, 6.4, 4.2, 1.9 Hz, 1H), 3.74 (t, J = 8.4 Hz, 1H), 3.49 (ddd, J = 8.2, 6.7, 1.6 Hz, 1H), 2.60 (q, 
J = 7.6 Hz, 2H), 2.17 (s, 1H), 1.41 (s, 3H), 1.29 (s, 3H), 1.22 (t, J = 7.6 Hz, 3H), 1.10 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 208.7, 143.6, 141.6, 135.7, 130.8, 130.1, 128.3, 126.6, 125.0, 68.2, 
67.5, 64.7, 42.4, 40.7, 28.3, 28.1, 27.6, 22.0, 21.8, 15.5. 
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IR (Diamond-ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3434 (br m), 2967 (m), 2932 (w), 2247 (w), 1772 (s), 1612 (w), 
1497 (w), 1497 (w), 1462 (m), 1388 (m), 1372 (w), 1319 (m), 1240 (w), 1138 (m), 1108 (w), 1087 
(w) 1025 (s), 970 (w), 907 (s), 852 (w), 825 (m), 774 (m), 727 (s), 687 (m), 647 (m), 558 (m), 543 
(w), 490 (w), 457 (w) 
HRMS (ESI): calcd for C20H24NaO2 [M+Na]
+: 319.1669; found: 319.1666. 
 
Schönecker oxidation of 5:118 
 
 
 
To flame-dried 4 Å molecular sieves (1.00 g, 500 w%) in a Schlenk flask was added cyclobutanone 
5 (200 mg, 0.711 mmol, 1 equiv), dry toluene (3 mL) and (4-methylpyridin-2-yl)methanamine 
(260 mg, 2.14 mmol, 3.00 equiv). The flask was heated to 115 °C and stirred for 16 h. Subsequently 
the reaction was cooled to 23 °C and diluted with diethyl ether (20 mL). The mixture was washed 
with saturated aqueous ammonium chloride solution (2 × 20 mL), saturated aqueous sodium 
bicarbonate solution (20 mL) and saturated aqueous sodium chloride solution (20 mL). The organic 
layer was dried over sodium sulfate and the filtrate was concentrated under reduced pressure. To 
the crude imine in a round-bottom flask was added sodium ascorbate (410 mg, 2.07 mmol, 
3.00 equiv) and tetrakis(acetonitrile)copper(I) hexafluorophosphate (515 mg, 1.38 mmol, 
2.00 equiv). The flask was capped with a septum and sparged with nitrogen for 2 min. Acetone 
(2.0 mL) and methanol (2.0 mL) were added and the brownish suspension was stirred at 23 °C for 
5 min. Oxygen gas from a balloon was sparged through the solution for 5 min whereupon the color 
changed to dark green-blueish. The flask was heated to 40 °C and stirred for 16 h under an 
atmosphere of oxygen. Ethyl acetate (3 mL) and saturated aqueous sodium 
ethylenediaminetetraacetate solution (7 mL, ca. pH 10) were added and the biphasic system was 
stirred at 23 °C for 1 h. The mixture was extracted with ethyl acetate (3 × 10 mL) and the combined 
organic layers were concentrated under reduced pressure. To the brown residue was added 
                                                   
118 Y. Y. See, A. T. Herrmann, Y. Aihara, P. S. Baran, J. Am. Chem. Soc., 2015, 137, 13776–13779. 
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tetrachloromethane (15 mL) and water (15 mL). The biphasic system was stirred vigorously at 
23 °C for 22 h and extracted with dichloromethane (3 × 15 mL). The combined organic layers were 
dried over sodium sulfate and the filtrate was concentrated under reduced pressure. Purification by 
flash column chromatography on silica gel (5% ethyl acetate in cyclohexane initially, grading to 
10% ethyl acetate in cyclohexane, grading to 25% ethyl acetate in cyclohexane) afforded next to 
recovered cyclobutanone 5 (38 mg, 19%) the allylic alcohol 22 (44 mg, 21%) as a yellow wax.  
 
The analytical data matched those obtained by selenium dioxide oxidation (see above).  
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8-ethyl-4,5,5-trimethyl-3a,4,5,9b-tetrahydro-4,1-prop[1]enonaphtho[1,2-c]furan-3,12(1H)-dione 
(24) 
 
 
 
To a solution of allylic alcohol 22 (11.3 mg, 38 µmol, 1 equiv) in 1,2-dichloroethane (1 mL) was 
added pivalaldehyde (20 µL, 0.19 mmol, 5.0 equiv) and copper(II) acetate monohydrate ( 7.1 mg, 
38 µmol, 1.0 equiv). The flask was capped with a septum and sparged with oxygen gas from a 
balloon for 2 min. The solution was stirred under oxygen at 23 °C until monitoring by thin layer 
chromatography indicated full conversion of the starting material (2 h). Sodium bicarbonate (16 mg, 
0.19 mmol, 5.0 equiv) and Dess–Martin periodinane (32 mg, 76 µmol, 2.0 equiv) were added and 
the reaction was stirred at 23 °C. After 1.5 h, an additional portion of Dess-Martin periodinane 
(32 mg, 76 µmol, 2.0 equiv) was added and the reaction was stirred at 23 °C for 1 h. Excess Dess–
Martin periodinane was quenched by addition of saturated aqueous sodium bicarbonate solution 
(2 mL) and saturated aqueous sodium thiosulfate solution (1 mL). The mixture was extracted with 
dichloromethane (3 × 5  mL). The combined organic layers were dried over sodium sulfate and the 
filtrate was concentrated under reduced pressure. Purification by flash column chromatography on 
silica gel (5% ethyl acetate in cyclohexane) afforded a mixture of lactones 24 and 23 (9.4 mg, 79%, 
ratio 24:23 = 3.2:1).  
Table 1: Selected examples for the Baeyer-Villiger oxidation of 22 
Entry conditions scale 
[mg] 
time [h] yield (24 + 23)  ratio 24 : 23 
1 mCPBA (1.2 equiv),  
then DMP 
84 mg 1 + 2 83%   1.0 : 1.4 
2 MeCHO, Cu(OAc)2, O2 5 mg  no reaction  
3 PhCHO, Cu(OAc)2, O2 5 mg  no reaction  
4 t-BuCHO, Cu(OAc)2, O2, 
then DMP 
5 mg 3 + 2 n.d.   3.2 : 1.0 
5 t-BuCHO (5 equiv), 
Cu(OAc)2, O2, then DMP 
11 mg 2 + 2 78%   3.2 : 1.0 
 1-Adamantanecarbaldehyde 
(5 equiv), 
Cu(OAc)2, O2, then DMP 
5 mg  n.d   3.2 : 1.0 
6 MeCO3H, Cu(OAc)2, then 
DMP 
5 mg 1 + 2 n.d.   1.0 : 1.2 
7 mCPBA, Cu(OAc)2, then 
DMP 
5 mg 1 + 2 n.d.   1.0 : 1.2 
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8 t-BuCHO (5 equiv), 
Cu(OAc)2, O2, then DMP 
247 mg 60 + 2 47%   2.0 : 1.0 
 
 
 
Large-Scale Oxidation: 
To a solution of allylic alcohol 22 (247 mg, 0.83 mmol, 1 equiv) in 1,2-dichloroethane (21 mL) was 
added pivalaldehyde (0.45 mL, 4.2 mmol, 5.0 equiv) and copper(II) acetate monohydrate (166 mg, 
0.83 mmol, 1.00 equiv). The flask was capped with a septum and sparged with oxygen gas from a 
balloon for 5 min. The solution was stirred under oxygen at 23 °C until monitoring by thin layer 
chromatography indicated full conversion of the starting material (60 h). Sodium bicarbonate 
(350 mg, 4.12 mmol, 5.0 equiv) and Dess–Martin periodinane (1.4 g, 3.3 mmol, 4.0 equiv) were 
added and the solution was stirred for 2 h at 23 °C. Excess DessMartin periodinane was quenched 
by addition of saturated aqueous sodium bicarbonate solution (30 mL) and saturated aqueous 
sodium thiosulfate solution (10 mL). The mixture was extracted with dichloromethane (3 × 30 mL). 
The combined organic layers were dried over sodium sulfate and the filtrate was concentrated under 
reduced pressure. Purification by flash column chromatography on silica gel (10% ethyl acetate in 
cyclohexane initially, grading to 25% ethyl acetate in cyclohexane) afforded a mixture of lactones 
24 and 23 (122 mg, 47%, ratio 24:23 = 2.0:1). Separation by slow flash column chromatography on 
silica gel (5% ethyl acetate in cyclohexane initially, grading to 10% ethyl acetate in cyclohexane) 
afforded lactone 24 (83 mg, 32%) and lactone 23 (34 mg, 14%) as both colorless crystalline solids.  
 
Analytical data of lactone 24: 
 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.45 (UV) 
mp: 138.0 – 139.1 °C 
1
H NMR (400 MHz, CDCl3) δ 7.21 (d, J = 8.2 Hz, 1H), 7.06 (dd, J = 8.2, 1.4 Hz, 2H), 6.93 (d, J = 
1.4 Hz, 1H), 6.10 (dd, J = 13.1, 1.3 Hz, 1H), 5.61 (dd, J = 13.1, 1.9 Hz, 1H), 5.04 (dd, J = 8.6, 
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1.9 Hz, 1H), 4.06 (t, J = 8.7 Hz, 1H), 3.15 (dd, J = 8.8, 1.2 Hz, 1H), 2.57 (q, J = 7.6 Hz, 2H), 1.59 
(s, 3H), 1.43 (s, 3H), 1.22 (s, 3H), 1.19 (t, J = 7.6 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 195.9, 177.0, 148.2, 142.9, 140.8, 128.5, 127.7, 127.1, 126.3, 126.2, 
84.7, 45.6, 43.7, 42.5, 39.4, 28.5, 28.2, 22.1, 21.4, 15.4. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2966 (s), 2930 (m), 1776 (s), 1681 (s), 1615 (m), 1502 (w), 1479 (w), 1455 
(w), 1423 (w), 1408 (w), 1391 (w), 1377 (w), 1368 (w), 1332 (w), 1317 (m), 1283 (w), 1265 (w), 
1245 (w), 1205 (m), 1173 (w), 1158 (w), 1143 (w), 1124 (w), 1112 (w), 1085 (w), 1067 (m), 1026 
(w), 981 (w), 950 (w), 916 (m), 897 (w), 825 (w), 732 (w), 705 (w), 690 (w), 655 (w), 503 (w), 589 
(w), 563 (w), 494 (w), 476 (w), 452 (w), 407 (w) cm-1. 
HRMS (ESI): calcd for C20H22NaO3 [M+Na]
+: 333.1461; found: 333.1452. 
The structure was validated by single crystal X-ray analysis (see X-ray section). 
Analytical data of lactone 23: 
 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.38 (UV) 
mp: 189.3 – 190.5 °C 
1
H NMR (500 MHz, CDCl3) δ 7.19 (d, J = 8.2 Hz, 1H), 7.06 (d, J = 8.2 Hz, 1H), 6.92 (s, 1H), 6.04 
(d, J = 13.2 Hz, 1H), 5.69 (d, J = 13.2 Hz, 1H), 5.11 (d, J = 8.2 Hz, 1H), 4.19 (t, J = 8.5 Hz, 1H), 
3.92 (d, J = 8.8 Hz, 1H), 2.57 (q, J = 7.6 Hz, 2H), 1.50 (s, 3H), 1.45 (s, 3H), 1.26 (s, 3H), 1.19 (t, J 
= 7.6 Hz, 3H). 
13
C NMR (126 MHz, CDCl3) δ 192.4, 171.7, 147.9, 143.1, 140.7, 129.5, 128.5, 128.3, 127.9, 126.0, 
81.6, 60.2, 49.2, 43.5, 40.5, 28.6, 28.2, 23.1, 19.1, 15.4. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2967 (m), 2933 (w), 1774 (s), 1672 (s), 1615 (w), 1573 (w), 1500 (w), 1479 
(w), 1454 (w), 1416 (w), 1391 (w), 1374 (w), 1359 (w), 1342 (w),1315 (w), 1300 (w), 1275 (w), 
1259 (w), 1221 (w), 1204 (w), 1187 (m), 1161 (s), 1146 (w), 1125 (w), 1068 (w), 1017 (s), 950 (w), 
908 (s), 868 (w), 854 (w), 827 (m), 809 (w), 781 (m), 727 (s), 677 (w), 647 (m), 611 (w), 597 (w), 
568 (w), 540 (w), 520 (w), 493 (w), 475 (w), 447 (w), 408 (w) cm-1. 
HRMS (ESI): calcd for C20H22NaO3 [M+Na]
+: 333.1461; found: 333.1459 
The structure was validated by single crystal X-ray analysis (see X-ray section). 
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7-ethyl-11-methoxy-3,4,4-trimethyl-2a,3,4,8b-tetrahydro-3,1-prop[1]enocyclobuta[a]naphthalen-
2(1H)-one (S6) 
 
 
 
To a suspension of sodium hydride (60% in mineral oil, 6.1 mg, 0.15 mmol, 3.0 equiv) in 
tetrahydrofuran (0.50 mL) was added allylic alcohol 22 (15 mg, 0.050 mmol, 1 equiv). The 
suspension was stirred at 23 °C for 30 min and methyl iodide (10 µL, 0.15 mmol, 3.0 equiv) was 
added. The reaction mixture was stirred at 23 °C for 2 h. Excess base was quenched by addition of 
saturated aqueous ammonium chloride solution (0.5 mL). The mixture was extracted with 
dichloromethane (3 × 1 mL) and the combined organic layers were dried over sodium sulfate. The 
filtrate was concentrated under reduced pressure. Purification by flash column chromatography on 
silica gel (1% ethyl acetate in cyclohexane initially, grading to 10% ethyl acetate in cyclohexane) 
afforded the ether S6 (5.1 mg, 32%) as a colorless oil. 
 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.48 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.22 (d, J = 8.1 Hz, 1H), 7.04 (dd, J = 8.1, 1.6 Hz, 1H), 6.95 (d, J = 
1.3 Hz, 1H), 5.48 (dt, J = 12.8, 1.9 Hz, 1H), 5.35 (dt, J = 12.8, 2.2 Hz, 1H), 3.91 – 3.86 (m, 1H), 
3.72 (t, J = 8.5 Hz, 1H), 3.59 (dt, J = 4.0, 2.3 Hz, 1H), 3.47 (ddd, J = 8.1, 6.6, 1.6 Hz, 1H), 3.32 (s, 
3H), 2.61 (q, J = 7.6 Hz, 2H), 1.41 (s, 3H), 1.29 (s, 3H), 1.23 (t, J = 7.6 Hz, 3H), 1.09 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 207.0, 144.0, 141.6, 136.5, 130.8, 128.6, 128.2, 126.8, 125.2, 76.4, 
65.0, 64.9, 56.2, 42.3, 40.7, 28.4, 28.0, 27.8, 22.2, 21.9, 15.6. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2966 (s), 2933 (w), 2877 (w), 2829 (w), 1776 (s), 1740 (w), 1689 (w), 1662 
(w), 1611 (w), 1570 (w), 1497 (w), 1462 (m), 1420 (w), 1388 (w), 1371 (w), 1323 (w), 1281 (w), 
1260 (w), 1242 (w), 1184 (m), 1086 (s), 1022 (w), 987 (w), 969 (w), 948 (w), 920 (w), 850 (w), 825 
(w), 804 (m), 774 (w), 732 (w), 688 (w), 643 (w), 589 (w), 543 (w), 492 (w), 459 (w), 430 (w) cm-1.  
HRMS (ESI): calcd for C21H26NaO2 [M+Na]
+: 333.1825; found: 333.1802  
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8-ethyl-12-methoxy-4,5,5-trimethyl-3a,4,5,9b-tetrahydro-4,1-prop[1]enonaphtho[1,2-c]furan-
3(1H)-one (S7) 
 
 
 
To a solution of cyclobutanone S6 (5.0 mg, 0.016 mmol, 1 equiv) in 1,2-dichloroethane (0.40 mL) 
was added pivalaldehyde (9 µL, 0.08 mmol, 5 equiv) and copper(II) acetate hydrate (3.2 mg, 
0.016 mmol, 1.0 equiv). The vial was sparged with oxygen gas from a balloon for 2 min and stirred 
under an oxygen atmosphere for 16 h (ca. 50% conversion of S6). The mixture was flushed through 
a pad of silica (100% ethyl acetate). The filtrate was concentrated under reduced pressure. 
Purification by flash column chromatography on silica gel (10% ethyl acetate in cyclohexane) 
afforded a mixture of lactones S7 and S8 (2.1 mg, 40%, ratio S7:S8 = 1.1:1) as a colorless film. 
Separation by flash column chromatography on silica gel (1% ethyl acetate in cyclohexane initially, 
grading to 10% ethyl acetate in cyclohexane) afforded S7 (0.7 mg, 13%) as a colorless film.  
 
Analytical data of S7 (major regioisomer): 
 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.31 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.32 (d, J = 8.2 Hz, 1H), 7.11 (dd, J = 8.1, 1.7 Hz, 1H), 6.98 (d, J = 
1.7 Hz, 1H), 5.42 (ddd, J = 13.2, 2.5, 1.6 Hz, 1H), 5.23 (dt, J = 13.2, 2.0 Hz, 1H), 5.16 (dt, J = 8.8, 
2.2 Hz, 1H), 4.02 (t, J = 8.8 Hz, 1H), 3.38 (q, J = 2.2 Hz, 1H), 3.34 (s, 3H), 2.96 (dd, J = 8.8, 1.5 Hz, 
1H), 2.64 (q, J = 7.6 Hz, 2H), 1.48 (s, 3H), 1.43 (s, 3H), 1.25 (t, J = 7.6 Hz, 3H), 1.15 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 177.8, 142.7, 142.2, 134.9, 129.6, 127.6, 127.2, 126.9, 124.5, 80.8, 
79.9, 56.8, 43.4, 43.3, 41.8, 39.7, 29.0, 28.2, 22.4, 21.6, 15.6. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2971 (s) 2930 (w), 2823 (w), 1770 8s), 1688 (w), 16114 (w), 1502 (w), 
1461 (w), 1423 (w), 1391 (w), 1366 (w), 1310 (w), 1278 (w), 1247 (w), 1187 (w), 1177 (m), 1147 
(m), 1136 (w), 1099 (s), 1068 (w), 1019 (m), 976 (w), 948 (w), 929 (w), 894 (w), 849 (w), 828 (m), 
777 (w), 743 (w), 712 (w), 689 (w), 658 (w), 623 (w), 584 (w), 539 (w), 519 (w), 496 (w), 475 (w), 
438 (w), 426 (w), 410 (w) cm-1.  
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HRMS (ESI): calcd for C21H26NaO3 [M+Na]
+: 349.1774; found: 349.1749. 
 
Salimabromide (1) 
 
 
 
To a vigorously stirred solution of lactone 24 (65 mg, 0.21 mmol, 1 equiv) and silver(I) 
trifluoroacetate (139 mg, 0.63 mmol, 3.0 equiv) in trifluoroacetic acid (2.0 mL) was added bromine 
(32 µL, 0.63 mmol, 3.0 equiv) at 0 °C. The instantly formed milky suspension was stirred at 0 °C 
for 10 min. Excess bromine and trifluoroacetic acid was quenched by addition of saturated aqueous 
sodium bicarbonate solution (140 mL) and saturated aqueous sodium thiosulfate solution (10 mL). 
The suspension was extracted with dichloromethane (4 × 20 mL). The combined organic layers 
were dried over sodium sulfate and the filtrate was concentrated under reduced pressure. 
Purification by flash column chromatography on silica gel (5% ethyl acetate in cyclohexane) 
afforded salimabromide 1 (49.4 mg, 50%) and mono-brominated lactone S9 (15.4 mg, 19%) as both 
crystalline colorless solids.  
Analytical data of salimabromide 1: 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.56 (UV) 
mp: 251.2 – 252.4 °C (slight decomposition already) 
1
H NMR (600 MHz, MeOD) δ 7.63 (s, 1H), 6.32 (dd, J = 13.1, 1.4 Hz, 1H), 5.67 (dd, J = 13.1, 
2.0 Hz, 1H), 5.62 (dd, J = 8.3, 2.0 Hz, 1H), 4.41 (t, J = 8.3 Hz, 1H), 3.35 (dd, J = 8.4, 1.4 Hz, 1H), 
3.07 (qd, J = 7.5, 4.0 Hz, 2H), 1.59 (s, 3H), 1.49 (s, 3H), 1.23 (s, 3H), 1.15 (t, J = 7.5 Hz, 3H).  
13
C NMR (151 MHz, MeOD) δ 197.7, 177.9, 149.8, 147.5, 142.7, 131.5, 130.1, 128.1, 126.5, 125.7, 
83.5, 45.8, 45.2, 44.7, 42.6, 31.9, 29.1, 22.5, 21.8, 12.7. 
The solubility in MeOD is very low! 
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1
H NMR (400 MHz, CDCl3) δ 7.48 (s, 1H), 6.12 (dd, J = 13.1, 1.3 Hz, 1H), 5.68 (dd, J = 13.2, 
1.7 Hz, 1H), 5.66 (dd, J = 8.4, 1.8 Hz, 1H),4.22 (t, J = 8.4 Hz, 1H), 3.15 (dd, J = 8.4, 1.4 Hz, 1H), 
3.09 – 2.95 (m, 2H), 1.59 (s, 3H), 1.45 (s, 3H), 1.20 (s, 3H), 1.14 (t, J = 7.5 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 195.7, 176.1, 147.4, 145.5, 142.2, 130.4, 127.9, 127.4, 126.1, 125.4, 
82.1, 44.6, 44.2, 43.6, 41.7, 31.3, 29.2, 22.5, 21.7, 12.4. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2955 (w), 2924 (s), 2853 (m), 1783 (s), 1736 (w), 1685 (s), 1618 (w), 1578 
(w), 1532 (w), 1463 (m), 1440 (w), 1392 (w), 1380 (w), 1324 (w), 1311 (w), 1280 (w), 1262 (w), 
1219 (m), 1177 (m), 1159 (s), 1127 (w), 1111 (w), 1063 (m), 1034 (s), 979 (m), 948 (w), 908 (s), 
875 (w), 825 (s), 793 (m), 731 (s), 648 (w), 624 (w), 586 (w), 558 (w), 501 (w), 486 (w), 449 (w) 
cm-1. 
HRMS (ESI): calcd for C20H21Br2O3 [M+H]
+: 468.9832; found: 468.9825 
The structure was validated by single crystal X-ray analysis (see X-ray section). 
 
Analytical data of S9: 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.51 (UV) 
mp: 155.2 – 157.8 °C 
1
H NMR (400 MHz, CDCl3) δ 7.43 (s, 1H), 6.96 (s, 1H), 6.10 (dd, J = 13.1, 1.4 Hz, 1H), 5.64 (dd, 
J = 13.1, 1.9 Hz, 1H), 5.03 (dd, J = 8.6, 1.9 Hz, 1H), 4.02 (t, J = 8.8 Hz, 1H), 3.14 (dd, J = 8.8, 
1.4 Hz, 1H), 2.67 (q, J = 7.5 Hz, 2H), 1.59 (s, 3H), 1.43 (s, 3H), 1.22 (s, 3H), 1.18 (t, J = 7.5 Hz, 
3H). 
13
C NMR (101 MHz, CDCl3) δ 195.6, 176.6, 147.8, 143.2, 142.3, 130.7, 129.2, 126.8, 126.5, 124.8, 
84.4, 45.5, 43.6, 42.6, 39.1, 28.9, 28.5, 22.1, 21.3, 14.2. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2967 (m), 2932 (w), 2873 (w), 1781 (s), 1683 (s), 1616 (w), 1556 (w), 1480 
(w), 1462 (w), 1394 (w), 1370 (w), 1315 (w), 1261 (m), 1236 (w), 1204 (w), 1156 (s), 1124 (w), 
1092 (m), 1070 (m), 1028 (s), 983 (w), 951 (w), 906 (m), 874 (w), 825 (s9, 800 (s), 732 (s), 697 
(w), 648 (w), 616 (w), 577 (w), 542 (w), 521 (w), 471 (w) cm-1. 
HRMS (ESI): calcd for C20H21NaBrO3 [M+Na]
+: 411.0566; found: 411.0539.  
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NMR comparison data of Salimabromide (1)119 
 
 
 
 
  
                                                   
119 S. Felder, S. Dreisigacker, S. Kehraus, E. Neu, G. Bierbaum, P. R. Wright, D. Menche, T. F. Schäberle, 
G. M. König, Chem. Eur. J., 2013, 19, 9319–9324. 
No.  1H NMR  
(500 MHz, MeOD) 
isolated 
Salimabromide (1) 
[ppm] 
1H NMR  
(600 MHz, MeOD) 
synthetic 
Salimabromide (1) 
[ppm] 
Δ ppm 13C NMR  
(125 MHz, MeOD) 
isolated Salimabromide 
(1) [ppm] 
13C NMR  
(150 MHz, 
MeOD) 
synthetic 
Salimabromide 
(1) [ppm] 
Δ ppm 
1    197.7 197.7 ±0.0 
2    177.9 177.9 ±0.0 
3 6.35 (d, J = 13.1 Hz, 
1H) 
6.32 (dd, J = 13.1, 
1.4 Hz, 1H) 
−0.03 149.8 149.8 ±0.0 
4    147.6 147.6 ±0.0 
5    142.7 142.7 ±0.0 
6 7.65 (s, 1H) 7.63 (s, 1H) −0.02 131.5 131.5 ±0.0 
7    130.1 130.1 ±0.0 
8    128.1 128.1 ±0.0 
9 5.70 (d, J = 13.1 Hz, 
1H) 
5.67 (dd, J = 13.1, 
2.0 Hz, 1H) 
−0.03 126.5 126.5 ±0.0 
10    125.7 125.7 ±0.0 
11 5.65 (d, J = 8.5 Hz, 
1H) 
5.62 (dd, J = 8.3, 
2.0 Hz, 1H) 
−0.03 83.5 83.5 ±0.0 
12    45.8 45.8 ±0.0 
13 3.38 (d, J = 8.5 Hz, 
1H) 
3.35 (dd, J = 8.4, 
1.4 Hz, 1H) 
−0.03 45.2 45.2 ±0.0 
14    44.7 44.7 ±0.0 
15 4.44 (t, J = 8.5 Hz, 
1H) 
4.41 (t, J = 8.3 Hz, 
1H) 
−0.03 42.6 42.6 ±0.0 
16 3.09 (q, J = 7.6 Hz, 
2H) 
3.07 (qd, J = 7.5, 
4.0 Hz, 2H) 
−0.02 31.9 31.9 ±0.0 
17 1.25 (s, 3H) 1.23 (s, 3H) −0.02 29.1 29.1 ±0.0 
18 1.52 (s, 3H) 1.49 (s, 3H) −0.03 22.5 22.5 ±0.0 
19 1.61 (s, 3H) 1.59 (s, 3H) −0.02 21.8 21.8 ±0.0 
20 1.17 (t, J = 7.6 Hz, 
3H) 
1.15 (t, J = 7.5 Hz, 
3H) 
−0.02 12.7 12.7 ±0.0 
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Asymmetric Synthesis of 12 
 
1-(4,4-dimethyl-3-methylenepentyl)-3-methoxybenzene (S10) 
 
 
 
To a suspension of potassium tert-butoxide (1.83 g, 16.3 mmol, 1.80 equiv) in diethyl ether (33 mL) 
was added methyltriphenylphosphonium bromide (5.84 g, 16.3 mmol, 1.80 equiv) at 0 °C. The 
yellow suspension was stirred for 15 min at 0 °C. The reaction was then concentrated at 40 °C under 
a stream of nitrogen for 1 h. Subsequently ketone 11 (2.00 g, 9.08 mmol, 1 equiv) was added and 
the slurry was stirred at 50 °C for 4 h. The reaction mixture was cooled to 23 °C and excess base 
was quenched by addition of saturated aqueous ammonium chloride solution (100 mL). The 
reaction mixture was extracted with ethyl acetate (3 × 50 mL). The combined organic layers were 
washed with saturated aqueous sodium chloride solution (100 mL) and the washed solution was 
dried over sodium sulfate. The filtrate was concentrated under reduced pressure. Purification by 
flash column chromatography on silica gel (1% ethyl acetate in cyclohexane) afforded alkene S10 
(1.73 g, 87%) as a colorless oil.  
 
TLC (5% ethyl acetate in cyclohexane): Rf: 0.52 (UV) 
1
H NMR (400 MHz, CDCl3) δ 7.22 (t, J = 7.8 Hz, 1H), 6.83 (d, J = 7.6 Hz, 1H), 6.79 (d, J = 2.2 Hz, 
1H), 6.76 (dd, J = 8.1, 2.5 Hz, 1H), 4.94 (q, J = 0.8 Hz, 2H), 4.81 (q, J = 1.2 Hz, 2H), 3.82 (s, 3H), 
2.81 – 2.71 (m, 2H), 2.36 (dd, J = 10.4, 6.2 Hz, 2H), 1.10 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 159.8, 157.7, 144.5, 129.4, 120.9, 114.4, 111.1, 106.3, 55.2, 36.4, 
35.9, 33.3, 29.4. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2955 (s), 2910 (w), 2869 (w), 2834 (w), 1633 (m), 601 (s), 1584 (s), 1488 (s), 
1464 (s), 1455 (s), 1436 (w), 1387 (w), 1361 (m), 1313 (w), 1261 (s), 1201 (w), 1191 (w), 1152 (s), 
1081 (w), 1053 (ss), 996 (w), 960 (w), 890 (s), 847 (w), 776 (s), 750 (m), 693 (s), 637 (w), 572 (w), 
541 (m), 503 (w), 479 (w), 451 (m) cm-1. 
HRMS (ESI): calcd for C15H23O [M+H]
+: 219.1743 found: 219.1734.  
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(R)-2-(3-methoxyphenethyl)-3,3-dimethylbutane-1,2-diol (S11) 
 
 
 
Potassium hexacyanoferrate(III) (9.9 g, 30 mmol, 6.0 equiv), potassium carbonate (4.1 g, 30 mmol, 
5.0 equiv), potassium osmate(VI) dihydrate (11 mg, 30 µmol, 0.6 mol%) and hydroquinidine 1,4-
phthalazinediyl diether (75 mg, 96 µmol, 1.9 mol%) were finely grinded in a mortar and the 
obtained powder was added to a mixture of water (30 mL) and t-butanol (30 mL). The suspension 
was sonicated for 30 min and then cooled to 0 °C. Methanesulfonamide (0.95 g, 10 mmol, 1.7 equiv) 
was added, followed by alkene S10 (1.09 g, 4.99 mmol, 1 equiv). The suspension was vigorously 
stirred for 16 h at 0 °C until analysis by thin layer chromatography indicated full conversion of the 
alkene S10. The reaction was allowed to warm to 23 °C and sodium sulfite (6.5 g) was added. The 
reaction mixture was stirred for 1 h followed by addition of aqueous sodium hydroxide solution 
(1 M, 30 mL). The aqueous layer was extracted with ethyl acetate (3 × 100 mL). The combined 
organic layers were washed with saturated aqueous sodium chloride solution (100 mL) and the 
washed solution was dried over sodium sulfate. The filtrate was concentrated under reduced 
pressure. Purification by flash column chromatography on silica gel (25% ethyl acetate in 
cyclohexane initially, grading to 50% ethyl acetate in cyclohexane) afforded diol S11 (1.21 g, 96%) 
as a colorless oil that crystallized upon storage.  
 
TLC (50% ethyl acetate in cyclohexane): Rf: 0.39 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.21 (t, J = 7.8 Hz, 1H), 6.83 (d, J = 7.6 Hz, 1H), 6.79 (d, J = 2.2 Hz, 
1H), 6.75 (dd, J = 8.1, 2.4 Hz, 1H), 3.80 (s, 3H), 3.79 – 3.75 (m, 1H), 3.66 (dd, J = 11.0, 6.0 Hz, 
1H), 2.83 – 2.67 (m, 2H), 2.55 (t, J = 5.3 Hz, 1H), 2.44 (s, 1H), 1.95 (ddd, J = 14.1, 11.4, 5.7 Hz, 
1H), 1.82 (ddd, J = 14.1, 11.5, 5.9 Hz, 1H), 0.99 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 159.7, 144.8, 129.5, 120.9, 114.3, 111.1, 76.4, 64.3, 55.2, 37.8, 
36.5, 31.0, 25.6. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3444 (br s), 2958 (s), 2836 (w), 1601 (m), 1584 (m), 1488 (m), 1455 (m), 1436 
(w), 1395 (w), 1368 (w), 1314 (w), 1258 (s), 1192 (w), 1153 (s), 1037 (s), 908 (s), 777 (m), 730 (s), 
694 (s), 648 (m), 556 (w), 488 (w), 454 (w) cm-1. 
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HRMS (ESI): calcd for C15H24NaO3 [M+Na]
+: 275.1618 found: 275.1604.  
[𝜶]𝑫
𝟐𝟎 = +1.6 (c = 1.03, CH2Cl2). 
 
(R)-2-hydroxy-2-(3-methoxyphenethyl)-3,3-dimethylbutyl 4-methylbenzene-sulfonate (S12) 
 
 
 
To a solution of diol S11 (86 mg, 0.34 mmol, 1 equiv) in pyridine (1.0 mL) at 0 °C was added 4-
methylbenzene-1-sulfonyl chloride (130 mg, 0.682 mmol, 2.00 equiv) in one portion. The solution 
was stirred at 23 °C for 16 h. Subsequently the reaction mixture was concentrated under reduced 
pressure. Purification by flash column chromatography on silica gel (25% ethyl acetate in 
cyclohexane) afforded the title compound (128 mg, 92%) as a colorless oil.  
 
TLC (50% ethyl acetate in cyclohexane): Rf: 0.51 (CAM) 
1
H NMR (400 MHz, Chloroform-d) δ 7.83 (d, J = 8.3 Hz, 2H), 7.36 (d, J = 8.0 Hz, 2H), 7.19 (t, J 
= 7.8 Hz, 1H), 6.76 – 6.68 (m, 3H), 4.13 (d, J = 9.9 Hz, 1H), 4.07 (d, J = 9.9 Hz, 1H), 3.80 (s, 3H), 
2.63 (ddd, J = 13.3, 9.9, 7.2 Hz, 1H), 2.52 (ddd, J = 13.3, 10.3, 7.0 Hz, 1H), 2.45 (s, 3H), 1.94 – 
1.83 (m, 3H), 0.95 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 159.8, 145.2, 144.0, 132.6, 130.1, 129.5, 128.1, 120.8, 114.3, 111.3, 
75.8, 71.4, 55.2, 37.9, 35.1, 30.3, 25.6, 21.7. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3548 (m br), 2961 (m), 2836 (w), 1599 (m), 1585 (m), 1487 (m), 1455 (w), 
1437 (w), 1399 (w), 1358 (m), 1290 (w), 1260 (m), 1212 (w), 1189 (w), 1174 (s), 1154 (w), 1120 
(w), 1096 (m), 1044 (m), 1019 (w), 975 (s), 953 (s), 840 (s), 813 (s), 783 (m), 736 (m), 696 (m), 665 
(s), 579 (m), 554 (s), 528 (s), 477 (w), 450 (w) cm-1. 
HRMS (ESI): calcd for C15H24NaO3 [M+Na]
+: 429.1706 found: 429.1650.  
[𝜶]𝑫
𝟐𝟎 = −17.0 (c = 0.79, CH2Cl2). 
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(R)-2-(tert-butyl)-2-(3-methoxyphenethyl)oxirane (7) 
 
 
 
To a solution of tosylate S12 (116 mg, 0.285 mmol, 1 equiv) in diethyl ether (1.0 mL) was added 
freshly grinded potassium hydroxide (65 mg, 1.2 mmol, 4.0 equiv) in one portion at 0 °C. The 
suspension was stirred for 45 min at 0 °C until analysis by thin layer chromatography indicated full 
conversion of the tosylate S12. The reaction solution was directly purified by flash column 
chromatography on silica gel (1% ethyl acetate in cyclohexane) to afford epoxide 7 (61 mg, 91%) 
as a colorless oil. 
[𝜶]𝑫
𝟐𝟎 = +8.0 (c = 0.77, CH2Cl2). 
82% ee (HPLC conditions: Chiralcel IA column, heptane/EtOAc = 99.7/0.3, 1.5 mL/min, λ = 
272 nm, tR(minor) = 8.6 min, tR(major) = 9.8 min) 
The analytical data matched those obtained by direct epoxidation of 11.  
 
(6-methoxy-1,1,2-trimethyl-1,2,3,4-tetrahydronaphthalen-2-yl)methanol (12) 
 
 
Table 2: Rearrangement of enantioenriched 7 towards 12 under different conditions. 
Entry* conditions ee of 7 comments ee of 12  
1 HFIP, H2SO4, 23 °C, 5 min 82%  38% 
2 n-hexane, H2SO4, 23 °C, 5 min 82%  39% 
3 n-hexane, H2SO4, −78 °C, 2.5 h, 
warm to 23 °C, 5 min 
82% solubility of H2SO4 at -78 °C is very 
low, probably no reaction till warm up 
37% 
4 DCM, TiCl4, 23 °C, 10 min 82%  59% 
5 DCM, TiCl4, −78 °C, 1 h, warm 
to 23 °C, 5 min 
82% 25% yield 70% 
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6 DCM, S13, −78 °C, 4 h, warm 
to 23 °C, 16 h 
0% only very minor traces of product 
detectable, >90% of 7 
ca. 0%  
 
, *all reactions were performed on a 3 till 5 mg scale 
 
HPLC conditions: Chiralcel IA column, heptane/i-PrOH = 99/1, 1.5 mL/min, λ = 210 nm,  
tR (minor) = 17.7 min, tR(major) = 18.7 min 
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2.2 NMR spectra 
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Figure 2-2: Original 1H-NMR spectra of salimabromide (1) published by König et. al.120  
                                                   
120 S. Felder, S. Dreisigacker, S. Kehraus, E. Neu, G. Bierbaum, P. R. Wright, D. Menche, T. F. Schäberle, 
G. M. König, Chem. Eur. J., 2013, 19, 9319–9324. 
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2.3 X–Ray crystallographic analysis data 
Cyclobutanone (5) 
 
 
Identification code mar1810 
Empirical formula C20H24O 
Formula weight 280.39 
Temperature 173(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
Space group P21/c (no. 14) 
Unit cell dimensions a = 9.9024(4) Å  = 90°. 
b = 17.7073(8) Å  = 100.9080(10)° 
c = 8.9301(3) Å   = 90°. 
Volume 1537.55(11) Å3 
Z 4 
Density (calculated) 1.211 Mg/m3 
Absorption coefficient 0.072 mm-1 
F(000) 608 
Crystal size 0.220 x 0.160 x 0.120 mm3 
Theta range for data collection 2.094 to 24.998°. 
Index ranges -11<=h<=11, -21<=k<=21, -10<=l<=10 
Reflections collected 16633 
Independent reflections 2713 [R(int) = 0.0310] 
Completeness to theta = 25.242° 100.0 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.988 and 0.973 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2713 / 3 / 203 
Goodness-of-fit on F2 1.028 
Final R indices [I>2sigma(I)] R1 = 0.0449, wR2 = 0.1109 
R indices (all data) R1 = 0.0547, wR2 = 0.1174 
Absolute structure parameter 0.032(3) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.363 and -0.238 e.Å-3 
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Lactone (24) 
 
 
 
Identification code mar187 
Empirical formula C20H22O3 
Formula weight 310.37 
Temperature 183(2) K 
Wavelength 0.71073 Å 
Crystal system Triclinic 
Space group P-1 (no. 2) 
Unit cell dimensions a = 10.2423(9) Å    = 88.506(3)°. 
b = 11.5267(11) Å = 80.899(3)°. 
c = 14.1776(14) Å  = 76.244(3)°. 
Volume 1605.2(3) Å3 
Z 4 
Density (calculated) 1.284 Mg/m3 
Absorption coefficient 0.085 mm-1 
F(000) 664 
Crystal size 0.180 x 0.180 x 0.080 mm3 
Theta range for data collection 2.316 to 24.998°. 
Index ranges -12<=h<=12, -13<=k<=13, -16<=l<=16 
Reflections collected 40208 
Independent reflections 5650 [R(int) = 0.0328] 
Completeness to theta = 25.242° 99.9% 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.958 and 0.942 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5650 / 0 / 416 
Goodness-of-fit on F2 1.031 
Final R indices [I>2sigma(I)] R1 = 0.0395, wR2 = 0.0993 
R indices (all data) R1 = 0.0498, wR2 = 0.1053 
Extinction coefficient 0.0198(15) 
Largest diff. peak and hole 0.277 and -0.370 e.Å-3 
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Lacton (23) 
 
 
Identification code mar183 
Empirical formula C20H22O3 
Formula weight 310.37 
Temperature 183(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
Space group Pc (no. 7) 
Unit cell dimensions a = 27.498(6) Å    = 90°. 
b = 7.6508(18) Å  = 90.715(6)°. 
c = 15.583(4) Å   = 90°. 
Volume 3278.1(14) Å3 
Z 8 
Density (calculated) 1.258 Mg/m3 
Absorption coefficient 0.083 mm-1 
F(000) 1328 
Crystal size 0.180 x 0.180 x 0.060 mm3 
Theta range for data collection 2.222 to 24.000°. 
Index ranges -31<=h<=31, -8<=k<=8, -17<=l<=17 
Reflections collected 26356 
Independent reflections 9751 [R(int) = 0.0664] 
Completeness to theta = 25.242° 99.6 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.972 and 0.963 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9751 / 2 / 830 
Goodness-of-fit on F2 1.314 
Final R indices [I>2sigma(I)] R1 = 0.1179, wR2 = 0.3162 
R indices (all data) R1 = 0.1484, wR2 = 0.3419 
Absolute structure parameter 0.1(10) 
Extinction coefficient 0.008(3) 
Largest diff. peak and hole 0.912 and -0.480 e.Å-3 
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Salimabromide (1) 
 
 
Identification code mar185 
Empirical formula C20H20Br2O3 
Formula weight 468.18 
Temperature 183(2) K 
Wavelength 0.71073 Å 
Crystal system Orthorhombic 
Space group Pca21 (no. 29) 
Unit cell dimensions a = 17.2220(6) Å    = 90°. 
b = 9.8655(4) Å  = 90°. 
c = 20.9582(8) Å   = 90°. 
Volume 3560.9(2) Å3 
Z 8 
Density (calculated) 1.747 Mg/m3 
Absorption coefficient 4.570 mm-1 
F(000) 1872 
Crystal size 0.140 x 0.080 x 0.035 mm3 
Theta range for data collection 2.365 to 25.498°. 
Index ranges -20<=h<=18, -11<=k<=11, -25<=l<=25 
Reflections collected 59510 
Independent reflections 6607 [R(int) = 0.0402] 
Completeness to theta = 25.242° 99.9% 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.825 and 0.673 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6607 / 1 / 452 
Goodness-of-fit on F2 1.051 
Final R indices [I>2sigma(I)] R1 = 0.0324, wR2 = 0.0784 
R indices (all data) R1 = 0.0376, wR2 = 0.0813 
Absolute structure parameter 0.287(13) 
Extinction coefficient n/a 
Largest diff. peak and hole 1.255 and -1.083 e.Å-3 
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2.4 Chiral HPLC data 
 
Epoxide 7 
 
HPLC conditions: Chiralcel IA column, heptane/EtOAc = 99.7/0.3, 1.5 mL/min, λ = 272 nm,  
tR (minor) = 8.6 min, tR(major) = 9.8 min 
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Tetraline 12 
 
HPLC conditions: Chiralcel IA column, heptane/i-PrOH = 99/1, 1.5 mL/min, λ = 210 nm,  
tR (minor) = 17.7 min, tR(major) = 18.7 min 
 
Racemic 12 
 
 
HFIP, H2SO4, 23 °C, 5 min 
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n-Hexane, H2SO4, 23 °C, 5 min
 
 
n-Hexane, H2SO4, −78 °C (2.5 h,), then slowly to 23 °C, 5 min
 
 
DCM, TiCl4, 23 °C, 10 min
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DCM, TiCl4, −78 °C, 1 h, then slowly to 23 °C, 5 min
 
 
(R)-(−)-1,1′-Binaphthyl-2,2′-diyl hydrogenphosphate, DCM, −78 °C, 3 h, then 23 °C, 16 h
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3 Supporting information for chapter II – 2.2 
 
3.1 X-Ray crystallographic analysis data 
 
The X-ray intensity data of 27, 48 and 49 were measured at 100 K on a Bruker D8 Venture TXS 
system equipped with a multilayer mirror optics monochromator and a Mo Kα rotating-anode X-
ray tube (λ = 0.71073 Å). The frames were integrated with SAINT [1], the data were corrected for 
absorption effects using the Multi-Scan method (SADABS) [2]. The structures were solved and 
refined using the Bruker SHELXTL Software Package [3]. In 48, the coordinates of the O-bound 
hydrogen atom were restrained to refine to a O-H distance of 0.83 Å, the temperature factor was 
refined freely. All other hydrogen atoms were calculated in ideal geometry riding on their parent 
atoms.  
The figures below were created with ORTEP [4].   
 
Single-crystal X-ray analysis of compound 27: 
 
Fig. 1 The molecular structure of 27 (ORTEP drawing at the 50% ellipsoid probability level). 
 
net formula C21H20O5 
Mr/g mol
−1 352.37 
crystal size/mm 0.100 × 0.090 × 0.010 
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T/K 100(2) 
radiation MoKα 
diffractometer 'Bruker D8Venture' 
crystal system monoclinic 
space group 'C 2/c' 
a/Å 30.2456(18) 
b/Å 7.6603(4) 
c/Å 18.2737(11) 
α/° 90 
β/° 122.731(2) 
γ/° 90 
V/Å3 3561.6(4) 
Z 8 
calc. density/g cm−3 1.314 
μ/mm−1 0.094 
absorption correction multi-scan 
transmission factor range 0.8940–0.9580 
refls. measured 18840 
Rint 0.0480 
mean σ(I)/I 0.0356 
θ range 3.202–25.38 
observed refls. 2358 
x, y (weighting scheme) 0.0393, 2.6371 
hydrogen refinement constr 
refls in refinement 3250 
parameters 237 
restraints 0 
R(Fobs) 0.0402 
Rw(F
2) 0.0956 
S 1.058 
shift/errormax 0.001 
max electron density/e Å−3 0.223 
min electron density/e Å−3 −0.210 
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Single-crystal X-ray analysis of compound 48: 
 
 
Fig. 2 The molecular structure of 48 (ORTEP drawing at the 50% ellipsoid probability level). 
 
 
net formula C14H18O3 
Mr/g mol
−1 234.28 
crystal size/mm 0.090 × 0.040 × 0.030 
T/K 100.(2) 
radiation MoKα 
diffractometer 'Bruker D8 Venture TXS' 
crystal system monoclinic 
space group 'P 1 21/n 1' 
a/Å 7.0271(3) 
b/Å 17.0529(7) 
c/Å 10.0184(4) 
α/° 90 
β/° 91.650(2) 
γ/° 90 
V/Å3 1200.03(9) 
Z 4 
calc. density/g cm−3 1.297 
μ/mm−1 0.090 
absorption correction Multi-Scan 
transmission factor range 0.9017–0.9705 
refls. measured 18124 
Rint 0.0421 
mean σ(I)/I 0.0268 
θ range 3.137–26.365 
observed refls. 2013 
x, y (weighting scheme) 0.0528, 1.1304 
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hydrogen refinement H(C) constr, H(O) restr 
refls in refinement 2450 
parameters 162 
restraints 1 
R(Fobs) 0.0561 
Rw(F
2) 0.1404 
S 1.116 
shift/errormax 0.001 
max electron density/e Å−3 0.496 
min electron density/e Å−3 −0.358 
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Single-crystal X-ray analysis of compound 49: 
 
 
 
Fig. 3 The molecular structure of 49 (ORTEP drawing at the 50% ellipsoid probability level). 
 
net formula C14H16O2 
Mr/g mol
−1 216.27 
crystal size/mm 0.090 × 0.070 × 0.030 
T/K 100.(2) 
radiation MoKα 
diffractometer 'Bruker D8 Venture TXS' 
crystal system orthorhombic 
space group 'P n m a' 
a/Å 15.3960(5) 
b/Å 7.0864(2) 
c/Å 10.4521(3) 
α/° 90 
β/° 90 
γ/° 90 
V/Å3 1140.35(6) 
Z 4 
calc. density/g cm−3 1.260 
μ/mm−1 0.083 
absorption correction Multi-Scan 
transmission factor range 0.9123–0.9705 
refls. measured 12854 
Rint 0.0310 
mean σ(I)/I 0.0191 
θ range 3.287–28.272 
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observed refls. 1332 
x, y (weighting scheme) 0.0630, 0.3244 
hydrogen refinement constr 
refls in refinement 1533 
parameters 97 
restraints 0 
R(Fobs) 0.0394 
Rw(F
2) 0.1145 
S 1.065 
shift/errormax 0.001 
max electron density/e Å−3 0.402 
min electron density/e Å−3 −0.210 
 
 
References 
 
[1] Bruker (2015). SAINT. Bruker AXS Inc., Madison, Wisconsin, USA. 
[2] Bruker (2001). SADABS. Bruker AXS Inc., Madison, Wisconsin, USA. 
[3] Sheldrick, G. M. (2015). Acta Cryst. A71, 3–8. 
[4] Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849–854. 
 
 
 
  
194   Supporting information for chapter II – 2.2 
 
3.2 NMR spectra 
  
 
Supporting information for chapter II – 2.2  195 
 
 
 
196   Supporting information for chapter II – 2.2 
 
 
 
Supporting information for chapter II – 2.2  197 
 
 
 
198   Supporting information for chapter II – 2.2 
 
 
 
Supporting information for chapter II – 2.2  199 
 
 
 
200   Supporting information for chapter II – 2.2 
 
 
 
Supporting information for chapter II – 2.2  201 
 
 
 
202   Supporting information for chapter II – 2.2 
 
 
 
Supporting information for chapter II – 2.2  203 
 
 
 
204   Supporting information for chapter II – 2.2 
 
 
 
Supporting information for chapter II – 2.2  205 
 
 
 
206   Supporting information for chapter II – 2.2 
 
 
 
Supporting information for chapter II – 2.2  207 
 
 
 
208   Supporting information for chapter II – 2.2 
 
 
 
Supporting information for chapter II – 2.2  209 
 
 
 
210   Supporting information for chapter II – 2.2 
 
 
 
Supporting information for chapter II – 2.2  211 
 
 
 
 
212   Supporting information for chapter II – 2.2 
 
 
 
 
 
 
 
 
 
 
Supporting information for chapter II – 2.2  213 
 
 
 
214   Supporting information for chapter II – 2.2 
 
 
 
 
 
 
 
 
 
Supporting information for chapter II – 2.2  215 
 
 
 
 
216   Supporting information for chapter II – 2.2 
 
 
 
 
 
  
Supporting information for chapter II – 2.2  217 
 
 
 
218   Supporting information for chapter II – 2.2 
 
 
 
Supporting information for chapter II – 2.2  219 
 
 
 
220   Supporting information for chapter II – 2.2 
 
 
 
Supporting information for chapter II – 2.2  221 
 
 
 
222   Supporting information for chapter II – 2.2 
 
 
 
Supporting information for chapter II – 2.2  223 
 
 
 
224   Supporting information for chapter II – 2.2 
 
 
 
 
Supporting information for chapter II – 2.2  225 
 
 
 
  
226   Supporting information for chapter II – 2.2 
 
 
 
Supporting information for chapter II – 2.2  227 
 
 
 
228   Supporting information for chapter II – 2.2 
 
 
 
 
Supporting information for chapter II – 2.2  229 
 
 
  
230   Supporting information for chapter II – 2.2 
 
Supporting information for chapter II – 2.2  231 
 
 
 
232   Supporting information for chapter II – 2.2 
 
 
 
Supporting information for chapter II – 2.2  233 
 
 
 
234   Supporting information for chapter II – 2.2 
 
 
Supporting information for chapter II – 2.2  235 
 
 
236   Supporting information for chapter II – 2.2 
 
 
 
Supporting information for chapter II – 2.2  237 
 
 
 
238   Supporting information for chapter II – 2.2 
 
 
 
Supporting information for chapter II – 2.2  239 
 
 
  
240   Supporting information for chapter II – 2.2 
 
 
 
 
Supporting information for chapter II – 2.2  241 
 
 
 
 
 
 
242   Supporting information for chapter II – 2.2 
 
 
 
Supporting information for chapter II – 2.2  243 
 
 
244   Supporting information for chapter II – 2.2 
 
 
Supporting information for chapter II – 2.2  245 
 
 
 
246   Supporting information for chapter II – 2.2 
 
 
Supporting information for chapter II – 2.2  247 
 
 
248   Supporting information for chapter II – 2.2 
 
Supporting information for chapter II – 2.2  249 
 
250   Supporting information for chapter II – 2.2 
 
Supporting information for chapter II – 2.2  251 
 
 
 
252   Supporting information to chapter II – 2.3 
 
4 Supporting information to chapter II – 2.3 
 
4.1 General experimental details  
 
Synthesis of methoxysalimabromide (II.18) 
 
 
 
To a vigorously stirred solution of lactone II.17 (8.9 mg, 28 µmol, 1 equiv) and silver(I) 
trifluoroacetate (19 mg, 85 µmol, 3.0 equiv) in trifluoroacetic acid (0.3 mL) was added bromine 
(4.3 µL, 85 µmol, 3.0 equiv) at 0 °C. The instantly formed milky suspension was stirred at 0 °C for 
10 min. Excess bromine and trifluoroacetic acid was quenched by addition of saturated aqueous 
sodium bicarbonate solution (10 mL) and saturated aqueous sodium thiosulfate solution (1 mL). 
The suspension was extracted with dichloromethane (4 × 10 mL). The combined organic layers 
were dried over sodium sulfate and the filtrate was concentrated under reduced pressure. 
Purification by flash column chromatography on silica gel (1. Column: 5% ethyl acetate in 
cyclohexane, 2. Column: 30% dichlormethane in cyclohexane) afforded the title compound II.18 
(8.9 mg, 66%) crystalline colorless solid.  
 
TLC (50% ethyl acetate in cyclohexane): Rf: 0.46 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.48 (s, 1H), 6.13 (dd, J = 13.1, 1.4 Hz, 1H), 5.68 (dd, J = 13.1, 2.0 
Hz, 1H), 5.63 (dd, J = 8.3, 2.0 Hz, 1H), 4.19 (t, J = 8.4 Hz, 1H), 3.84 (s, 3H), 3.15 (dd, J = 8.4, 1.4 
Hz, 1H), 1.59 (s, 3H), 1.45 (s, 3H), 1.20 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 195.63, 175.91, 153.29, 147.28, 143.42, 130.77, 128.91, 126.16, 
121.03, 118.50, 81.92, 60.79, 44.70, 43.96, 43.51, 41.12, 29.18, 22.53, 21.70. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2982 (m), 2938 (m), 1785 8s), 1685 (s), 1616 (w), 1538 (w), 1510 (w), 
1469 (m), 1423 (w), 1393 (w), 1378 (w), 1324 (w), 1305 (w), 1276 8m), 1233 (w), 1218 (w), 1177 
(w), 1159 (m), 1127 (m), 1110 (w), 1069 (w), 1038 (s), 984 (w), 962 (m), 909 (w), 875 (w), 827 
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(m), 769 (w), 737 (s), 689 (w), 649 (w), 626 (w), 606 (w), 566 (w), 545 (w), 509 (w), 454 (w), 413 
(w).  
HRMS (ESI): calcd for C19H18Br
79Br81NaO4 [M+Na]
+: 492.9444 found: 492.9430  
 
Synthesis of isosalimabromide (II.20) 
 
 
To a vigorously stirred solution of lactone II.19 (30 mg, 97 µmol, 1 equiv) and silver(I) 
trifluoroacetate (64 mg, 0.29 mmol, 3.0 equiv) in trifluoroacetic acid (0.5 mL) was added bromine 
(15 µL, 0.29 µmol, 3.0 equiv) at 0 °C. The instantly formed milky suspension was stirred at 0 °C 
for 10 min. Excess bromine and trifluoroacetic acid was quenched by addition of saturated aqueous 
sodium bicarbonate solution (15 mL) and saturated aqueous sodium thiosulfate solution (1 mL). 
The suspension was extracted with dichloromethane (4 × 10 mL). The combined organic layers 
were dried over sodium sulfate and the filtrate was concentrated under reduced pressure. 
Purification by flash column chromatography on silica gel (5% ethyl acetate in cyclohexane) 
afforded the title compound II.20 (17.4 mg, 38%) and the monobrominated compound II.21 
(3.4 mg, 9%) as both crystalline colorless solids.  
 
Analytical data of II.20  
TLC (50% ethyl acetate in cyclohexane): Rf: 0.56 (CAM) 
1
H NMR (400 MHz, Chloroform-d) δ 7.46 (s, 1H), 6.06 (dd, J = 13.2, 1.8 Hz, 1H), 5.74 (dd, J = 
13.2, 1.8 Hz, 1H), 5.07 (dd, J = 7.9, 1.8 Hz, 1H), 4.55 (dd, J = 8.6, 1.8 Hz, 1H), 4.24 (t, J = 8.2 Hz, 
1H), 3.08 – 2.95 (m, 2H), 1.51 (s, 3H), 1.46 (s, 3H), 1.24 (s, 3H), 1.14 (t, J = 7.5 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 191.57, 171.35, 147.22, 145.26, 142.28, 130.01, 129.95, 127.93, 
127.81, 125.24, 80.89, 57.33, 48.46, 44.43, 42.78, 31.32, 29.18, 23.33, 19.36, 12.34. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2978 (m), 2934 (w), 2875 (w), 1778 (s), 1676 (s), 1618 (w), 1579 (w), 1529 
(w), 1463 (w), 1394 (w), 1375 (w), 1355 (w), 1341 (w), 1316 (w), 1259 (w), 1228 (w), 1185 (w), 
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1163 (m), 1130 (w), 1094 (w), 1064 (w), 1029 (m), 982 (w), 949 (w), 911 (w), 875 (w), 848 (w), 
793 (w), 731 (m), 702 (w), 678 (w), 648 (w), 564 (w), 525 (w), 502 (w), 484 (w), 458 (w), 431 (w).  
HRMS (ESI): calcd for C20H20Br
79Br81NaO3 [M+Na]
+: 490.9651 found: 490.9631.  
 
Analytical data of II.21 
TLC (50% ethyl acetate in cyclohexane): Rf: 0.52 (CAM) 
1H NMR (400 MHz, CDCl3) δ 7.41 (s, 1H), 6.94 (s, 1H), 6.03 (dd, J = 13.2, 1.8 Hz, 1H), 5.71 (dd, J = 13.2, 
1.7 Hz, 1H), 5.09 (dd, J = 8.3, 1.8 Hz, 1H), 4.14 (t, J = 8.6 Hz, 1H), 3.90 (dd, J = 8.9, 1.7 Hz, 1H), 2.67 (q, J 
= 7.5 Hz, 2H), 1.49 (s, 3H), 1.44 (s, 3H), 1.26 (s, 3H), 1.18 (t, J = 7.5 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 192.01, 171.32, 147.49, 143.02, 142.37, 130.33, 129.99, 129.19, 
128.13, 124.57, 81.20, 59.92, 48.97, 43.57, 40.05, 28.93, 28.44, 22.97, 19.04, 14.19. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥:  2966 (m), 2925 (m), 2853 (w), 1776 (s), 1672 (s), 1616 (w), 1482 (w), 1462 
(w), 1394 (w), 1374 (w), 1355 (w), 1341 (w), 1318 (w), 1260 (w), 1223 (w), 1204 (w), 1188 (w), 
1159 (s), 1128 (w), 1092 (w), 1064 (w), 1022 (s), 950 (w), 908 (s), 872 (w), 855 (w), 845 (w), 809 
(m), 729 (s), 686 (w), 648 (w), 616 (w), 553 (w), 524 (w), 498 (w), 452 (w), 406 (w).  
HRMS (ESI): calcd for C20H21Br
79NaO3 [M+Na]
+: 411.0566 found: 490.0560.  
 
Synthesis of isosalimamonochloride (II.22) 
 
 
To a suspension of N-chlorosuccinimide (17 mg, 0.13 mmol, 2.0 equiv) and lactone II.19 (20 mg, 
64 µmol, 1 equiv) in dichloromethane (0.6 mL) at 0 °C was added trifluoroacetic acid (19 µL, 
0.26 mmol, 4.0 equiv). The mixture was stirred for 20 h at 25 °C and excess acid was quenched by 
addition of saturated aqueous sodium bicarbonate solution (2 mL) and saturated aqueous sodium 
thiosulfate solution (0.5 mL). The mixture was extracted with dichloromethane (3 × 5 ml). The 
combined organic extracts were dried over sodium sulfate, filtered and concentrated under reduced 
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pressure. Purification by flash column chromatography on silica gel (5% ethyl acetate in hexanes) 
afforded the title compound II.22 (5.6 mg, 25%) as colorless solid.  
 
TLC (50% ethyl acetate in cyclohexane): Rf: 0.50 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.11 (d, J = 8.3 Hz, 1H), 7.08 (d, J = 8.3 Hz, 1H), 5.99 (dd, J = 13.2, 
1.8 Hz, 1H), 5.65 (dd, J = 13.2, 1.7 Hz, 1H), 5.02 (dd, J = 8.0, 1.8 Hz, 1H), 4.37 (dd, J = 8.5, 1.8 
Hz, 1H), 4.22 (t, J = 8.3 Hz, 1H), 2.71 – 2.60 (m, 2H), 1.44 (s, 3H), 1.40 (s, 3H), 1.17 (s, 3H), 1.13 
(t, J = 7.5 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 191.94, 171.85, 147.54, 143.53, 141.03, 134.29, 129.59, 128.26, 
127.79, 124.52, 81.22, 57.74, 48.60, 44.12, 40.48, 29.09, 27.01, 23.39, 19.32, 13.78. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2975 (m), 2925 (m), 1775 (s), 1677 (s), 1618 (w), 1477 (w), 1463 (w), 1404 
(w), 1375 (w), 1356 (w), 1340 (w), 1261 (w), 1225 (w), 1184 (m), 1164 (m), 1129 (w), 1095 (w), 
1065 (w), 1025 (s), 910 (w), 876 (w), 849 (w), 829 (w), 808 (w), 733 (m), 677 (w), 649 (w), 473 
(w), 412 (w),  
HRMS (ESI): calcd for C20H21Cl
35NaO3 [M+Na]
+: 369.1071 found: 367.1067. 
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4.2 NMR spectra 
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